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Functionalized triarylmethanes were 
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The reaction of the dianion of 1,1,1-
trifluoro-pentane-2,4-dione with 
aldehydes and subsequent addition of 
hydrochloric acid afforded 2,3-dihydro-
6-trifluoromethyl-pyran-4-ones. 
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The Suzuki-Miyaura reaction of 
bis(triflate) of 2,4 
dihydroxybenzophenone with aryl 
boronic acids gave 2,4-
diarylbenzophenones. The reaction with 
one equivalent of arylboronic acids 
resulted in site-selective attack on less 
hindered carbon atom at C-4 and two 
different aryl groups were prepared by 
sequential addition of two different aryl 
boronic acids. 
 9  
 
CHAPTER 5                                 Page 43-47 
Synthesis of Bis(diaryl)sulfones by Site-Selective Suzuki-Miyaura Cross-Coupling 
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Suzuki-Miyaura reactions of the 
bis(triflate) of 2,4-
bis(hydroxy)diphenylsulfone with 
aryl boronic acids gave 2,4-
bis(aryl)diphenylsulfones. The 
reaction with one equivalent of 
arylboronic acids resulted in site-
selective attack onto carbon atom C-
4. 2,4-Diarylsulfones containing two 
different aryl groups were prepared 
by sequential addition of two 
different boronic acids.  
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Sonogashira cross-couplings 
of bis(triflate)  of 2,4-
bis(hydroxy)diphenylsulfone 
with terminal alkynes. This 
reaction displays remarkable 
compatibility with regard to 
the formation of 
symmetrical, unsymmetrical 
alkynyl-alkynyl and alkynyl-
aryl substitution. The first 
attack occurs on the less 
hindered C-4 carbon atom.  
 
 










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The Suzuki-Miyaura reaction of 2,3-
dibromo-1H-inden-1-one with one 
equivalent of arylboronic acid gave 
2-bromo-3-aryl-1H-inden-1-ones 
with very good regioselectivity and 
with two different arylboronic acids 
afforded 2,3-diaryl-1H-inden-1-ones 
containing two different terminal aryl 
groups in excellent yields.  
The Sonogashira cross-coupling of 
2,3-dibromo-1H-inden-1-one with 
terminal alkynes. This reaction gave 
us the formation of symmetrical, 
alkynyl-alkynyl, alkynyl-aryl 
substitution. The first attack occurs 
on the less hindered C-3 carbon 
atom.  

 








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Suzuki-Miyaura reactions of N- 
protected 3,4,5-tribromopyrazoles 
allowed a convenient synthesis of 
symmetrical and unsymmetrical 
monoaryl and triaryl pyrazoles by 
using the corresponding equivalents 
of aryl boronic acids. All reactions 
proceeded with excellent yields and 
site-selectivity. 
 
CHAPTER  9                                      Page 70-76 
Synthesis of Unsymmetrical Arylated Furans by Suzuki-Miyaura Cross Coupling and 
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Suzuki-Miyaura reactions of 
2,3,4,5-tetrabromofuran allowed a 
convenient synthesis of aryl-
substituted furans, such as 
symmetrical and unsymmetrical 
monoaryl, diaryl, and 
tetraarylfurans by using the 
corresponding equivalents of aryl 
boronic acids. Aryl-substituted  
furans are prepared which are not 
readily available by other methods. 
All reactions proceeded with 
excellent yields and site-selectivity. 
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1 Synthesis of Functionalized Triarylmethanes by Combination of FeCl3-
Catalyzed  Benzylations of Acetylacetone with [3+3] Cyclocondensations 
1.1 Introduction 
Triarylmethanes1 and 1,1-diphenylmethyl-salicylates are of considerable biological relevance 
as antibiotics and cytotoxic agents.2 Natural products containing a (1,1-
diphenylmethyl)phenol moiety include mohsenone, chamaechromone and other molecules.1a,b 
For example, derivatives A and B were isolated as natural products1 formed by metabolism of 
the dye phenol red (Figure 23). The triphenylmethanes C and D were isolated from the leaves 
of the cajeput tree Melaleuca quinqueneruia  (Myrtaceae).2a 
 
SO
O
O
HO
OH
SO
O
NH
HO
OH
OMe
MeO
MeO
OMe
OMe
MeO
Me
OMe
MeO
MeO
OMe
OMe
MeO
A
B
C D  
Figure 1. Triarylmethane natural products 
 
Di- and triarylmethanes have been prepared by Friedel–Crafts alkylations. This method is 
limited by the harsh reaction conditions and by the low regioselectivity. An interesting way to 
solve this was found by novel FeCl3·6H2O-catalyzed Friedel–Crafts type benzylations of 
arenes using simple benzylic alcohols under mild conditions and with high regio- and 
chemoselectivity.3a,b Likewise, FeCl3-catalyzed conjugate additions of 1,3-dicarbonyl 
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derivatives4 and reactions of 1,3-dicarbonyl compounds with benzylic alcohols have been 
reported.5,6 
In my Ph.D work, I have developed an approach to sterically encumbered, highly substituted 
triarylmethanes by combination of FeCl3-catalyzed condensations with [3+3] cyclizations of 
1,3-bis(trimethylsilyloxy)-1,3-dienes, developed by Chan et al.,7a,b 8a,b, 9 with 3-
trimethylsilyloxy-2-en-1-ones. In this chapter, I have discussed my research results related to 
the scope of this approach. Reaction conditions and methodology discussed in this chapter 
provided a straightforward way to a variety of FeCl3-catalyzed benzylation/[3+3] 
cyclocondensation reactions, which other methods did not provide readily. Recently, these 
results have been published.9 
 
1.2 Results and Discussion 

1.2.1 Synthesis of 1,3-Bis-Silyl Enol Ethers 

The synthesis of 1,3-bis(trimethylsilyloxy)-1,3-dienes, electroneutral 1,3-dicarbonyl dianion 
equivalents10a-b, 8b of type 3, was carried out according to a two step procedure described by 
Molander and Chan10a-b which was slightly varied.  
OR2
OSiMe3Me3SiO
R1
OSiMe3Me3SiO
R1
OR2
O
R1 OR2
O i ii
R1 = H, Alkyl, Alkoxy, Benzyloxy
R2 = Alkyl,
1 2 3
 
Scheme 1. Synthesis of silyl enol ethers of type 2 and 3. Conditions: i) Benzene, NEt3 (1.4 
equiv.) 30 min, then 1.4 eq. Me3SiCl, 20 °C, 3 d; ii) THF, (1.4 equiv.) LDA, –78°C, 2, 1 h, 
then 1.7 eq. Me3SiCl, –78  20 °C in 12-18 h. 
The alkylation of -dicarbonyl compounds represents one of the most important C–C bond 
formation methodologies in organic synthesis11. Addition of -dicarbonyl compounds to 
olefins results in a highly atom efficient protocol. In general, these transformations were 
performed by the reaction of alcohols12,5 or alkyl halides13 with -dicarbonyl compounds. In 
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case of alcohols, hydroxy group is a poor leaving group which necessitates its preactivation 
and which can be achieved using high temperature or by suitable promoter14. 

1.2.2 Synthesis of Mono-Silyl Enol Ethers  

Recently, many acid catalysts were employed to perform nucleophilic substitution of benzyl 
alcohols with active methylene compounds,12c whereas, the alkylation of -dicarbonyl 
compounds with alcohols was also explored with different types of acid catalysts.6a-d  
The FeCl36H2O-catalyzed benzylation of acetylacetone 4 with benzylalcohols 5a-e, following 
conditions reported by Beller et al.5 afforded products 6a-e in very good yields (Scheme 2, 
Table 1). The silylation of 6a-e afforded the 3-silyloxy-2-en-1-ones 7a-e.  
Me Me
O O
Me Me
O O
Me Me
Me3SiO O
i
i i
6a-e
4
R4R3
R4R3
R3
OH
R4
5a-e
7a-e
+
 
Scheme 2. Synthesis of 7a-e, i: FeCl36H2O, NO2CH3, 50 oC, 4 h; ii: Me3SiCl, NEt3, C6H6, 20 
°C, 72 h 








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Table 1. Synthesis of 6a-e and 7a-e 
5 R3 R4 % (6)a %(7)a 
a Ph Ph 91 90 
b 4-FC6H4 4-FC6H4 87 89 
c 4-ClC6H4 4-ClC6H4 85 92 
d Me 4-BrC6H4 95 90 
e Me 4-(MeO)C6H4 86 90 
 a Isolated yields 
1.2.3 Synthesis of di- and triarylmethanes (8a-n)  
The TiCl4-mediated formal [3+3] cyclocondensation of 7a-e with 1,3-bis(silyloxy)-1,3-dienes 
3a-f, available from the corresponding 1,3-dicarbonyl compounds in two steps,8 afforded the 
triarylmethanes 8a-n (Scheme 3, Table 2).  
 
OSiMe3Me3SiO
OR2
R1
Me Me
Me3SiO O
OH
OR2
O
MeMe
R13a-f
R3 R4
R3 R4
7a-e
8a-n
+
i
 
Scheme 3. Synthesis of 8a-n, Conditions: i): 7a-e (1.0 equiv.), 3a-f (1.1 equiv.), TiCl4, CH2Cl2, -
78 -20 oC, 12 h. 

The formation of 8a-n can be explained by the mechanism depicted in Figure 2. The yields 
depended on the type of substrate employed. The best yields were obtained for those products 
derived from diene 3a (prepared from benzyl acetoacetate) (Scheme 3, Table 2). The yields of 
triarylmethanes 8a-n were similar to the yields of mono-silyl enol ethers 7a-e (comparing the 
same type of diene and aryl group R4). The aryl groups seem to have no major influence on 
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the yield. During the optimization, it proved to be important to carry out the reactions in a 
highly concentrated solution.  

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Figure 2. Possible mechanism of the formation of 8a-n 
 






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
Table 2. Synthesis of di- and triarylmethanes 8a-n 
7 3 8 R3 R4 R1 R2 % (8)a 
a a a Ph Ph H PhCH2 65 
a b b Ph Ph nDec Me 57 
b a c 4-FC6H4 4-FC6H4 H PhCH2 68 
b c d 4-FC6H4 4-FC6H4 Me Et 39 
b d e 4-FC6H4 4-FC6H4 Et Me 41 
b e f 4-FC6H4 4-FC6H4 nBu Me 53 
b f g 4-FC6H4 4-FC6H4 nNon Me 53 
b b h 4-FC6H4 4-FC6H4 nDec Me 55 
c a i 4-ClC6H4 4-ClC6H4 H PhCH2 69 
c c j 4-ClC6H4 4-ClC6H4 Me Et 43 
c d k 4-ClC6H4 4-ClC6H4 Et Me 42 
c b l 4-ClC6H4 4-ClC6H4 nDec Me 57 
d a m Me 4-BrC6H4 H PhCH2 72 
e e n Me 4-(MeO)C6H4 Et Me 47 
a Isolated yields 
The structures of 8a-n were established by spectroscopic methods. The structures of 8d and 
8m were independently confirmed by X-ray crystal structure analyses (Figures 3,4). 
Triarylmethane 8d adopts a propeller-type structure, due to steric interaction of the aryl with 
the methyl groups.  
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Figure 3. Ortetp plot of 8d (50 % probability level) 
 
 
Figure 4. Ortetp plot of 8m (50 % probability level) 
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1.3 Conclusions 
In conclusion, I have synthesized a variety of functionalized and sterically encumbered 
triarylmethanes by combination of FeCl3-catalyzed benzylations of 1, 3-diketones and formal 
[3+3] cyclocondensation reactions. The products prepared and discussed in this chapter are 
not readily accessible by other available methods.  
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2 Cyclization versus Elimination Reactions of 5-Aryl-5-hydroxy-1,3-diones. 
One-pot Synthesis of 6-Aryl-2,3-dihydro-4H-pyran-4-ones 
 
2.1 Introduction 
2,3-Dihydro-4H-pyran-4-ones are of considerable pharmacological relevance and occur in a 
variety of natural products (e. g. curcumin, Figure 5).15 They have been prepared by hetero-
Diels–Alder reaction of electron-rich dienes with aldehydes.16-18 Catalytic variants have also 
been reported (using chiral Lewis acids or bases).19 Other syntheses rely on reactions of -
hydroxyenones20 and -ethoxy-,-unsaturated lactones.21 In addition, the LDA-mediated 
reaction of 3-methoxy-2-en-1-ones with aldehydes along with acid-mediated cyclization has 
been reported.22 Lithiated dithianes have also been reacted with epoxides to give the desired 
products.23  
In Peter Langer group, which have discovered the synthesis of diverse number of compounds 
by [3+3] cyclocondensation strategy by using Lewis acid TiCl4-mediated as a catalyst to form 
highly substituted compounds by the treatment of masked dianions24 (1,3-Bis-Silyl Enol 
Ethers) with mono-silyl enol Ethers. Due to this detailed study, The reaction of 6-aryl-2,3-
dihydro-4H-pyran-4-one with 1,3-silyloxy-1,3-butadiene by using TiCl4-mediated resulted in 
cleavage of pyranones moiety and the formation of highly functionalized benzene derivatives. 
O
O
MeO
HO
OMe
OH  
Curcumin 
    Figure 5. Structure of curcumin 
 
1,3-Dicarbonyl dianions have been reacted with aldehydes to give 5-hydroxy-1,3-dicarbonyl 
compounds which undergo HCl/MeOH-mediated dehydration or transformation into 2,3-
dihydro-4H-pyran-4-ones. Importantly, the natural product stegobinone has been prepared 
using this methodology.25 6-Alkyl-2,3-dihydro-4H-pyran-4-ones are available from 5-
hydroxy-1,3-diketones by action of para-toluenesulfonic acid (p-TsOH, CH2Cl2, 24 h, reflux, 
Dean-Stark trap, 3Å MS).26 However, this method is limited to 6-alkyl-2,3-dihydro-4H-pyran-
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4-ones. Dehydration (elimination of water) was observed in case of aromatic substrates. In 
fact, the reaction of p-TsOH with 6-hydroxy-6-phenyl-hexane-2,4-dione, prepared by 
condensation of the dianion of acetylacetone with benzaldehyde, has been reported to give 
(E)-6-phenylhex-5-ene-2,4-dione and not the desired pyran-4-one (Scheme 2).27 The facile 
formation of (E)-6-phenylhex-5-ene-2,4-dione might be a result of the conjugation of the 
double bond with the aryl group. Denmark et al. earlier reported the TFA-mediated 
transformation of 6-hydroxy-6-phenyl-hexane-2,4-dione into pyran-4-one (0.001 equiv. of 
TFA in CH2Cl2, 0 °C). Recently, the results of my efforts reported in this chapter have been 
published.28  
 
2.2 Results and Discussions 
 
Based on the initial work of my colleague Rasheed Ahmad, who established the methodology 
in the Langer group (Rasheed Ahmad, Ph.D thesis, 2009, University of Rostock), I extended 
the scope of this methodology by using different types of masked dianions of -diketones 
with LDA mediated and then treated with different types of aldhyde to get an intermediate 
such as 5-Aryl-5-hydroxy-1,3-dione which is then work-up with hydrochloric acid (10%) to 
get different substituted pyranones in good yields.  
 
The reaction of the dianions of acetylacetone 9a and benzoylacetone 9b with aldehydes 10a-l 
afforded the 6-aryl-2,3-dihydro-4H-pyran-4-ones 11a-o in very good yields (Scheme 4, Table 
3). The structures of all products were established by spectroscopic methods. The structures of 
11i and 11m were independently confirmed by X-ray crystal structure analysis (Figures 6 and 
7). 
i
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Scheme 4. Synthesis of 11a-o. Conditions: i) 1) LDA (2.5 equiv), THF, 0 °C, 1 h;  2) 78 oC, 
9a,b, 1h; 3) 10a-l, 78  20 °C, 12 h;  ii) addition of HCl (10%), 15 min, 20 °C, then 
extraction (EtOAc).  
 
Table 3. Synthesis of 11a-o 
9 10 11 R Ar %(11)a 
a a a Me 2-ClC6H4 65 
a b b Me 3-ClC6H4 70 
a c c Me 4-ClC6H4 76 
a d d Me 3-MeC6H4 76 
a e e Me 2,3-(MeO)2C6H4 73 
a f f Me 3-(HO)C6H4 67 
a g g Me 4-(NO2)C6H4 67 
a h h Me 2-Thienyl 82 
b i i Ph C6H5 78 
b a j Ph 2-ClC6H4 62 
b c k Ph 4-ClC6H4 66 
b j l Ph 2,4-(OMe)2C6H4 61 
b i m Ph 3-BrC6H4 71 
b k n Ph 3-(NO2)C6H4 68 
b l o Ph 4-(NO2)C6H4 67 
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 a Isolated yields 
 
Figure 6. Ortep plot of 11i (50% probability level) 
 
Figure 7. Ortep plot of 11m (50% probability level) 
 
The reaction of 2-(4-chlorophenyl)-6-methyl-2H-pyran-4(3H)-one (11c) with 1,3-
bis(trimethylsilyloxy)-1,3-diene 3d resulted in the formation of (E)-methyl 6-(4-chlorostyryl)-
3-ethyl-2-hydroxy-4-methylbenzoate 12 (Scheme 5, Figure 8). The reaction proceeded in 
good yield and with very good regioselectivity. Its formation can be explained by 
condensation, pyranone ring opening and following recyclization and aromatization. 
Unfortunately, the scope could not be extended to other dienes.  
The structure 12 was independently confirmed by X-ray crystal structure (Figure 8). 
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Scheme 5. Synthesis of 12, Conditions: i): 11c (1.0 equiv.), 3d (1.1 equiv.), TiCl4 (1.1 equiv.), 
CH2Cl2, -78 -20 oC, 12 h. 
 
 
 Figure 8. Ortep plot of 12 (50% probability level) 
 
2.3 Conclusion 

In conclusion, I have developed a convenient synthesis 6-aryl-2,3-dihydro-4H-pyran-4-ones 
by reaction of the dianion of pentane-2,4-dione and  1-phenylbutane-1,3-dione with aldehydes 
and subsequent addition of hydrochloric acid. The reaction of the dianion of acetylacetone 
with benzaldehydes gave the corresponding 2-aryl-2,3-dihydro-6-methyl-4H-pyran-4-ones. 
The TiCl4-mediated cyclization of a 6-aryl-2,3-dihydro-4H-pyran-4-one with 1,3-silyloxy-
1,3-butadiene resulted in ring opening of the pyranone moiety and formation of a highly 
functionalized benzene derivative. All reactions proceeded in very good yields and with very 
good regioselectivity. 
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3. Synthesis of Fluorinated 2,3-Dihydro-4H-pyran-4-ones by 
Cyclocondensation of 1,3-Dicarbonyl Dianions with Aldehydes 

3.1. Introduction 
Fluorinated compounds are relevant in medicinal and agricultural chemistry as they show 
very good bioavailability and metabolic stability29.  Examples of important fluorinated drugs 
include 5-fluorouracil (antineoplastic activity), ciprofloxacin and flurithromycin 
(antimicrobial activity), fluoxetine (prozac, antidepressant activity), and faslodex (antitumor 
activity), efavirenz (antiviral activity).30 Organofluorine molecules are also used as ligands31 
and as organocatalysts.32. The trifluoromethyl group is of great importance in this context. 
The high electron-withdrawing effect of the CF3 group, compared to the methyl group, results 
in a great difference in the physical properties. This effect plays an important role in drug–
receptor interactions. The lipophilicity of CF3-substituted molecules is often higher than the 
lipophilicity of their methyl-substituted analogues, which often results in an improvement of 
their in vivo transport. Unwanted metabolic pathways are often avoided, due to the high 
chemical and biological stability of the CF3 group. Therefore, CF3-substituted arenes and 
heterocycles play an increasingly important role in drug discovery. Trifluoromethyl- and 
perfluoroalkyl-substituted molecules show an excellent solubility in fluorophilic solvents. 
Therefore, CF3-substituted molecules have been used as ligands31 in catalytic processes in 
fluorous biphasic systems and supercritical carbon dioxide. It is worth to be mentioned that 
CF3-substituted arenes are present in many organocatalysts 32. 
I have synthesized for the first time, fluorinated 2,3-dihydropyran-4-ones by reaction of 
(either) the dianion of 1,1,1-trifluoro-pentane-2,4-dione with various aldehydes and (or the 
dianion of) acetylacetone with different fluorinated aldehydes.  
 
3.2 Results and Discussion 
The reaction of the dianion of commercially available 1,1,1-trifluoro-pentane-2,4-dione 13 
with aldehydes 10 and subsequent addition of hydrochloric acid (stirring for 15 min, then 
aqueous work-up) afforded the 2,3-dihydro-6-trifluoromethyl-pyran-4-ones 14a-j in good 
yields (Scheme 6, Table 4). The formation of the products can be explained as dicussed in 
Chapter 2. Aromatic, heterocyclic and aliphatic aldehydes could be successfully employed. 
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The yields of products derived from electron-poor aromatic aldehydes are lower than the 
yields of products derived from electron-rich aromatic aldehydes and from aliphatic 
aldehydes. 
CF3
OO
R H
O
R O
O
CF3
+
i , i i
13 10 14a-j  
Scheme 6. Synthesis of 14a-j. Conditions: i) 1) LDA (2.5 equiv), THF, 0 °C, 1 h;  2) 78 oC, 
1 h; 3) 2a-l , 78  20 °C, 12 h;  ii) HCl (10%), 15 min, 20 °C; 2) extraction (EtOAc). 
     Table 4. Synthesis of 14a-j 
13 10 14 R % (14)a 
a i a C6H5 80 
a a b 2-ClC6H4 62 
a c c 4-ClC6H4 72 
a k d 3-(NO2)C6H4 63 
a l e 4-(NO2)C6H4 60 
a m f 4-PhC6H4 81 
a h g 2-Thienyl 71 
a n h n-Hep 78 
a o i n-Oct 79 
a p j n-Non 83 
 a Isolated yields 
The reaction of the dianion of acetylacetone 9a with the fluorinated benzaldehydes 15a-f gave 
the 2-aryl-2,3-dihydro-6-methyl-pyran-4-ones 16a-f (Scheme 7, Table 5). Fluoro substituents 
 34
and trifluoromethyl groups at all positions of the phenyl ring were tolerated and the products 
were isolated in good yields. 
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Scheme 7. Synthesis of 16a-f. Conditions: i) 1) LDA (2.5 equiv), THF, 0 °C, 1 h;  2) 78 oC, 
4, 1 h; 3) 15a-f , 78  20 °C, 12 h;  ii): HCl (10%), 15 min, 20 °C, 2) extraction (EtOAc) 
 
Table 5. Synthesis of 18a-f 
15,16 R1 R2 R3 % (16)a 
a CF3 H H 73 
b Cl CF3 H 71 
c Cl H CF3 75 
d F H H 67 
e H F H 72 
f H H F 78 
a Isolated yields 
 
The structures of 16c was independently confirmed by X-ray crystal structure analysis (Figure 
9). 
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Figure 9. Ortep plot of 16c (50% probability level) 
 
3.3 Conclusion 
In conclusion, I have discussed the regioselective synthesis of fluorinated 2,3-dihydro-6-
trifluoromethyl-pyran-4-ones by reaction of the dianion of 1,1,1-trifluoro-pentane-2,4-dione 
with aldehydes and subsequent addition of hydrochloric acid. The reaction of the dianion of 
acetylacetone with fluorinated benzaldehydes gave the corresponding fluorinated 2-aryl-2,3-
dihydro-6-methyl-pyran-4-ones.  
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4 Synthesis of 2,4-Diarylbenzophenones by Site-Selective Suzuki-Miyaura 
Reactions of 2,4-Bis(trifluoromethylsulfonyloxy)benzophenone 
4.1 Introduction 
Sterically encumbered and functionalized benzophenones are of considerable 
pharmacological relevance and are present in various natural products.33 Examples include 
cynandione A (Figure 10).  
OOHOH O
O
O
OH
MeO OH
O OOH
HOR2
R1
 
                                 Cynandione A                Knipholone 
Figure 10. Structure of cynandion A and knipholone 
 
Also, aryl-substituted benzophenones have great pharmacological significance. Biological 
properties include, for example, cytotoxic and antibacterial activity,34 inhibition of various 
enzymes,35 and activity as selectin antagonists.36 Structurally associated benzoylfluorenones 
are also important in this context.37 knipholone has the center of 4-Arylbenzophenone in the 
structures of anthraquinones and tetracyclines.38 2-Hydroxy- and 2-aminobenzophenones are 
of importance in anticancer therapy.39 Functionalized benzophenones are also important as 
UV-filters (e. g., suncremes) and photosensitizers.40  
A classic approach to benzophenones relies on the Friedel-Crafts acylation.39,41 These 
acylations of highly substituted derivatives not always proceed with excellent regioselectivity. 
Benzophenones are obtainable also by reaction of organometallic reagents with aldehydes and 
subsequent oxidation. 
Regioselective palladium-catalyzed cross-coupling reactions are of current interest in organic 
chemistry.42 Recently, the Langer group reported the synthesis of 3,4-diarylbenzophenones 
based on site-selective Suzuki-Miyaura cross-coupling reactions of bis(triflates) of 3,4-
dihydroxybenzophenones43  
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I have developed the first regioselective palladium(0)-catalyzed cross-coupling reactions of 
the bis(triflate) of 2,4-dihydroxybenzophenone. The regioselective Suzuki-Miyaura and 
Sonogashira reactions of 2,4-bis(trifluoromethylsulfonyloxy)benzophenone and optimization 
of corresponding reaction conditions are described. Reaction conditions and methodology 
discussed in this chapter provided a straightforward way to a variety of alkynyl- and aryl 
substituted benzophenones, which other methods did not provide readily.  
 
4.2  Results and Disscussion 
 
The reaction of 2,4-dihydroxybenzophenone 17 with trifluoromethanesulfonic anhydride by 
using pyridine as a weak base in CH2Cl2 as a solvent at -78 C, 4h, resulted the formation of 
2,4-bis(trifluoromethylsulfonyloxy)benzophenone 18 in 84% yield (Scheme 8).  
O
i
O
17 18 (84%)
OH OTf
OTfOH
 
Scheme 8. Synthesis of 18. Reagents and conditions: i) CH2Cl2, 17 (1.0 equiv), -78C, 
pyridine (4.0 equiv), Tf2O (2.4 equiv), -78 0C, 4 h. 
 
The Suzuki-Miyaura reaction of 18 with aryl boronic acids 19a-d (2.2 equiv.) afforded the 
formation of 2,4-diarylbenzophenones 20a-d in good yields (Scheme 9, Table 6). 
Optimization reaction using Pd(PPh3)2Cl2 (6 mol-%) with 2.2 equiv. of arylboronic acid did 
not work satisfactorily in terms of yields.  
However, when Pd(PPh3)4 (6 mol-%) was used as a catalyst with (2.2 equiv.) of arylboronic 
acid in 1,4-dioxane (reflux, 4 h) using the inorganic base K3PO4 as the base, the yield was 
good to excellent (Scheme 9, Table 6). The structures of all products were established by 
spectroscopic methods.  
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Scheme 9. Synthesis of 20a-d. Reagents and conditions: i) 18 (1.0 equiv.), 19a-d (2.6 equiv.), 
K3PO4 (3.0 equiv.), Pd(PPh3)4 (6 mol-%), 1,4-dioxane (5 mL per 1 mmol of 2),  110 C, 4 h 
Table 6. Synthesis of 20a-d 
19,20 Ar % (20) a
a  C6H5 82 
b  4-MeC6H4  84 
c  3-ClC6H4  75 
d  4-(OMe)C6H4  71 
                                                    a Yields of isolated products 
 
The Suzuki-Miyaura reaction of 18 with (1.1 equiv.) of boronic acids 19b-c,e-j in the 
presence of Pd(PPh3)4 (3 mol-%) as a catalyst, proceeded with very good regioselectivity 
(first attack at carbon atom C-4) to give the monoaryl benzophenones 21a-i (Scheme 10, 
Table 7). In some cases, a small amount of bis-coupled products could be detected in the 
crude product (by 1H NMR and GC-MS). The pure mono-coupled products were obtained 
after chromatographic purification.  
The reaction of 21a,e-f with 4-methoxyphenyl boronic acid (19d, 1.1 equiv.) gave the aryl 
substituted benzophenones 22a-d which have two different aryl substituents at the positions 2 
and 4 (Scheme 10, Table 7). 
 
 
 
 39  
ArB(OH)2
19d
OTf
i
O
18 21a-j
O
Ar
OTf OTf O
Ar
Ar1
22a-d
Ar1B(OH)2
ii
19b-j
 
Scheme 10. Synthesis of 21a-i and 22a-d. Reagents and conditions: i) 18 (1.0 equiv), 19b-
c,e-j (1.1 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol %), 1,4-dioxane, 90 C, 4 h; ii) 21a,e-f 
(1.0 equiv), 19d (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol%), 1,4-dioxane, 90 C, 4 h. 
 
Table 7. Synthesis of 21a-i, 22a-d 
19 Ar 21 %(21)a Ar1 22 %(22)a 
b, d 4-MeC6H5 a 73 4-(MeO)C6H5 a 70 
e 4-EtC6H5 b 75 - - - 
f 3,4-Me2C6H5 c 68 - - - 
g 3,5-Me2C6H5 d 67 - - - 
h, d 4-tBuC6H5 e 76 4-(MeO)C6H5 e 71 
c, d 3-ClC6H5 f 65 4-(MeO)C6H5 f 62 
j 3-(MeO)C6H5 g 64 - - - 
d 4-(MeO)C6H5 h 63 - - - 
k 3,4,5-
(MeO)3C6H5 
i 58 - - - 
 a Yields of isolated products 
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Scheme 11. Synthesis of 24a-d.  Reagents and conditions: i) 18 (1.0 equiv), 23a-d (2.2 
equiv.), dry CuI (10%), Pd(PPh3)2Cl2 (6-mol%), Et3N (1.25 equiv), DMF, 90 C, 4 h. 
 
The double Sonogashira reactions of 2,4-bis(trifluoromethylsulfonyloxy)benzophenone (18), 
were accomplished using the catalyst Pd(PPh3)2Cl2 (6-mol%), the terminal alkynes (2.2 
equiv.), CuI (20 mol%), and Bu4NI (15 mol%) in DMF. All reactions proceed with good 
yields (Scheme 11, Table 18).  
 
Table 8. Synthesis of 24a-d 
 23 R 24 %(24)a 
a C6H5 a 78 
b 3-MeC6H4 b 71 
c 4-MeC6H4 c 75 
d n-Oct d 74 
 a Yields of isolated products 
To accomplish the regioselective Sonogashira reactions with 2,4-
bis(trifluoromethylsulfonyloxy)benzophenone (18), I attempted to optimize the reaction 
conditions by changing reaction temperature, reaction time, base, solvent, and amount of 
alkynes. The best yields for the mono-Sonogashira reactions were obtained when 
Pd(PPh3)2Cl2 (3-mol%) was the catalyst, when 1.1 equivalents of the terminal alkyne was 
used and when CuI (10 mol%), Bu4NI (15 mol%) in DMF were used.  
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Scheme 12. Synthesis of 25a-c and 26c. Reagents and conditions: i) 18 (1.0 equiv), 23a-c 
(1.1 equiv), dry CuI (10%), Pd(PPh3)2Cl2 (3%), Et3N (1.25 equiv), DMF, 90 C, 8 h. ii) 25c 
(1.0 equiv), 4-tert-butylphenylboronic acid (1.3 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 
mol%), 1,4-dioxane, 90 C, 4 h. 
Table 9. Synthesis of 25a-c, 26c 
23 R (25) %(25)a 19 26 Ar %(26)a 
e n-propyl a 78 - - - - 
d n-octyl b 81 - - - - 
f 4-(MeO)C6H4 c 68 d c 4-tBuC6H4 73 
a Yields of isolated products 
The mono-Sonogashira product 25c was treated with 4-tert-butylphenylboronic acid (1.2 
equiv), in the presence of K3PO4 (1.5 equiv) and Pd(PPh3)4 (3 mol%) in 1,4-dioxane at 
temperature 90 C, to give 26c in good yield (73%).  
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Figure 11. Ortep plot of 25c (50% probability level) 
The structure of 25c was independently confirmed by X-ray crystal structure  
 
4.3 Conclusion 
In conclusion, a versatile and inexpensive optimized reaction conditions for the synthesis of 
functionalized benzophenones by Suzuki-Miyaura reactions and Sonogashira reactions of the 
bis(triflate) of 2,4-dihydroxybenzophenone. The reaction with one equivalent of arylboronic 
acids resulted in a regioselective attack onto carbon atom C-4. Furthermore the same strategy 
was used successfully for Sonogashira which worked well from good to excellent yields. A 
Combination of Sonogashira and Suzuki reaction was also investigated in good yield. 
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5 Synthesis of Bis(diaryl)sulfones by Site-Selective Suzuki-Miyaura and 
Sonogashira Cross-Coupling Reactions of 2,4-
Bis(trifluoromethylsulfonyloxy)diphenylsulfone 

5.1 Introduction  

Diarylsulfones are of considerable pharmacological importance and occur in many natural 
products.44 They have been prepared by oxidation of diaryl sulfides45 and by Friedel-Crafts-
type acylations.46 These methods suffer from low yields, harsh reaction conditions and low 
regioselectivities. Diaryl sulfones have also been prepared by CuI/proline-mediated reaction 
of aryl iodides with sodium benzenesulfinate and by Suzuki reactions of 4-
methoxyphenylboronic acid with benzenesulfonic acid chloride.47 In addition, Cu(OAc)2-
catalyzed reactions48 of sodium benzenesulfinate with 4-methoxyphenylboronic acid have 
been reported.49 The Langer group reported the synthesis of diaryl sulfones by cyclizations of 
sulfone-containing building blocks.50  
 
5.2 Results and Discussions 

The project reported in this chapter was started by my colleague Mr. Asad Ali (Ph.D thesis, 
submitted, University of Rostock, 2010). He studied the synthesis of bis-triflate 28 and its 
Suzuki reactions with 2 equivalents of boronic acids resulting in a double-coupling. I have 
studied in my thesis regioselective transformations of 28. Recently, first results have been 
published.51 
The reaction of 2,4'-sulfonyldiphenol 27 with trifluoromethanesulfonic anhydride by using 
pyridine as a weak base in CH2Cl2 as a solvent at -78 C, 4h, resulted the formation of 2,4-
bis(trifluoromethylsulfonyloxy)benzophenone 28 in 81% yield (Scheme 13).  

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Scheme 13. Synthesis of 28. Reagents and conditions: i) CH2Cl2, 27 (1.0 equiv), -78 C, 
pyridine (4.0 equiv), Tf2O (2.4 equiv), -78  0 C, 4 h. 
The Suzuki reaction of bis(trifluoromethylsulfonyloxy)diphenylsulfone 28 with arylboronic 
acids 19a-d (1.1 equiv.) and (2.2 equiv.) afforded the mono- and di-substituted products, 
respectively. For electron rich and also for electron deficient arylboronic acids, the 
monoarylated products 29a-d could be isolated in good yields (Scheme 14 and Table 10). The 
best yields were obtained when the reactions were carried out by using Pd(PPh3)4 (6 mol %) 
as a catalyst and the inorganic base K3PO4 in dioxane. The employment of other catalysts, 
such as Pd(OAc)2/XPhos, Pd(OAc)2/SPhos resulted in a decreased yield. 
 
PCy2
OMe
Cy = Cyclohexyl
MeOXPhos =
PCy2
iPriPr
iPr
SPhos =

Figure 12: Buchwald ligands 
In conclusion, the use of Pd(PPh3)4 (6 mol-%) as the catalyst for mono- and cross-Suzuki 
reactions of bis(trifluoromethylsulfonyloxy)diphenylsulfone using the inorganic base K3PO4  
are given in (Scheme 14 and Table 10). 
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Scheme 14. Synthesis of 29a-d. Reagents and conditions: i) 28 (1.0 equiv), 19b,d,e,h (1.1 
equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol-%), 1,4-dioxane (5 mL per 1 mmol of 28), 110 
C, 4 h. 
 
Table 10. Synthesis of 29a-d 
19 29 Ar % (29)a 
b a 4-MeC6H4 77 
e b 4-EtC6H4 81 
h c 4-tBuC6H4 83 
d d 4-(MeO)C6H4 74 
a Yields of isolated products 

The structures of the products were proved by 2D NMR experiments (NOESY, HMBC).  
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Figure 13: 2D NMR correlations (NOESY and HMBC) of 29b 
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The structure of compound 29b was confirmed by 2D NMR spectroscopy (Figure 13). 
Assignments of chemical shifts of C and H were done with the help of 1H NMR, HMQC and 
COSY. The NOESY correlation between CH2 & H-5, H-5 & H-6 and H-5 and H-6 
provided the information that the aryl group is connected to carbon C-4. The structure was 
further confirmed by the HMBC extensive correlations of H-6 to C-1 and H-6 to C-4 and 
from the other ring H-5 to C-1. These careful and clear correlations proved unambiguously 
the connectivity of the first aryl group to C-4. 
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Scheme 15. Synthesis of 30a-e. Reagents and conditions: i) 29a,c (1.0 equiv), 19a-b,d,e,k-l 
(1.1 equiv), K3PO4 (1.5 equiv), Pd(PPh3)4 (3 mol-%), 1,4-dioxane, 110 C, 4 h. 
The Suzuki-Miyaura reaction of 29a and 29c with aryl boronic acids 19a-b,d-e,k-l (1.1 
equiv.) gave the unsymmetrical 2,4-bis(aryl)diphenylsulfones 30a-e containing two different 
aryl groups (Scheme 15, Table 11). 

Table 11. Synthesis of 30a-e 
29 19 Ar1 30 % (30)a 
a a C6H5 a 86 
a e 4-EtC6H4 b 91 
a d 4-(MeO)C6H4 c 73 
a l 4-(CF3)C6H4 d 81 
c b 4-MeC6H4 e 87 
a Yields of isolated products 
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5.3 Conclusions 
The Suzuki-Miyaura reaction of the bis(triflate) of 2,4-bis(hydroxy)diphenylsulfone with two 
equivalents of aryl boronic acids gave 2,4-bis(aryl)diphenylsulfones. The reaction with one 
equivalent of arylboronic acids resulted in site-selective attack onto carbon atom C-4. The 
first attack occured on sterically less hindered position due to electronic reasons.  
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6 Site-Selective Sonogashira Reactions of 2,4-Bis 
(trifluoromethylsulfonyloxy)diphenylsulfone 

6.1 Introduction 
The discovery of strong pharmacological importance such as antifungal agents52 and novel 
powerful antitumor antibiotics53 has motivated intense interest in the chemistry of enynes54, 
which is at the source of biological properties of these substances. The conjugated enynes are 
also important synthetic intermediates since the conjugated enyne moiety can be with good 
grace converted into the corresponding enynes system in a regioselective manner 55. Recently, 
Takahashi et al. described the formation of highly substituted enynes by coupling reaction of 
alkenylzirconium compounds with alkynyl halides56. Gimeno et al. reported the 
stereoselective synthesis of chiral terminal (E)-1,3-enynes derived from optically active 
aldehydes57. The synthesis of enynes containing functional groups is also of considerable 
interest in recent years. The stereoselective synthesis of 1,3-enynylsulfides58, 1,3-
enynylselenides59, 1,3-enynyltellurides60, 1,3-enynylsilanes61, 1,3-enynylstannanes62 and 
fluoro or CF3-substituted 1,3-enynes63 has previously been described in the literature. 
However, the synthesis of enynylsulfones has received less attention64 and enynylsulfones 
have, to the best of my knowledge, not been reported so far. The transition metal-catalyzed 
cross-coupling reaction is a highly multipurpose method for carbon–carbon bond formation 
and has been widely used as synthetic tool65. The palladium-catalyzed coupling reaction of 
alkenyl halides with terminal alkynes (Sonogashira reaction) provides a direct approach to 
1,3-enynes.66 I synthesized mono- and dialkynylated as well as aryl substituted 
diphenylsulfones with very good site-selectivity 
6.2 Results and discussions 
Based on the results shown in chapter 5 for Suzuki reactions, I was also interested to see the 
regioselectivity in Sonogashira reactions.  
The Sonogashira reaction of 28 with (2.2 equiv.) of aliphatic and aromatic terminal alkynes 
23a,c,d-f proceeded to the formation of dialkynylated products 31a-e in good to excellent 
yields (Scheme 16, Table 12). 
The reactions were carried out by using a pressure tube (glass bomb) and a suspension of 
Pd(PPh3)2Cl2 (2.5-5.0 mol%), 30 (258 mg, 0.5 mmol), alkyne (0.50-1.10 mmol), (Bu)4NI (27 
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mg, 15 mol%), CuI (10 mol%), and Et3N (0.62-1.25 mmol) in DMF (5 mL). The reaction 
mixture was stirred at 60 °C for 2-4 h. The product was purified by flash chromatography and 
isolated in excellent yield. 
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Scheme 16. Synthesis of 31a-e. Reagents and conditions: i) 30 (1.0 equiv), 23a,c-f (2.2 
equiv), (Bu)4NI (15 mol %), CuI (10 mol%), Pd(PPh3)2Cl2 (5 mol %), Et3N (2.5 equiv), DMF, 
80 °C, 4 h.  
 
Table 12 Synthesis of 31a-e 
23  31 R % (31)a 
a a C6H5 88 
c b 4-MeC6H4 92 
e c n-propyl 85 
d d n-pentyl 88 
f e n-octyl 90 
   a Yields of isolated products 
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Figure 14. Ortep plot of 31b (50% probability level) 
            
The structures of 31c was independently confirmed by X-ray crystal structure (Figure 14). 
The Sonogashira-coupling reaction of 28 with alkynes (1.0 equiv.) and Pd(PPh3)2Cl2 (2.5 mol- 
%) resulted in the formation of monoalkynyl substituted diarylsulfones 32a-e (Scheme 18, 
Table 13). During the optimization, it proved to be important to use exactly 1.0 equiv. of 
terminal alkyne and to carry out the reaction at 60 °C (2 h) instead of 80 °C (8 h). Both 
aliphatic and aromatic terminal acetylenes gave the products which were isolated in good to 
excellent yields. During optimization, the use of Pd(PPh3)4 resulted in considerable amount of 
dimerization of alkynes and regioselectivity was low giving a mixture of products. In case of 
ligand-free Pd(OAc)2-catalysis, no products were found but all the starting material was 
recovered. In case of Cu-free reaction conditions, a total decomposition of the starting 
material was observed. Finally, Pd(PPh3)2Cl2 gave fast and selective reactions. A catalyst 
loading of as low as 3 mol-% for twofold Sonogashira reaction was possible with slight 
decrease in yield. Both aliphatic and aromatic terminal alkynes were suitable starting 
materials for this reaction. Mono-alkynyl sulfones were used to prepare alkynyl- and aryl-
substituted sulfones as well. 

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Scheme 17. Synthesis of 32a-e. Reagents and conditions: i) 28 (1.0 equiv), 23a,c-d,f-g (1.0 
equiv), (Bu)4NI (15 mol %), CuI (10 mol%), Pd(PPh3)2Cl2 (2.5 mol %), Et3N (1.25 equiv), 
DMF, 60 °C, 1h. 
Table 13. Synthesis of 32a-e 
23  32 R %(32)a 
a a 3-MeC6H4  75 
c b 4-MeC6H4  83 
g c 4-tBuC6H4  88 
d d (CH2)4C6H4 86 
f e n-octyl 91 
a Yields of isolated products 
The cross Sonogashira-coupling reaction of monoalkynyl substituted diaryl sulfones 32d,e 
with terminal alkynes (1.0 equiv.), in the presence of Pd(PPh3)2Cl2 (2.5 mol-%), CuI (10 
mol%), (Bu)4NI (15 mol %), Et3N (2.5 equiv) (DMF, 80 °C, 4h), gave products 33a-c in good 
yields (83-89%), (Scheme 18, Table 14).  
 
 
S
O
O
OTf R2i
32d,e 33a-c
S
O
O
R2 R1
23a,e,g
R1
 
 52
Scheme 18. Synthesis of 33a-c. Reagents and conditions: i) 32 (1.0 equiv), 23a,e,g (1.0 
equiv), (Bu)4NI (15 mol %), CuI (10 mol%), Pd(PPh3)2Cl2 (2.5 mol %), Et3N (2.50 equiv), 
DMF, 60 °C, 2 h.  
 
Table 14. Synthesis of 33a-c 
33 23 R2 %(33)a 
a e (CH2)2CH3 87 
b a C6H5 83 
c g 4-tBuC6H4 79 
a Yields of isolated products 
The Suzuki-Miyaura reaction of 32b,e with arylboronic acids 19a,d,e,,h,k, in the presence of 
Pd(PPh3)4 and K3PO4, gave us the substituted alkynyl-aryl sulfones 34a-e (Scheme 19). All 
these reactions resulted in good yields (80-91%) (Scheme 19, Table 15). 
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Scheme 19. Synthesis of 34a-e. Reagents and conditions: i) 31 (1.0 equiv), ArB(OH)2 (1.1 
equiv), Pd(PPh3)4 (2.5 mol %),  K3PO4 (1.5 equiv), Dioxane, 100 °C, 6 h. 
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Table 15. Synthesis of 34a-e 
 19 31 34 R Ar %(34)a 
a e a (CH2)7CH3 C6H5 88 
e e b (CH2)7CH3 4-EtC6H4 91 
l e c (CH2)7CH3 4-(CF3)C6H4 85 
h b d 4-MeC6H4 4-tBuC6H4 91 
d b e 4-MeC6H4 4-(MeO)C6H4 80 
   a Yields of isolated products 
For 2-(4-(dec-1-ynyl)phenylsulfonyl)-4'-(trifluoromethyl)biphenyl 34c, the connectivity was 
established on the basis of 2D NMR. Besides HMQC and COSY, in 13C NMR JC,F coupling 
constants helped to differentiate the 4-(trifluoromethyl)benzene C and CH atoms. Aliphatic 
CH2 (t,  2.33) connected to acetylenic quarternary carbon ( 95.2) showed HMBC 
correlation with acetylenic C-1 ( 79.3), phenyl C-4`` ( 129.2) and CH-3``/5`` ( 131.4). In 
aromatic region H-3``/5`` ( 7.10) showed connectivity to aliphatic CH2 ( 19.1) and C-4`` ( 
129.1) to show that 1-decyne is connected to C-4``. Furthermore the NOESY correlation of 
H-6` ( 7.41) to H-6 verified the connectivity of 4-(trifluoromethyl)benzene to C-1. So by 2D 
NMR assignments it is recognized explicitly that 1-decyne connectivity is connected to C-4`` 
and 4-(trifluoromethyl)benzene is linked with C-1 (Figure 15). 
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Figure 15: 2D NMR correlations (HMQC and HMBC) of 34c 
 
6.3 Conclusion 
In conclusion, I have developed site-selective Sonogashira reactions of 2-(4-
(trifluoromethylsulfonyloxy)diphenylsulfone. As a result, functionalized sulfones were 
prepared by sequential Sonogashira–Sonogashira and Sonogashira–Suzuki reactions. 










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7. One-Pot Synthesis of 2,3-Diarylindenones by Site-Selective Suzuki-
Miyaura/Sonogashira coupling Reactions Reactions of 2,3-
Dibromoindenone 
7.1 Introduction 
2,3-Diaryl-1H-inden-1-ones are of considerable pharmacological relevance.67 They are 
available, for example, by intramolecular Friedel-Crafts acylation reactions.68 2,3-Diaryl-1H-
inden-1-ones have also been prepared from dibenzoylmethane69 and benzophenone 
derivatives.70 Recent transition metal-catalyzed syntheses of 2,3-diaryl-1H-inden-1-ones 
include the reaction of 1-methoxy-4-(4'-methoxyphenylethynyl)-benzene with 2-
bromobenzaldehyde,71 and the reaction of diphenyl acetylene with 2-bromophenylboronic 
acid.72 
As already mentioned above, a number of site-selective palladium(0)-catalyzed cross-
coupling reactions of polyhalogenated heterocycles have been developed. The site-selectivity 
of these reactions is generally influenced by electronic and steric parameters.73 We have 
reported site-selective Suzuki-Miyaura reactions of tetrabrominated thiophene, N-
methylpyrrole, selenophene, and of other polyhalogenated arenes and hetarenes.74 
It occurred to us that 2,3-dibromo-1H-inden-1-one might be a suitable starting material for 
such reactions. The reactions of 2,3-dibromo-1H-inden-1-one with amines and C-
nucleophiles, such as Grignard reagents, ethyl cyanoacetate and ethyl acetoacetate, are 
already known for a long time.75 Transition metal-catalyzed cross-coupling reactions of 2,3-
dibromo-1H-inden-1-one have not been reported so far. In this chapter, I report my results 
related to Suzuki and Sonogashira reactions of this substrate.  
7.2 Results and Discussion 
2,3-Dibromo-1H-inden-1-one 35 was transformed into 3-aryl-2-bromo-1H-inden-1-ones and 
2,3-diaryl-1H-inden-1-ones in excellent yields, depending of the amount of the introduced 
boronic acid. The best yields were obtained when the reactions were carried out by using 
Pd(PPh3)4 (3 mol%) as catalyst and the inorganic base K2CO3 (dioxane, 45 °C, 4 h). 
The employment of other catalysts, such as Pd(PPh3)2Cl2, Pd(OAc)2/XPhos, Pd(OAc)2/SPhos 
resulted in a decreased yield and/ or regioselectivity 
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Scheme 20. Synthesis of 36a-c. Conditions: i) 35 (1.0 equiv.), 19d-e,h,l (1.0 equiv.), 
Pd(PPh3)4 (3 mol-%), 2M K2CO3, dioxane, 45 °C, 4 h. 
The S-M reaction of 35 with arylboronic acids 19d,e,h,k (1.0 equiv.) afforded the 3-aryl-2-
bromo-1H-inden-1-ones 36a-d in excellent yields and with very good site-selectivity (Scheme 
20, Table 16). The first attack occurred at position 3 of 1 in 2,3-Dibromoindenone. During the 
optimization it proved to be very important to use exactly 1.0 equiv. of the arylboronic acid 
and Pd(PPh3)4 (3 mol-%) as catalyst. The temperature played an important role. A good 
selectivity was achieved only when the reaction was carried out at 45 °C because the second 
cross-coupling was slow at this temperature. The formation of a mixture of starting material, 
mono- and di-substituted products was generally observed when the reaction was carried out 
at temperatures between 45 and 70 °C. In the case of the highly reactive methoxy-substituted 
arylboronic acid the temperature had to be further decreased to 40 °C to achieve a good site-
selectivity. The reactions were successful for both donor and acceptor substituted arylboronic 
acids. 

Table 16. Synthesis of 3-aryl-2-bromoinden-1-ones 36a-d 
36 19 Ar % (36)a 
a e 4-EtC6H4 93 
b h 4-tBuC6H4 89 
c l 4-(CF3)C6H4 88  
d d 4-(MeO)C6H4 85 
a Yields of isolated products; b reaction temperature: 40 °C 
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Scheme 21. Synthesis of 37a-c. Conditions: i) 36 (1.0 equiv.), 19a,d,e (1.0 equiv.), Pd(PPh3)4 
(3 mol-%), 2M K2CO3, dioxane, at70 °C, 6 h. 

The reaction of 36a,b,d with different arylboronic acids, which were sequentially added, 
afforded the 2,3-diaryl-1H-inden-1-ones 37a-c containing two different aryl groups (Scheme 
21, Table 17). During the optimization, it proved to be important that the first step was carried 
out at 45 °C (or at 40 °C in case of 36d) to achieve a good site-selectivity in favour of position 
3 of the substrate. The second step had to been carried out at 70 °C to guarantee a complete 
reaction of position 2. All reactions proceeded in excellent yields. The structure of 37c was 
independently confirmed by X-ray crystal structure analyses (Figure 16). 

Table 17. Synthesis of 37a-c 
19 36 37 Ar Ar1 % (37) a 
d a a 4-EtC6H4 4-(MeO)C6H4 93 
a b b 4-(CF3)C6H4 C6H5 87 
e d c 4-(MeO)C6H4 4EtC6H4 86 
 a Yields of isolated products 
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Figure 16. Ortetp plot of 37b (50 % probability level) 
 
The site-selective formation of 36a-d and 37a-c can be explained by electronic reasons. The 
first attack of palladium(0) catalyzed cross-coupling reactions (oxidative addition step) 
generally occurs at the more electron deficient and sterically less hindered position.74,78 
Position 3 of 2,3-dibromo-1H-inden-1-one 35 is considerably more electron-deficient than 
position 2 (Figure 17). Handy and Zhang reported a simple guide for the prediction of the site-
selectivity of palladium (0) catalyzed cross-coupling reactions of polyhalogenated substrates 
based on the 1H NMR chemical shift values of the non-halogenated analogues.78 In fact; the 
1H NMR signal of proton H-3 of inden-1-one is shifted downfield compared to proton H-2. 
Less electron deficient
More electron deficient
O
Br
Br
35  
Figure 17. Possible explanation for the site-selectivity of cross-coupling reactions of 35. 
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Scheme 22. Synthesis of 38a-f. Reagents and conditions: i, 36 a,c,d (1.0 equiv), alkynes (1.0 
equiv), (iPr)2NH (1.5 equiv), CuI (10 mol%), Pd(PPh3)2Cl2 (3 mol %), at room temperature, 
2h.  
In prolongation of our research work, Sonogashira coupling products 39a-f were prepared in 
high yields from 36a,c,d and the terminal alkynes 23a,g,f using Pd(PPh3)2Cl2 (5 mol %) as 
catalyst as well as CuI and (iPr)2NH. The structures of compounds 39a-f were confirmed by 
spectroscopy. The aliphatic alkynes gave better yields than aromatic alkynes. 
 
    Table 18. Synthesis of 39a-f 
38 36 23 R2 % (38)a 
a a a C6H5 85 
b c a C6H5 88 
c d g 4-tBuC6H4 80 
d c f n-Oct. 89 
e d h C11H9O 78 
 a Yields of isolated products 
 
In addition, I also successfully carried out dialkynylations (products 39) by Sonogashira 
couplings (Scheme 23, Table 19). All reactions proceeded in high yields. 
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Scheme 23. Synthesis of 39a-d . Reagents and conditions: i) 35 (1.0 equiv), alkynes (2.2 
equiv), (iPr)2NH (1.5 equiv), CuI (20 mol%), Pd(PPh3)2Cl2 (15 mol %), at room temperature, 
2 h. 
 
Table 19. Synthesis of 39a-d 
39 23 R % (39)a 
a a C6H5  89 
b c 4-MeC6H4 93 
c g 4-tBuC6H4 94 
d f (CH2)7CH3 92 
  a Yields of isolated products 
 
7.3 Conclusion 
In conclusion, I developed an efficient method for site-selective Suzuki-Miyaura reactions of 
2,3-dibromo-1H-inden-1-one which provide a convenient approach to 2,3-diaryl-1H-inden-1-
ones and 3-aryl-2-bromo-1H-inden-1-ones. The scope and applications of the methodology 
outlined herein are currently studied in our laboratories by my colleague Mr. Hung Nguyen 
(Ph.D thesis in preparation). Site-selective Suzuki reactions combined with Sonogashira 
couplings were also developed.  



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8. Synthesis of Arylated Pyrazoles by Site-Selective Suzuki-Miyaura 
Reactions of Tribromopyrazoles 

8.1 Introduction 

Pyrazoles are common building blocks in material42, agricultural and pharmaceutical76 
sciences. Pyrazole derivatives, specifically 1-phenylpyrazole derivatives, are known to have a 
broad spectrum of biological activities. For example, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl) 
benzensulfonamide (sulfaphenazole) derived from 5-amino-1-phenylpyrazole is a potent 
antibacterial drug77, while 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPD) 
has been identified as a positive allosteric metabotropic modulator of the glutamate receptor 
(Figure 16)78. Nonsteroidal anti-inflammatory drugs such as Lonazolac are (1,3-diphenyl-1H-
pyrazol-4-yl)acetic acid derivatives (Figure 18)79. The anti-inflammatory activity is also 
typical for (1,4-diphenylpyrazol-3-yl)acetic acid and related compounds.80                      
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Lonazolac                      Celecoxib 
Figure 18. Some pharmaceuticals bearing the N-phenylpyrazole moiety. 

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Pyrazoles containing heterocyclic moieties such as pyrimidine, 1,3,4-oxadiazole or 1,2,4-
triazole81 have been tested for their antimicrobial, antifungal, and antiviral activities82. 4-
Alkyl-1,2,5-tris(4-hydroxyphenyl)pyrazoles have been studied as estrogen receptor-selective 
agonists83. Many methods have been described in the literature for the synthesis of 
symmetrical substituted pyrazoles.84 However, in the case of unsymmetrical pyrazoles, these 
routes85 often face a problem of regioselectivity because pyrazole can act as an ambident 
nucleophile85. In order to develop an efficient synthetic approach, we chose to explore the 
palladium-catalyzed coupling reactions for incorporating the desired substituents to the fully 
assembled core. There have been several literature reports on palladium-catalyzed cross-
coupling reactions of halo- and pseudohalo-substituted pyrazoles. Most of these studies report 
the Suzuki cross-couplings with arylboronic acids86. Suzuki reactions of tribrominated 
pyrazoles have, to my knowledge, not yet been reported. 
My colleague Mr. Asad Ali started in the Langer group a project related to Suzuki-Miyaura 
reactions of tribrominated pyrazoles (Asad Ali, Ph.D thesis, University of Rostock, 2010). He 
studied N-benzyl- and N-vinyl derivatives in these reactions. In this chapter, I have discussed 
my results related to Suzuki-Miyaura reactions of tribrominated pyrazole containing a methyl 
group attached to the nitrogen. The products, monoaryl- and triaryl-pyrazoles, were prepared 
in good to excellent yields. The methodology discussed in this chapter provided a 
straightforward way to a variety of aryl-substituted pyrazoles which other methods did not 
provide readily.  
 
8.2 Results and discussion 
N-Benzyl-tribromopyrazole 41 and N-methyl-tribromopyrazole 42 were prepared from 
commercially available tribromopyrazole by a known procedure (Scheme 25). Instead of 
benzylchloride, which was used in the original procedure for the preparation of 41, 
benzylbromide was employed.  



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Scheme 24. Synthesis of 41a, 41b. Reagents and conditions: i) 40 (1.0 equiv), methyliodide 
(1.0 equiv), NEt3 (1.1 equiv), CH2Cl2 (5 mL per mmol of 40), 20 °C, 8 h. ii) 40 (1.0 equiv), 
benzylbromide (1.0 equiv), NEt3 (1.1 equiv), CH2Cl2 (5 mL per mmol of 40), 20 °C, 4 h.  

The Suzuki-Miyaura reaction of 41a-b with arylboronic acids 19b-e,g,h,j (1.0 equiv.) 
afforded the 5-aryl-3,4-dibromopyrazoles 42a-h in 66-73% yield (Table 20, Scheme 25).  
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Scheme 25. Synthesis of 5-aryl-3,4-dibromopyrazoles 42a-h. Reagents and conditions: i) 41 
(1.0 equiv), ArB(OH)2 (1.0 equiv), K2CO3 (2 M), Pd(PPh3)4 (3 mol-%), 1,4-dioxane / H2O 
(4:1), 60 C, 4 h. 

The best yields were obtained when Pd(PPh3)4 (3 mol-%) was used as catalyst (dioxane, 60 
°C, 4 h). The yields dropped when Pd(PPh3)2Cl2 was used as a catalyst. The use of K3PO4 as 
the base resulted in lower yields compared to the use of a 2M aqueous solution of K2CO3. In 
conclusion, the application of the reaction conditions allowed the preparation of the 5-
monoarylated products in good yields (Scheme 25, Table 20). 
The regioselectivity of the monoarylation can be explained by the fact that the oxidative 
addition of palladium usually occurs first at the most electron deficient carbon atom C-5. The 
structures of the products were confirmed by 2D NMR experiments. 

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Figure 19: 2D NMR correlations (HMQCand NOSEY) of 42a 
For example, the regioselectivity of compound 42a was established unambiguously by 2D 
NMR using H-H (NOESY) and HMQC correlations. Methyl H at  = 3.70 attached to C at  = 
38.5 showed clear correlation through space with the phenyl H at  = 7.24 which confirmed 
that the 4-methylphenyl group is attached to C-5 of pyrazole (Figure 19). 
 
Table 20. Synthesis of 42a-g 
42 R 19 Ar % (42)a 
a Me b 4-MeC6H4 76 
b Me e 4-EtC6H4 79 
c Me h 4-tBuC6H4  81 
d Me c 3-ClC6H4  73 
e Me i 4-ClC6H4 71 
f Me l 4-FC6H4 75 
g Me d 4-(MeO)C6H4 78 
h Benzyl d 4-(MeO)C6H4 84 
a Yields of isolated compounds 
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The structure of 42h was independently confirmed by X-ray crystal structure (Figure 20). 
 
Figure 20. Ortep plot of 42h (50% probability level) 
During the study of the Suzuki reactions of N-protected tribromopyrazoles with 3.3 
equivalents of boronic acids it was found, that mixtures of products were formed when I used 
Pd(PPh3)4 (3 mol-%) and Pd(PPh3)2Cl2 as catalysts. Good yields of triarylated products were 
obtained when Pd(OAc)2 (5 mol-%) in the presence of XPhos (10 mol-%) was used as 
catalyst (dioxane, 90 °C, 6 h), (entry 4, Table 21). The best yields were obtained when 
Pd(OAc)2 (5 mol-%) was used in the presence of SPhos (10 mol-%) in an aqueous solution of 
K2CO3 (2 M) (entry 3, Table 21) (for the structures of XPhos and SPhos see (Figure 12, 
chapter 5). As test reaction for these optimization studies, I investigated the conversion of 42a 
with 4-tolylboronic acid. In conclusion, the application of the reaction conditions given in 
entry 3 of Table 21 allowed the preparation of all triarylated products in good to excellent 
yields. It was also noted that electron-poor arylboronic acids provided slightly lower yields 
than electron-rich arylboronic acids. This can be explained by the lower nucleophilicity of 
electron-poor boronic acids. 
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Table 21. Reaction condition optimization for the synthesis of 1-methyl-3,4,5-tri(4-
methylphenyl)pyrazole (43a) 
a Yields of isolated compounds 
 
N N
Me
Br
Br
Br N N
Me
Ar
Ar
Ar
i
41a 43a-e
ArB(OH)2
19b,d-e,g-h
 
Scheme 26. Synthesis of 3,4,5-triaryl-pyrazoles: 43a-e. Reagents and conditions: i) 42 (1.0 
equiv), 19b,c,d,e,h (3.3 equiv), K2CO3 (2 M, 1 mL), Pd(OAc)2 (5 mol-%), SPhos (10 mol-%), 
1,4-dioxane/H2O (4:1), 100 C, 5 h. 

Entry   Conditions %(43a)a 
1 Pd(PPh3)2Cl2 (5 mol-%), aq. K2CO3 (2 M) 42 
2 Pd(PPh3)4  (5 mol-%), aq. K2CO3 (2 M) 28 
3 
 
Pd(OAc)2 (5 mol-%), SPhos (10 mol-%), 
aq. K2CO3 (2M) 
97 
4 
 
Pd(OAc)2 (5 mol-%), XPhos (10 mol-%), 
aq. K2CO3 (2M) 
80 
5 Pd(OAc)2 (5 mol-%), (EtOH)3N, K2CO3 (2M) decomp. 
6 Pd(OAc)2 (5 mol-%), (EtO)2PPh, K2CO3 (2M) traces 
7 Pd(OAc)2 (5 mol-%), (nBu)3P, K2CO3 (2M) 20 
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The results of the Suzuki-Miyaura cross coupling reactions of N-methyl-2,3,4-
tribromopyrazole 41a with the different arylboronic acids 19b,d-e,g-h (3.3 equiv.) to the N-
methyl-3,4,5-triaaryl-pyrazoles 43a-e are summerized in Table 22 (Scheme 26).  
Table 22. Synthesis of  43a-e 
43 Ar 19 % (43)a 
a 4-MeC6H4 b 97 
b 4-EtC6H4 e 89 
c 4-tBuC6H4  h 86 
d 3,5-Me2C6H4  g 84 
e 4-(MeO)C6H4 d 81 
a Yields of isolated compounds 
 
The Suzuki reaction of 42a,b,e,g with 2.2 equiv. of arylboronic acids 19a-d afforded the 
diaryl-pyrazoles 44a-g in good yields (Scheme 27, Table 23). 
 
N N
Me
Br
Br
R
N N
Me
R
Ar
Ar
i
42a,b,e,g 44a-g
ArB(OH)2
19a-d
 
Scheme 27. Synthesis of 44a-g.: Reagents and conditions: i) 42 (1.0 equiv), ArB(OH)2 (2.2 
equiv), K2CO3 (2 M, 1 mL), Pd(OAc)2 (5 mol-%), SPhos (10 mol-%),, 1,4-dioxane / H2O 
(4:1), 100 C, 6 h. 
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Table 23. Synthesis of  44a-g 
19 44 R Ar % (44)a 
a a 4-MeC6H4 C6H5 92 
d b 4-MeC6H4 4-(MeO)C6H4 84 
a c 4-EtC6H4 C6H5 89 
d d 4-EtC6H4 4-(MeO)C6H4 82 
a e 4-ClC6H4 C6H5 86 
b f 4-(MeO)C6H4 4-MeC6H4 83 
c g 4-(MeO)C6H4 3-ClC6H4 71 
a Yields of isolated products 
 
The structure of 44a was independently confirmed by X-ray crystal structure (Figure 21).  

 
Figure 21. Ortetp plot of 44a (50 % probability level) 
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8.3 Conclusions 
In conclusion, I have studied a convenient synthesis of arylated N-methyl- and N-benzyl-
pyrazoles by Suzuki-Miyaura reactions of N-protected 3,4,5-tribromopyrazole. The products 
reported herein are not readily available by other methods. All reactions proceed with 
excellent site-selectivity.  
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9 Synthesis of Unsymmetrical Arylated Furans by Suzuki-Miyaura Cross-
Coupling and Metal-Halide Exchange Reactions of 2,3,4,5-
Tetrabromofuran  
9.1 Introduction: 
Furan ring systems are in abundance available in secondary plant metabolites. Furans are not 
found in animal metabolism.87 Most of these furan natural products demonstrate exciting 
biological activities, such as cytotoxic and antitumor properties,88 antispasmodic,89 and 
antifeeding activities.90 In addition, natural furan containing molecules continue to be 
uncovered at a rapid speed.91 Because of their outstanding properties, many synthetic furans 
are employed as pharmaceuticals.92 Furthermore, building blocks found in natural molecules 
polysubstituted furans93 are important precursors for the synthesis of natural and non-natural 
products.94 The synthetic work towards polysubstituted furans belongs therefore to a 
remarkably dynamic research domain.  
Traditionally, substituted furans have been synthesized by direct functionalization of existing 
furans or cyclization of acyclic substrates.95 Among these strategies developed for the 
synthesis of a multi-substituted furan ring, one of the simplest involves starting with either 
furan itself or a mono-substituted furan followed by introducing functional groups at various 
positions of the furan ring. This approach, yet, has some disadvantages. First, the introduction 
of functional groups into the 3- or 4-position is difficult as furan rings lithiate and add 
electrophiles preferentially at the 2- and 5- position96. Second, placement of a group at C-3 
results in the 2- and 5-positions becoming regioisomeric. In turn that either regioselective 
methods or blocking groups strategies must be used to establish new moieties.94 
 
9.2 Results and Discussions 
2,3,4,5-Tetrabromofuran 48 was prepared following a literature procedure.97 The reaction of 
48 with arylboronic acids 19b,i,m (4.4 equiv.) afforded the stable 2,3,4,5-tetraarylfurans 49a-
c (Scheme 29, Table 24).  
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O
Br
BrBr
Br
ArB(OH)2
i
19b,i,m
O
Ar
ArAr
Ar
45 46a-c  
Scheme 28. Synthesis of 46a-c. Conditions: i) 45 (1.0 equiv.), 19 (4.4 equiv.), Pd(PPh3)4 (3 
mol-%), aq. K2CO3 (2 M), dioxane, 80 °C, 5 h. 
 
The reaction conditions were systematically optimized. The best yields were obtained when 
Pd(PPh3)4(3 mol-%) was used as catalyst. The yields dropped when Pd(PPh3)2Cl2 or Pd(OAc)2 
(3 mol-%) in the presence of XPhos or (Cy)3P were employed. Furthermore, best yields were 
obtained when an aqueous solution of K2CO3 (2 M) or when K3PO4 were employed as the 
base. The products were isolated in good to excellent yields for both electron-rich and 
electron-poor arylboronic acids. 
 
Table 24. Synthesis of symmetrical tetraarylfurans 46a-c 
46 19 Ar % (46) a 
a b 4-MeC5H4 90 
b i 4-ClC5H4 82 
c m 4-(CF3)C5H4 89 
a Yields of isolated products 
The structure of 46c was independently confirmed by X-ray crystal structure (Figure 22).  
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Figure 22. Ortetp plot of 46c (50 % probability level) 
 
O
Br
BrBr
Br
ArB(OH)2
i
19c-d,l,n
O
Ar
BrBr
Br
45 47a-d  
Scheme 29. Synthesis of 47a-d. Conditions: i), 45 (1.0 equiv.), 19 (1.0 equiv.), Pd(PPh3)4 (2 
mol %), aq. K2CO3 (2 M), toluene/dioxane (4:1), 80 °C, 3 h. 
 
The Suzuki-Miyaura reaction of 45 with arylboronic acids 19c,d,l,n (1.0 equiv.) afforded the 
2-aryl-3,4,5-tribromofurans 47a-d (Scheme 30, Table 25). Andrew and co-workers studied 
site-selective Suzuki-Miyaura reactions of 2,3-dibromofuran. These reactions, which were 
carried out in a DME/H2O/K2CO3 system, provided low yields. When I applied these 
conditions, I could not observe the regioselective formation of 2-substituted 3,4,5-
tribromofurans. Solvents like toluene, DME, dioxane and THF provided always a mixture of 
products. A binary solvent system comprising dioxane and toluene in a 1:4 ratio gave the 
desired 2-monoarylfurans 47a-d regioselectively. The stoichiometry (employment of exactly 
1.0 equiv. of the arylboronic acid) also played an important role. The best yields (87-89%) 
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were obtained by using of Pd(PPh3)4 (2 mol %) as catalyst, the use of an aqueous solution of 
K2CO3 (2 M) as base, and the use of a 4:1 mixture of toluene and dioxane.  
 
Table 25. Synthesis of 2-aryl-3,4,5-tribromofurans 47a-d 
47 19 Ar % (47) a 
a c 3-ClC5H4 87 
b n 3-(CF3)C5H4 85 
c l 4-FC5H4 88 
d d 4-(MeO)C5H4 89 
a Yields of isolated compounds 
 
A one-pot strategy to accomplish the synthesis of tetraarylfurans 48a-d with different aryl 
substituents at 2-/ 5- and 3-/ 4- positions, respectively, was also studied. The Suzuki-Miyaura 
reaction of 45 with arylboronic acid 19n (2.0 equiv.) in toluene/dioxane (4:1), separation of 
the solution into four equal portions, and subsequent addition of arylboronic acids 19a-c,g 
(only one boronic acid to one of the separated portions) afforded products 48a-d in high 
yields, respectively (Scheme 30, Table 26).  
 
O
Br
BrBr
Br
1) Ar1B(OH)2
i, ii
19n
45
O
Ar1
Ar2Ar2
Ar1
48a-d
2) Ar2B(OH)2
19a-c,g  
Scheme 30. Synthesis of 48a-d. Conditions: i) 45 (1.0 equiv.), arylboronic acid 19n (2.0 
equiv.) Pd(PPh3)4 (3 mol %), aq. K2CO3 (2 M), toluene/dioxane (4:1), 80 °C, 3 h,  ii) 19 a-c,g 
(2.0 equiv.), 80 °C, 3 h. 
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Table 26. Synthesis of 2,5-diaryl-3,4-diaryl2furans 48a-d 
48 19 Ar1 Ar2 % (48) a 
a c 3-(CF3)C5H4 4-tBuC5H4 93 
b a 3-(CF3)C5H4 C5H5 86 
c b 3-(CF3)C5H4 4-MeC5H4 93 
d g 3-(CF3)C5H4 3,5-Me2C5H4 88 
a Yields of isolated compounds 
 
In addition, the unsymmetrical 2-monoaryl1-3,4,5-triaryl2furans 49a-b were prepared by one-
pot Suzuki-Miyaura reaction of 2-aryl-3,4,5-tribromofuran 47b with the boronic acids 19g 
and 19h in dioxane at 80 °C for 5 h (sequential addition of the boronic acids). The products 
were isolated in excellent yields (Scheme 31, Table 27).  
 
O
BrBr
Br
i
CF3
O
RR
R
CF3
ArB(OH)2
19g,h
47b 49a-b  
Scheme 31. Synthesis of 49a-b. Conditions: i) 47b (1.0 equiv.), 19g,h (3.3 equiv.), Pd(PPh3)4 
(2 mol %), aq. K2CO3 (2 M), dioxane 80 °C, 5 h. 
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Table 27. Synthesis of 2-monoaryl1-3,4,5-triaryl2furans 49a-b 
49 19 R % (49) a 
a g 3,5-(Me2)C5H3 87 
b h 4-tBuC5H4 93 
a Yields of isolated compounds 
 
Beside our investigations of the Suzuki-Miyaura reaction, we have also found that the 
addition of n-butyllithium (1.1 equiv.) to a THF solution of tetrabromofuran 45 (1.0 equiv.) 
and subsequent addition of trimethylchlorosilane or benzyl chloride (1.0 equiv., slow addition 
during 3 h) directly afforded the 2-substituted 3,4,5-tribromofurans in 87–93% yield (Scheme 
31, Table 28). 
 
OBr
Br Br
Br OBr
Br Br
R
i
50a-b45
RX
 
Scheme 32. Synthesis of 2-substituted 3,4,5-triibromofurans 50a-b. Conditions: i) 1) n-BuLi 
(1.1 equiv.), TMEDA (1.1 equiv.), - 78 to 20°C, 1 h; 2), RX (1.0 equiv., addition during 3 h), 
6h. 
 
                               Table 28. Synthesis of 2-substituted 3,4,5-tribromofurans 50a-b 
 50 R % (50) a 
a Me3Si 87 
b (CH2)C6H5 93 
a Yields of isolated compounds 
 
 76
 
9.3 Conclusions 
In conclusion, I have prepared different types of symmetrical and unsymmetrical 
tetraarylfurans. I have also studied regioselective issues for the synthesis of monoarylfurans 
by the first Suzuki-Miyaura reactions of 2,3,4,5-tetrabromofuran. The use of a binary solvent 
system toluene/dioxane was found to play a key role during the optimization of the site-
selectivity of these monoarylation reactions. All reactions proceeded with excellent site-
selectivity in favour of the more electron-deficient position 2. Metal-halide exchange reaction 
with tetrabromofuran also provided selectivity at C-2. 
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Summary 
In this work, new diversely substituted heterocycles and aromatic carbacycles could be 
synthesized by metal catalyzed C-C-bond formation reactions 
Functionalized triarylmethanes were prepared in two steps by FeCl3-catalyzed benzylation of 
acetylacetone to give 3-(diarylmethyl)pentane-2,4-diones and subsequent formal [3+3] 
cyclization with 1,3-bis(trimethylsilyloxy)-1,3-dienes. 
6-Aryl-2,3-dihydro-4H-pyran-4-ones were prepared in one step by cyclocondensation of 1,3-
diketone dianions with aldehydes. The TiCl4-mediated cyclization of a 6-aryl-2,3-dihydro-4H-
pyran-4-one with 1,3-bis(silyloxy)-1,3-butadiene resulted in a ring-opening of the pyranone 
moiety and formation of a highly functionalized benzene derivative. 
The reaction of the dianion of 1,1,1-trifluoro-pentane-2,4-dione with aldehydes and 
subsequent addition of hydrochloric acid afforded 2,3-dihydro-6-trifluoromethylpyran-4-ones. 
The Suzuki-Miyaura reaction of the bis(triflate) of 2,4-dihydroxybenzophenone with aryl 
boronic acids gave 2,4-diarylbenzophenones. The reaction with one equivalent of arylboronic 
acids resulted in a regioselective selective attack at the less hindered carbon atom C-4. 2,4-
Diarylbenzophenones containing two different aryl groups were prepared by sequential 
addition of two different boronic acids. The Sonogashira cross-coupling reactions with 
terminal alkynes display remarkable compatibility with regard to the formation of mono- and 
dialkynyl-substituted benzophenones and could be also carried out in combination with a 
Suzuki-Miyaura reaction in a one-pot procedure. Analogously to the bis(triflate) of 2,4-
dihydroxybenzophenone, 2,4-bis(trifluoromethylsulfonyloxy)diphenylsulfone could be 
reacted with aryl boronic acids in Suzuki-Miyaura reactions to give 2,4-
bis(aryl)diphenylsulfones or (with one equivalent of arylboronic acid) monoarylated products 
at C-4. Sonogashira cross-coupling reactions of 2,4-
bis(trifluoromethylsulfonyloxy)diphenylsulfone with terminal alkynes were likewise 
successful. Additionally, 2,4-Diarylsulfones containing two different aryl groups were 
prepared by sequential addition of two different boronic acids.  
The Suzuki-Miyaura reaction of 2,3-dibromo-1H-inden-1-one with one equivalent of 
arylboronic acid gave 2-bromo-3-aryl-1H-inden-1-ones with very good regioselectivity and 
with two different arylboronic acids afforded 2,3-diaryl-1H-inden-1-ones containing two 
different terminal aryl groups in excellent yields.  
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The Sonogashira cross-coupling of 2,3-dibromo-1H-inden-1-one with terminal alkynes. This 
reaction gave us to the formation of symmetrical, alkynyl, alkynyl, alkynyl, aryl substitution. 
The first attack on less hindered C-3 carbon atom.  
 
Suzuki-Miyaura reactions of N- protected 3,4,5-tribromopyrazole allowed a convenient 
synthesis of mono- and triarylpyrazoles by using corresponding equivalents of aryl boronic 
acids. All reactions proceeded with excellent yields and in the case of monosubstitution also 
with high regioselectivity. Suzuki-Miyaura reactions of 2,3,4,5-tetrabromofuran allowed a 
convenient synthesis of aryl-substituted furans (mono-, tri- and tetraarylfurans) by using the 
corresponding equivalents of aryl boronic acids. Unsymmetrically aryl-substituted furans 
were prepared, which are not readily available by other methods. The reactions proceeded 
with excellent yields and high regioselectivity. Furthermore, regioselective metal-halide 
exchange reactions at 2-position of the tetrabromofuran afforded an approach to 2-substituted 
3,4,5-tribromofurans. 

Zusammenfassung (Übersetzung) 
In der Arbeit ist es gelungen neue, verschiedenartig substituierte Heterozyklen sowie 
aromatische Carbazyklen durch Metall-katalysierte C-C-Knüpfungsreaktionen darzustellen. 
Funktionalisierte Triarylmethane wurden in zwei Schritten dargestellt. Zunächst erfolgte die 
FeCl3- katalysierte Benzylierung von Acetylaceton zu 3-(Diarylmethyl)pentan-2,4-dionen, die 
anschließend in einer formalen [3+3]-Zyklisierung mit 1,3-Bis(trimethylsilyloxy)-1,3-dienen 
umgesetzt wurden.  
MeMe
O O
+
R2R1
OSiMe3
OR4R
3
OH
OR4
O
MeMe
R3
R1 R2
OH
Me3SiO
TiCl4
FeCl3
 
6-Aryl-2,3-dihydro-4H-pyran-4-one wurden durch die Zyklokondensation von 1,3-
Diketondianionen mit Aldehyden in einem Schritt dargestellt. Die TiCl4-vermittelte 
Zyklisierung der 6-Aryl-2,3-dihydro-4H-pyran-4-one mit 1,3-Bis(silyloxy)-1,3-butadienen 
führte unter Ringöffnung des Pyranonfragments zu hochfunktionalisierten Benzenderivaten. 
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OO
Ar
O
H
O
O
MeAr
+
Me3SiO
OR1
R
Me3SiO
TiCl4
Ar
Me
R
OH
CO2R1
2) HCl
(10%)
1) LDA
(2.5 equiv.)
 
Die Reaktion des Dianions des 1,1,1-Trifluorpentan-2,4-dions mit Aldehyden und 
anschließende Addition von Chlorwasserstoff führte zu 2,3-Dihydro-6-trifluoromethylpyran-
4-onen. 
CF3
OO
R H
O
R O
O
CF3
+
2) HCl (10%)
1) LDA
(2.5 equiv.)
 
Szuki-Miyaura-Reaktionen des Bistriflates des 2,4-Dihydroxybenzophenons mit 
Arylboronsäuren ergaben 2,4-Diarylbenzophenone. The Reaktion mit einem Äquivalent der 
Arylboronsäure führte zu einem regioselektiven Angriff am sterisch weniger gehinderten 
Kohlenstoffatom C-4-Atom. 2,4-Diarylbenzophenone mit unterschiedlichen Arylsubstituenten 
wurden durch aufeinanderfolgende Addition von zwei verschiedenen Boronsäuren erhalten. 
Die Sonogashira-Kreuzkupplungsreaktion mit terminalen Alkinen erwies sich für die 
Darstellung von mono- und dialkinyl-substituierten Benzophenonen als besonders geeignet, 
und konnte auch in Kombination mit einer Suzuki-Miyaura-Reaktion in einem 
Eintopfverfahren durchgeführt werden. 
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Ar
O
X
X
X = OTf
(1.0 equiv.) ArB(OH)2
Ar
O
Ar
Ar
(2.6 equiv.)
ArB(OH)2
ArB(OH)2
ArB(OH)2
AlkyneAlkyne
 
In Analogie zum Bistriflat des 2,4-Dihydroxybenzophenons konnte auch das 2,4-
Bis(trifluormethylsulfonyloxy)diphenylsulfon mit Arylboronsäuren in entsprechenden 
Suzuki-Miyaura-Reaktionen zu 2,4-Diaryldiphenylsulfonen bzw. zu am C-4 monoarylierten 
Produkten (bei Einsatz von nur einem Äquivalent Arylboronsäure) umgesetzt werden.  
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O
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ArB(OH)2
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Die Sonogashira- Kreuzkupplungsreaktionen der Bis(triflate) der 2,4-
bis(hydroxy)diphenylsulfone mit terminalen Alkynen wurden ebenfalls untersucht. Diese 
Reaktion erwies sich als besonders geeignet für symmetrische und unsymmetrische 
Substitutionen.  
S
O
S
O
S
O
R
R
R
R
[Pd]
(2.2 equiv.)
(1.1 equiv.)
(1.1 equiv.) ArB(OH)2
S
O
X
X
O
O
O
S
O
R
(1.1, 1.1 equiv.), Alkyne
O
X=OTf
(1.1 equiv.), Alkyne
O
R X
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i
i i
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Suzuki- und Sonogashira-Reaktionen von 2,3-Dibromindanon liefert einen regioselektiven 
Zugang zu verschiedenen Indanonderivaten. 
O
Br
Br
O
R
R1
R
O
Br
R
O
R
R
O
R1
R
i
i i
i i
i
ArB(OH)2
(1.0 equiv.)
ArB(OH)2
(1.0 equiv.)
(1.0 equiv.)
(2.2 equiv.)
R

 
Suzuki-Miyaura-Reaktionen von N-geschütztem 3,4,5-Tribrompyrazol erlauben, durch den 
Einsatz entsprechender Äquivalente an Arylboronsäuren, eine bequeme Synthese von Mono-
und Triarylpyrazolen. Alle Reaktionen verliefen in exzellenten Ausbeuten und im Fall der 
Monosubstitution auch mit hohen Regioselektivitäten. 
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(1.0, 2.2 equiv.)
N
N
Br
Br
Br
N
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Ar1
Ar
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N
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Ar
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N
N
Ar
Ar
Ar
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ArB(OH)2
R
R = Me, Benzyl
R R
R
+
+

 
In Analogie zum N-geschützten 3,4,5-Tribrompyrazol lassen sich durch Suzuki-Miyaura-
Reaktionen des 2,3,4,5-Tetrabromfurans in bequemer Weise arylsubstituierte Furane (Mono-, 
Tri- und Tetraarylfurane) bei Einsatz entsprechender Mengen von Arylboronsäuren darstellen. 
Es konnten auch unsymmetrisch Aryl-substituierte Furane dargestellt werden, die bisher 
durch andere Synthesestrategien nur schwer zugänglich sind. Die Reaktionen verliefen mit 
exzellenten Ausbeuten und hoher Regioselektivität. Ferner ermöglichten regioselektive 
Metall-Halogen-Austauschreaktionen in 2-Position des Tetrabromfurans einen Zugang zu 2- 
subtituierten 3,4,5-Tribromfuranen. 
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10 Experimental Section  
 
10.1 General Remarks  
 
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Pressure tubes were used to avoid condenser. 
Solvents for reactions were dried and distilled by standard methods or purchased from Merck, 
Aldrich, Acros Organics, and others whenever exclusion of water was desired. Solvents for 
liquid chromatography and extraction were always distilled prior to use and partly reused after 
fractional distillation (n-heptane, ethyl acetate).  
 
10.2 Methods for Compound Characterization and Analysis  
 
NMR Spectroscopy  
 
Bruker AC 250, Bruker ARX 300, Bruker ARX 500. For NMR characterization the one-
dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 spectra were collected. If 
necessary, other techniques (NOESY, COSY, HMQC, HMBC) were applied as well. All 
NMR spectra presented in this work were collected in CDCl3 solution. All chemical shifts are 
given in ppm.  
References (1H NMR): TMS ( = 0.00) or residual CHCl3 ( = 7.26) were taken as internal 
standard.  
References (13C NMR): TMS ( = 0.0) or residual CHCl3 ( = 77.0) were taken as internal 
standard.  
Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad signal. More complex coupling patterns are represented by combinations 
of the respective symbols. For example, td indicates a triplet of doublets with the larger 
coupling constant associated with the first symbol (here: triplet).  
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Infrared Spectroscopy (IR)  
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w 
= weak, m = medium, s = strong, br = broad.  
 
Mass Spektrometry (MS)  
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
 
High Resolution Mass Spectrometry (HRMS)  
Varian MAT 311, Intecta AMD 402.  
 
Elemental Analysis  
LECO CHNS-932, Thermoquest Flash EA 1112.  
 
Melting Points  
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
 
X-ray Structures 
Bruker X8Apex diffractometer with CCD camera (Mo K radiation and graphite 
monochromator,  = 0.71073 Å). The space group is determined by the XPREP program and 
the structures were solved via the SHELX-97 program package. Refinements were carried out 
according to the minimum square error method.  
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10.3 Chromatographic Methods  
 
Thin Layer Chromatography (TLC)  
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83-
84/100 methanol.  
 
10.4 Column Chromatography  
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel Silica 
Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-0.063 mm, 
230-400 mesh) was chosen when appropriate.  
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11 General Procedures 

11.1 Synthesis of Functionalized Triarylmethanes by Combination of FeCl3-Catalyzed 
Benzylations of Acetylacetone with [3+3] Cyclocondensations 

11.1.1 Synthesis of benzylation of -dicarbonyl compounds 
In a pressure tube, FeCl3-6H2O (5 mol %), an alcohol (5.0 mmol), and acetylacetone (20 
mmol) were dissolved in 10 mL of nitromethane. After stirring for 4 h at 60 °C, the reaction 
was quenched with water followed by extraction with dichloromethane. The combined 
organic layers were dried over Na2SO4 and the solvents were distilled off. Then, the product 
was purified by column chromatography (heptanes/ethyl acetate = 1:1). 
 
11.1.2 Synthesis of mono silyl enol ethers of 3-benzhydrylpentane-2,4-dione 
To a stirred solution benzene (2.5Ml/1.0 mmol of 6a-e), triethylamine (16.0 mmol) and 
trimethylchlorosilane (18.0 mmol) was added drop wise. The reaction mixture was stirred  at 
room temperature for 72 hr, the solvent was removed in vacuo and hexane was added to the 
residue to give a suspension and filterd under argon atmosphere. The filtrate was concentrated 
in vacuo to give mono silyl enol ethers.  
11.1.3 Synthesis of substituted triarylmethanes (8a-n) 
 To a stirred solution of CH2Cl2 5 mL, 7a-e (1.0 equiv.), 3a-f (1.1 equiv.) and, subsequently, 
TiCl4 (1.0 equiv.) at 78°C. The temperature of the solution was allowed to warm to 20 °C 
during 14 h with stirring. To the solution was added hydrochloric acid (10%, 20 mL) and the 
organic and the aqueous layer were separated. The latter was extracted with CH2Cl2 (3 × 
20 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate was 
concentrated in vacuo. The residue was purifed by chromatography (silica gel, heptanes / 
EtOAc) to give 8a-n.  
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Benzyl 3-benzhydryl-6-hydroxy-2,4-dimethylbenzoate (8a). Starting with 7a (0.510 g, 1.5 
mmol) and 3a (0.555 g, 1.65 mmol), 8a was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a colourless oil 
(0.411 g, 65%). 1H NMR (300 MHz, CDCl3):  = 1.95 (s, 3 H, 
CH3), 2.10 (s, 3 H, CH3), 5.27 (s, 2 H, OCH2), 6.65 (s, 1 H, CH), 
6.98-7.19 (m, 10 H, ArH), 7.24-7.29 (m, 5 H, ArH), 10.51 (s, 1 
H, OH). 13C NMR (CDCl3, 62 MHz):  = 21.4, 22.8 (CH3), 50.7 (CH), 67.3 (CH2), 112.6 (C), 
117.9, 126.0, 128.2, 128.4, 128.5, 128.6, 129.0 (CH), 133.2, 135.1, 140.4, 142.0, 145.6 (C), 
160.0 (COH), 171.3 (CO). IR (KBr): v = 3082, 3058, 3023, 2973, 2928, 1729, 1654 (s), 1598, 
1566, 1493, 1450, 1379, 1320, 1289, 1260, 1209 (s), 1141 (m), 1140, 1064 (s), 1026 (m), 969 
(w), 949, 908 (w), 850, 800, 748, 734, 717, 694 (s), 614, 578 (m) cm-1. MS (EI, 70 eV): m/z 
(%) = 422 (M+, 6), 314 (19), 288 (36), 287 (10), 273 (40), 211 (12), 195 (17), 178 (10), 167 
(27), 166 (34), 165 (61), 152 (16), 115 (10), 92 (20), 91 (100), 89 (10), 79 (13), 78 (14), 77 
(18), 65 (22), 63 (10), 55 (10), 51 (12), 44 (36), 43 (13), 41 (14). HRMS (EI): calcd. for 
C29H26O3 [M]+: 422.18765; found: 422.188014. 
 
Methyl 3-benzhydryl-5-decyl-6-hydroxy-2,4-dimethyl-benzoate (8b). Starting with 7a 
(0.510 g, 1.5 mmol) and 3b (0.661 g, 1.65 mmol), 
8b was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a colourless oil (0.415 g, 57%). 
1H NMR (300 MHz, CDCl3):  = 0.70 (t, 3J = 6.8 
Hz, 3 H, (CH2)8CH2CH3), 1.07-1.12 (m, 14 H, 
7xCH2), 1.24-1.29 (m, 2 H, CH2), 1.84 (s, 3 H, CH3), 1.95 (s, 3 H, CH3), 2.48 (t, 3J = 7.2 Hz, 
2 H, CH2(CH2)8CH3), 3.70 (s, 3 H, OCH3), 5.89 (s, 1 H, CH), 6.90-7.09 (m, 10 H, ArH), 
10.61 (s, 1 H, OH). 13C NMR (CDCl3, 62 MHz):  = 15.2, 19.5, 22.4 (CH3), 23.8, 27.9, 30.3, 
30.5, 30.6, 30.8, 30.9, 31.2, 33.0 (CH2), 52.3 (CH), 53.1 (OCH3), 113.3 (C), 127.0, 129.3 
(CH), 129.4 (C), 130.3 (CH), 134.3, 138.0, 143.6, 144.3 (C), 159.0 (COH), 173.8 (CO). IR 
(KBr): v = 3059, 3023 (w), 2952 (m), 2921 (s), 2852 (m), 1933 (w), 1752, 1703 (m), 1656 (s), 
1598, 1493 (m), 1438 (s), 1377 (w), 1322, 1293, 1229 (m), 1201 (s), 1120, 1047, 1030 (m), 
959, 903 (w), 841, 806, 746, 724 (m), 698 (s), 623, 615, 583 (m) cm-1. HRMS (ESI): calcd. 
for C33H43O3 [M+H]+: 487.32067; found: 487.32048. 
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Benzyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4-dimethylbenzoate (8c). Starting with 
7b (0.564 g, 1.5 mmol) and 3a (0.555 g, 1.65 mmol), 8c was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as 
a colourless solid (0.467 g, 68%), mp. 112-113 °C. 1H NMR 
(300 MHz, CDCl3):  = 1.99 (s, 3 H, CH3), 2.12 (s, 3 H, CH3), 
5.33 (s, 2 H, OCH2), 5.87 (s, 1 H, CH), 6.70 (s, 1 H, ArH), 
6.89-7.01 (m, 8 H, ArH), 7.30-7.37 (m, 5 H, ArH), 10.56 (s, 1 H, OH). 13C NMR (CDCl3, 
62.8 MHz):  = 21.3, 22.7 (CH3), 49.3 (CH), 67.4 (OCH2), 112.8 (C), 114.6 (d, 2JC,F = 21.2 
Hz, CH), 118.5 (CH), 128.5 (d, 3JC,F = 7.7 Hz, CH), 128.6 (C), 137.5 (d, 4JC,F = 3.1 Hz, CAr), 
140.2, 145.2 (CAr), 160.1 (COH), 161.1 (d, 1JC,F = 245.1 Hz, CAr), 171.1 (CO). 19F NMR (282 
MHz, CDCl3):  = -116.8. IR (KBr): v = 3070, 3035, 2979, 2931, 2884 (w), 1649 (s), 1598, 
1574 (m), 1500 (s), 1426, 1381, 1316, 1292 (m), 1217, 1175 (s), 1145, 1067, 1029, 1012, 953, 
860, 829, 817 (m), 794, 748, 698 (s), 647, 598, 528 (m) cm-1. MS (EI, 70 eV): m/z (%) = 458 
(M+, 18), 350 (34), 91 (100). HRMS (ESI): calcd. for C29H25O3F2 [M+H]+: 459.17663; found: 
459.17593. 
 
Ethyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4,5-trimethylbenzoate (8d). Starting 
with 7b (0.564 g, 1.5 mmol) and 3c (0.476 g, 1.65 mmol), 8d was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as a 
solid (0.239 g, 39%), mp. 63-64 °C. 1H NMR (300 MHz, CDCl3):  
= 1.29 (t, 3J = 7.1 Hz, 3 H, OCH2CH3), 1.88 (s, 3 H, CH3), 2.10 (s, 
6 H, 2xCH3), 4.32 (q = 3J = 7.1 Hz, 2 H, OCH2CH3), 5.90 (s, 1 H, 
CH), 6.86-6.99 (m, 8 H, ArH), 10.83 (s, 1 H, OH). 13C NMR (CDCl3, 75.4 MHz):  = 12.2, 
14.1, 19.0, 21.0 (CH3), 49.7 (OCH3), 61.5 (OCH2CH3), 112.3 (C), 115.0 (d, 2JC,F = 21.0 Hz, 
CH), 123.5 (C), 130.4 (d, 3JC,F = 7.8 Hz, CH), 132.5, 136.5 (C), 137.5 (d, 4JC,F = 3.2 Hz, C), 
143.2 (C), 159.5 (COH), 160.4 (d, 1JC,F = 244.6 Hz, C), 172.0 (CO). 19F NMR (282 MHz, 
CDCl3):  = -117.0. IR (KBr): v = 3070, 3035, 2979, 2931, 2884 (w), 1649 (s), 1598, 1574 
(m), 1500 (s), 1426, 1381, 1316, 1292 (m), 1217, 1175 (s), 1145, 1067, 1029, 1012, 953 , 860, 
829, 817 (m), 794, 748, 698 (s), 647, 598, 528 (m) cm-1. MS (EI, 70 eV): m/z (%) = 410 (M+, 
30), 365 (29), 364 (100), 336 (22), 321 (28), 241 (18), 240 (10), 203 (26), 202 (11), 201 (25), 
197 (11), 196 (11), 183 (32), 109 (16), 91 (14), 44 (21), 43 (18). HRMS (ESI): calcd. for 
C25H24O3F2 [M]+: 410.16880; found: 410.169602. 
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Methyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4-dimethyl-5-ethylbenzoate (8e). 
Starting with 7b (0.564 g, 1.5 mmol) and 3d (0.476 g, 1.65 mmol), 8e 
was isolated after chromatography (silica gel, n-heptane/EtOAc) as a 
yellowish solid (0.252 g, 41%), mp. 82-83 °C. 1H NMR (300 MHz, 
CDCl3):  = 1.03 (t, 3J = 7.4 Hz, 3 H, CH2CH3), 1.94 (s, 3 H, CH3), 
2.03 (s, 3 H, CH3), 2.63 (q, 3J = 7.4 Hz, 2 H, CH2CH3), 3.82 (s, 3 H, 
OCH3), 5.90 (s, 1 H, CH), 6.86-6.99 (m, 8 H, ArH), 10.73 (s, 1 H, OH). 19F NMR (282 MHz, 
CDCl3):  = -117.0. 13C NMR (CDCl3, 75.4 MHz):  = 12.3, 16.9, 18.9 (CH3), 20.2 
(CH2CH3), 48.8 (CH), 51.0 (OCH3), 111.3 (C), 114.0 (d, 2JC,F = 21.2 Hz, CH), 128.5 (C), 
129.4 (d, 3JC,F = 7.7 Hz, CH), 131.7, 135.7 (C), 136.8 (d, 4JC,F = 3.2 Hz, C), 141.6 (C), 156.9 
(COH), 161.1 (d, 1JC,F = 244.7 Hz, C), 171.4 (CO). IR (neat, cm-1): 2961, 2929, 2873, 2852, 
1732 (w), 1656 (s), 1599 (m), 1563 (w), 1504 (s), 1439, 1398, 1350, 1293 (m), 1258 (s), 
1223, 1201 (m), 1157 (s), 1096 (m), 1014 (s), 953, 861, 832 (m), 795, 699 (s), 643 (m), 601 
(w), 567, 530 (m) cm-1. MS (EI, 70 eV): m/z (%) = 410 (M+, 46), 380 (10), 379 (32), 378 
(100), 377 (16), 363 (14), 353 (21), 352 (67), 351 (10), 350 (31), 338 (24), 337 (86), 336 (12), 
335 (25), 324 (16), 323 (45), 321 (18), 257 (14), 241 (12), 227 (17), 226 (14), 203 (15), 202 
(20), 201 (24), 196 (15), 189 (10), 183 (25), 109 (12). HRMS (EI): calcd. for C25H24O3F2 
[M]+: 410.16880; found: 410.169602. 
 
Methyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4-dimethyl-5-butylbenzoate (8f).   
Starting with 7b (0.564 g, 1.5 mmol) and 3e (0.521 g, 1.65 mmol), 
8f was isolated after chromatography (silica gel, n-heptane/EtOAc) 
as a solid (0.348 g, 53%), mp. 116-117 °C. 1H NMR (300 MHz, 
CDCl3):  = 0.75 (t, 3J = 6.9 Hz, 3 H, (CH2)2CH2CH3), 1.21-1.28 
(m, 4 H, 2xCH2), 1.83 (s, 3 H, CH3), 1.92 (s, 3 H, CH3), 2.49 (t, 3J 
= 7.3 Hz, 2 H, CH2(CH2)2CH3), 3.71 (s, 3 H, OCH3), 5.79 (s, 1 H, CH), 6.75-6.88 (m, 8 H, 
ArH), 10.62 (s, 1 H, OH). 19F NMR (282 MHz, CDCl3):  = -117.0. 13C NMR (CDCl3, 75.4 
MHz):  = 15.2, 18.2, 21.2 (CH3), 23.1, 26.5, 31.3 (CH2), 49.8 (CH), 52.08 (OCH3), 113.5 
(C), 116.1 (d, 2JC,F = 21.2 Hz, CH), 129.6 (C), 131.5 (d, 3JC,F = 7.7 Hz, CH), 133.9, 137.8 (C), 
139.1 (d, 4JC,F = 3.2 Hz, C), 144.0 (C), 159.2 (COH), 162.3 (d, 1JC,F = 244.7 Hz, CAr), 173.6 
(CO). IR (KBr): v = 3034, 2954, 2927, 2871, 2858 (w), 1737, 1655 (m), 1504 (s), 1438, 1397, 
1350, 1293 (m), 1223, 1200 (s), 1157 (s), 1115, 1044, 1015, 881, 832, 807 (m), 796, 731 (s), 
670, 639, 603 (m), 567 (s), 529 (m) cm-1. MS (EI, 70 eV): m/z (%) = 438 (M+ 100), 407 (28), 
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406 (72), 389 (24), 378 (18), 377 (16), 365 (10), 364 (40), 363 (28), 321 (13), 297 (15), 203 
(21), 201 (12), 183 (14), 109 (12). HRMS (ESI): calcd. for C27H29O3F2 [M+H]+: 439.20065; 
found: 439.20975. 
 
Methyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4-dimethyl-5-nonylbenzoate (8g). 
Starting with 7b (0.564 g, 1.5 mmol) and 3f (0.614 g, 
1.65 mmol), 8g was isolated after chromatography 
(silica gel, n-heptane/EtOAc) as a solid (0.402 g, 
53%), mp. 147-148 °C. 1H NMR (300 MHz, CDCl3): 
 = 0.70 (t, 3J = 7.0 Hz, 3 H, (CH2)7CH2CH3), 1.09-
1.16 (m, 12 H, 6xCH2), 1.27-1.31 (m, 2 H, CH2), 1.82 
(s, 3 H, CH3), 1.92 (s, 3 H, CH3), 2.48 (t, 3J = 7.1 Hz, 2 H, CH2(CH2)7CH3), 3.71 (s, 3 H, 
OCH3), 5.79 (s, 1 H, CH), 6.75-6.88 (m, 8 H, ArH), 10.67 (s, 1 H, OH). 19F NMR (282 MHz, 
CDCl3):  = -117.1. 13C NMR (CDCl3, 75.4 MHz):  = 15.2, 23.8, 27.9 (CH3) 28.3, 30.3, 
30.5, 30.7, 30.8, 30.9, 31.2, 33.0 (CH2), 51.0 (CH), 53.2 (OCH3), 113.5 (C), 116.1 (d, 2JC,F = 
21.2 Hz, CH), 129.6 (C), 131.5 (d, 3JC,F = 7.7 Hz, CH), 133.9, 137.8 (C), 139.1 (d, 4JC,F = 3.4 
Hz, C), 143.9 (CAr), 159.2 (COH), 162.3 (d, 1JC,F = 244.7 Hz, C), 173.6 (CO). IR (KBr): v = 
2952, 2922, 2853, 1751, 1654 (m), 1558 (s), 1506, 1446, 1351 (m), 1227, 1157 (s), 1148, 
1030, 1016, 841, 798, 778, 721, 667 (m), 628 (w), 568, 530 (m) cm-1. MS (EI, 70 eV): m/z 
(%) = 508 (M+ 100), 473 (18), 405 (16), 381 (20), 377 (18), 365 (19), 364 (51), 336 (14), 276 
(13), 275 (76), 183 (10), 109 (16), 57 (13), 43 (14). HRMS (ESI): calcd. for C32H38F2O3 
[M+H]+: 509.2789; found: 509.2787. 
 
Methyl 3-(bis(4-fluorophenyl)methyl)-6-hydroxy-2,4-dimethyl-5-decylbenzoate (8h). 
Starting with 7b (0.564 g, 1.5 mmol) and 3b(0.661 g, 
1.65 mmol), 8h was isolated after chromatography 
(silica gel, n-heptane/EtOAc) as a yellowish solid 
(0.429 g, 55%), mp. 161-162 °C. 1H NMR (300 MHz, 
CDCl3):  = 0.75 (t, 3J = 6.8 Hz, 3 H, (CH2)8CH2CH3), 
1.08-1.12 (m, 14 H, 7xCH2), 1.17-1.25 (m, 2 H, CH2), 
1.82 (s, 3 H, CH3), 1.92 (s, 3 H, CH3), 2.48 (t, 3J = 7.2 Hz, 2 H, CH2(CH2)8CH3), 3.71 (s, 3 H, 
OCH3), 5.78 (s, 1 H, ArH), 6.76-6.89 (m, 8 H, ArH), 10.61 (s, 1 H, OH). 19F NMR (282 MHz, 
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CDCl3):  = -117.0. 13C NMR (CDCl3, 75.4 MHz):  = 15.2, 19.4, 22.4 (CH3), 23.8, 27.9, 
28.3, 30.3, 30.5, 30.7, 30.8, 31.2, 33.0 (CH2), 51.0 (CH), 53.2 (OCH3), 113.5 (C), 116.1 (d, 
2JC,F = 21.1 Hz, CH), 129.6 (C), 131.5 (d, 3JC,F = 8.2 Hz, CH), 133.9, 137.8 (C), 139.1 (d, 4JC,F 
= 3.0 Hz, C), 144.0 (C), 159.2 (COH), 162.3 (d, 1JC,F = 245.0 Hz, C), 173.6 (CO). IR (KBr): v 
= 2952, 2922, 2853 (w), 1751, 1658, 1600 (m), 1505 (s), 1437, 1399, 1351, 1294 (m), 1225 
(s), 1201 (m), 1157 (s), 1120, 1048, 1015, 907, 840 (m), 797 (s), 733, 671, 628 (m), 568 (s), 
530 (m) cm-1. MS (EI, 70 eV): m/z (%) = 522 (100) (M+ 100), 490 (83), 473 (17), 405 (15), 
381 (23), 377 (14), 365 (11), 364 (51), 363 (34), 336 (13), 321 (11), 276 (12), 275 (80), 203 
(59), 201 (10), 183 (11), 109 (14), 57 (10), 43 (13). HRMS (ESI): calcd. for C33H41O3F2 
[M+H]+: 523.29465; found: 522.29452. 
 
Benzyl 3-(bis(4-chlorophenyl)methyl)-6-hydroxy-2,4-dimethylbenzoate (8i). Starting with 
7c (0.614 g, 1.5 mmol) and 3a (0.429 g, 1.65 mmol), 8i 
was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a solid (0.507 g, 69%), mp. 137-138 
°C. 1H NMR (300 MHz, CDCl3):  = 1.95 (s, 3 H, CH3), 
2.05 (s, 3 H, CH3), 5.28 (s, 2 H, CH2), 5.80 (s, 1 H, CH), 
6.66 (ArH), 6.89-6.93 (m, 4 H, ArH), 7.14-7.18 (m, 4 H, 
ArH), 7.26-7.31 (m, 5 H, ArH), 10.54 (s, 1 H, OH). 13C NMR (CDCl3, 62.8 MHz):  = 21.4, 
22.8 (CH3), 49.6 (CH), 67.4 (OCH2), 112.8 (C), 118.1, 128.2, 128.4, 128.6, 128.7, 130.3 
(CH), 132.0, 133.2, 135.0, 140.1, 140.2, 145.2 (C), 160.2 (COH), 171.1 (CO). IR (neat, cm-1): 
3031, 2979, 2928, 1660 (s), 1598, 1567, 1487, 1462, 1387, 1341, 1270, 1257, 1231, 1208, 
1144, 1089 (m), 1068 (s), 1012 (m), 949 (w), 838, 801, 749, 737 (m), 693 (s), 636, 583, 539 
(m) cm-1. MS (EI, 70 eV): m/z (%) = 492 ([M, 37Cl2, 39)]+ , 490 ([M, 35Cl37Cl, 60)]+, 488 ([M, 
35Cl2, 83)]+, 401 (10), 399 (16), 385 (15), 384 (75), 383 (28), 382 (100), 165 (15), 92 (22), 91 
(40), 57 (13), 54 (16), 43 (11). HRMS (EI): calcd. for C29H25Cl2O3 [(M+, Cl35,Cl37])+: 
490.10970; found: 490.110097. 
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Ethyl 3-(bis(4-chlorophenyl)methyl)-6-hydroxy-2,4,5-trimethylbenzoate (8j). Starting 
with 7c (0.614 g, 1.5 mmol) and 3c (0.476 g, 1.65 mmol), 8j was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as a 
yellowish solid (0.275 g, 43%), mp. 111-112 °C. 1H NMR (300 
MHz, CDCl3):  = 1.19 (t, 3J = 7.1 Hz, 3 H, OCH2CH3), 1.78 (s, 3 
H, CH3), 1.99 (s, 3 H, CH3), 2.00 (s, 3 H, CH3), 4.22 (q, 3J = 7.1 
Hz, 2 H, OCH2CH3), 5.78 (s, 1 H, CH), 6.82-6.85 (m, 4 H, ArH), 
7.06-7.09 (m, 4 H, ArH), 10.77 (s, 1 H, OH). 13C NMR (CDCl3, 62.8 MHz):  = 12.2, 14.1, 
19.0, 21.0 (CH3), 50.0 (CH), 61.6 (OCH2CH3), 112.3, 123.6 (C), 128.4, 130.3 (CH), 131.8, 
136.5, 139.5, 140.5, 143.2 (C), 158.1 (COH), 171.9 (CO). IR (KBr): v = 3070, 3035, 2979, 
2931, 2884 (w), 1649 (s), 1598, 1574 (m), 1500 (s), 1426, 1381, 1316, 1292 (m), 1217, 1175 
(s), 1145, 1067, 1029, 1012, 953, 860, 829, 817 (m), 794, 748, 698 (s), 647, 598, 528 (m) cm-
1. MS (EI, 70 eV): m/z (%) = 442 ([M, 37Cl2, 10])+, 440 ([M, 37Cl35Cl, 13)]+, 438 ([M, 35Cl2, 
56)]+, 413 (21), 412 (63), 411 (30), 410 (100), 384 (16), 382 (28), 367 (13), 285 (12), 285 
(12), 165 (15), 71 (11), 69 (12), 57 (14), 57 (11), 43 (16). HRMS (ESI-): calcd. for C25H23 
Cl2O3 [(M+, Cl35,Cl37])+: [M-1]+: 441.10297; found: 441.10289. 
 
Methyl 3-(bis(4-chlorophenyl)methyl)-5-ethyl-6-hydroxy-2,4-dimethylbenzoate (8k). 
Starting with 7c (0.614 g, 1.5 mmol) and 3d (0.476 g, 1.65 mmol), 
8k was isolated after chromatography (silica gel, n-heptane/EtOAc) 
as a yellowish solid (0.278 g, 42%), mp. 127-128 °C. 1H NMR (300 
MHz, CDCl3):  = 1.02 (t, 3J = 7.4 Hz, 3 H, OCH2CH3), 1.94 (s, 3 
H, CH3), 2.01 (s, 3 H, CH3), 2.63 (q, 3J = 7.4 Hz, 2 H, OCH2CH3), 
3.82 (s, 3 H, OCH3), 5.88 (s, 1 H, CH), 6.92-6.95 (m, 4 H, ArH), 7.16-7.19, (m, 4 H, ArH), 
10.77 (s, 1 H, OH). 13C NMR (CDCl3, 75.4 MHz):  = 12.3, 17.0, 19.0, 20.3 (CH3), 28.6 
(CH2), 49.1 (CH), 51.1 (OCH3), 111.3 (C), 127.4 (CH), 128.6 (C), 129.3 (CH), 130.8, 131.1, 
135.7, 139.5, 141.5 (C), 157.0 (COH), 171.4 (CO). IR (KBr): v = 2953, 2927, 2871, 2854, 
1731 (w), 1656 (s), 1593, 1561 (m), 1489 (s), 1439, 1350, 1324, 1290, 1223, 1178, 1106, 
1091 (m), 1013 (s), 877 (w), 807, 781, 705, 653 (m) cm-1. MS (EI, 70 eV): m/z (%) = 446 
([M, 37Cl2, 18]+), 444 ([M, 35Cl37Cl, 27]+), 442 ([M, 35Cl2, 42])+, 414 (10), 413 (17), 412 (63), 
411 (31), 410 (100), 384 (17), 382 (27), 367 (12), 285 (13), 285 (13), 165 (14), 71 (10), 69 
(10), 57 (16), 57 (10), 43 (17). HRMS (EI): calcd. for C24H25Cl2O3 [(M+, Cl35,Cl35]): 
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442.10970; found: 442.110226, calcd. for C24H25Cl2O3 [(M+, Cl35,Cl37]): 444.10675; found: 
444.107921. 
 
Methyl 3-(bis(4-chlorophenyl)methyl)-5-decyl-6-hydroxy-2,4-dimethylbenzoate (8l). 
Starting with 7c (0.614 g, 1.5 mmol) and 3b (0.661 g, 
1.65 mmol), 8l was isolated after chromatography 
(silica gel, n-heptane/EtOAc) as a solid (0.478 g, 
57%), mp. 141-142 °C. 1H NMR (300 MHz, CDCl3): 
 = 0.70 (t, 3J = 6.9 Hz, 3 H, CH2(CH2)8CH3), 1.03-
1.08 (m, 14 H, 7xCH2), 1.23-1.30 (m, 2 H, CH2), 1.82 
(s, 3 H, CH3), 1.91 (s, 3 H, CH3), 2.48 (t, 3J = 7.0 Hz, 2 H, CH2(CH2)8CH3), 3.71 (s, 3 H, 
OCH3), 5.77 (s, 1 H, CH), 6.81-6.84 (m, 4 H, ArH), 7.05-7.08 (m, 4 H, ArH), 10.65 (s, 1 H, 
OH). 13C NMR (CDCl3, 62.8 MHz):  = 15.2, 19.4, 22.5 (CH3), 23.8, 28.0, 28.3, 30.3, 30.5, 
31.2 (CH2), 51.3 (CH), 53.2 (OCH3), 113.5 (C), 129.6, 131.5 (CH), 133.0, 133.3, 137.8, 
141.7, 144.0 (C), 159.3 (COH), 173.6 (CO). IR (KBr): v = 2952, 2922, 2852, 1933 (w), 1745, 
1702 (m), 1658 (s), 1594, 1562, 1489, 1455, 1437 (m), 1377 (w), 1323, 1278, 1244 (m), 1235 
(s), 1201, 1178 (m), 1120 (w), 1091 (m), 1013 (m), 906 (w), 840 (s), 807, 766, 732, 627, 578 
(m) cm-1. MS (EI, 70 eV): m/z (%) = 558 ([M, 37Cl2, 13]+), 556 ([M, 37Cl35Cl, 47]+), 554 ([M, 
35Cl35Cl, 59]+), 552 ([M, 35Cl2, 74]+), 526 (12), 525 (22), 524 (62), 523 (40), 522 (89), 521 
(10), 509 (11), 507 (27), 505 (19), 457 (10), 439 (16), 437 (22), 423 (10), 411 (12), 409 (17), 
40 (10) 399 (31) 398 (45) 397 (100), 396 (45), 395 (30), 370 (13), 369 (15) 368 (19), 355 
(12), 353 (10), 333 (10), 285 (13), 257 (14), 256 (15), 243 (17), 237 (21), 235 (32), 201 (14), 
199 (12), 180 (10), 178 (10), 166 (10), 165 (30), 139 (12), 127 (10), 125 (24), 97 (14), 95 (1), 
85 (12), 83 (16), 81 (13), 71 (17), 69 (20), 67 (12), 57 (31), 56 (11), 55 (29), 45 (12), 44 (57) 
43 (52) 41 (29). HRMS (EI): calcd. for C33H40Cl2O3 [(M+, Cl35,Cl35]): 554.23490; found: 
554.23490, calcd. for C33H40Cl2O3 [(M+, Cl35,Cl37]): 556.23195; found: 556.233268. 
 
Benzyl 3-(1-(4-bromophenyl)ethyl)-6-hydroxy-2,4-dimethylbenzoate (8m). Starting with 
7d (0.535 g, 1.5 mmol) and 3a (0.429 g, 1.65 mmol), 8m 
was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a solid (0.473 g, 72%), mp. 147-148 
°C. 1H NMR (300 MHz, CDCl3):  = 1.53 (d, 3J = 7.2 Hz, 
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3 H, CH3), 2.10 (s, 3 H, CH3), 2.12 (s, 3 H, CH3), 4.45 (q, 3J, 7.2 Hz, 1 H, CH), 5.28 (s, 2 H, 
OCH2), 6.63 (s, 1 H, ArH), 6.89-6.92 (m, 2 H, ArH), 7.26-7.30 (m, 7 H, ArH), 10.45 (s, 1 H, 
OH). 13C NMR (CDCl3, 62.8 MHz):  = 16.3, 19.3, 21.1 (CH3), 36.2 (CH), 66.3 (CH2), 111.7, 
116.7 (CH), 118.1 (C), 128.1, 128.5, 128.6, 128.7, 131.2 (CH), 134.1, 138.2, 143.3, 143.4 (C), 
158.7 (COH), 170.0 (CO). IR (KBr): v = 3063, 3034, 2941, 2880 (w), 1650 (s), 1596, 1567, 
1482, 1463, 1453, 1383, 1343, 1328, 1291 (m), 1222 (s), 1162, 1069, 1017 (m), 1005 (s), 909, 
866, 843 (w) 817, 749, 733 (m), 698 (s), 644, 582, 546 (m) cm-1. MS (EI, 70 eV): m/z (%) = 
440 ([M+, 81Br, 3]), 438 ([M+, 79Br, 3]), 291 (10), 289 (11), 195 (10), 92 (13), 91 (100), 77 
(10), 65 (12), 44 (12). HRMS (EI): calcd. for C24H23O3Br [(M+, Br79])+: 438.08251; found: 
438.082911, calcd. for C24H23O3Br [(M+, Br79,Br81])+: 440.08046; found: 440.081149. 
 
Ethyl 6-hydroxy-3-(1-(4-methoxyphenyl)ethyl)-2,4-dimethylbenzoate (8n). Starting with 
7e (0.462 g, 1.5 mmol) and 3e (0.452 g, 1.65 mmol), 8n was isolated 
after chromatography (silica gel, n-heptane/EtOAc) as a colourless oil 
(0.225 g, 46%). 1H NMR (300 MHz, CDCl3):  = 1.26 (d, 3J = 7.1 Hz, 3 
H, OCH2CH3), 1.53 (d, 3J = 7.2 Hz, 3 H, CH3), 2.09 (s, 3 H, CH3), 2.14 
(s, 3 H, CH3), 3.67 (s, 3 H, OCH3), 4.28 (q, 3J, 7.1 Hz, 2 H, OCH2CH3), 
4.48 (q, 3J, 7.2 Hz, 1 H,  CH), 6.59 (s, 1 H, CH), 6.69-6.72 (m, 2H, ArH), 
6.92-6.95 (m, 2H, ArH), 10.44 (s, 1H, OH). 13C NMR (CDCl3, 62.8 MHz):  = 14.1, 17.5, 
20.0, 22.1 (CH3), 36.8 (CH), 55.2 (OCH3), 112.9 (C), 113.6 (CH), 117.5 (C), 127.31 (CH), 
135.8, 137.4, 139.2, 144.1, 157.3 (C), 159.3 (COH), 171.5 (CO). IR (KBr): v = 2975, 2935, 
2834, 1736 (w), 1655 (s), 1607, 1568 (m), 1509 (s), 1462, 1393, 1370, 1299 (m), 1242, 1224 
(s), 1117, 1153, 1074, 1030 (m), 953, 859 (w), 830, 755, 743, 607, 562 (m) cm-1. MS (EI, 70 
eV): m/z (%) = 328 (M+, 40), 313 (21), 283 (16), 282 (45), 268 (18), 267 (100). HRMS (EI): 
calcd. for C20H24O4 [M]+: 328.16691; found: 328.167020. 
 
11.2 Cyclization versus Elimination Reactions of 5-Aryl-5-hydroxy-1,3-diones. One-
pot Synthesis of 6-Aryl-2,3-dihydro-4H-pyran-4-ones 
 
11.2.1 Synthesis of 2,3-dihydro-4H-pyran-4-ones (11a-o): A THF Solution of LDA (12.5 
mmol) was prepared by addition of nBuLi (5 ml, 12.5 mmol, 2.5 M solution in hexanes) to a 
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THF solution (15 ml) of diisopropylamine (1.26 g, 12.5 mmol) at 0°C. After stiring for 1 h, 
the solution was cooled to -78 °C and 2,4-pentadion (0.50 g, 5.0 mmol) was added. After 
stirring for 1 h at -78 °C, aldehyde (5.0 mmol) was added and the solution was allowed to 
warm to 20 °C within 24 h. Hydrochloric acid (10%, 15 mL) was added and the mixture was 
allowed to stand for 15 min. The reaction mixture was extracted with ethyl acetate (3 x 30mL) 
and washed with a an aqueous solution of NaCl, dried (Na2SO4), filtered and concentrated in 
vacuo.  The residue was purified by chromatography (silica gel, heptanes/ethyl acetate = 2:1) 
to give 13a-o. 
 
2-(2-Chlorophenyl)-6-methyl-2H-pyran-4(3H)-one (11a). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10a (0.70 g, 5.0 mmol) in 
THF (15 mL), 13a was isolated as a colourless viscous oil (0.72 g, 65%). 
1H NMR (300 MHz, CDCl3):   = 2.07 (s, 3 H, CH3), 2.58 (dd, J = 13.7  
Hz, 1 H, HA), 2.71 (dd, J = 4.0, 16.8 Hz, 1H, HB), 5.44 (s, 1 H, CHOlf), 
5.76 (dd, J = 4.0, 13.7 Hz, 1 H, CH), 7.28 (t, J = 7.4 Hz, 1 H, ArH), 7.32 (d, J = 8.6 Hz, 1 H, 
ArH), 7.36 (t, J = 7.5 Hz, 1 H, ArH), 7.59 (d, J = 7.5 Hz, 1 H, ArH). 13C NMR (75.4 MHz, 
CDCl3):  = 21.0 (CH3), 41.1 (CH2), 77.7 (CH), 105.3 (CHOlf), 127.2, 127.3, 127.6, 127.8 
(CH), 131.7, 136.1 (C), 174.2 (COlf), 191.7 (CO). IR (KBr): v = 3411, 3066, 2918, 1706 (w), 
1604, 1575 (s), 1471, 1437, 1398, 1358, 1287, 1232 (m), 1032, 752 (s) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 224 ([M, 37Cl, 1)]+, 222 ([M, 35Cl, 3)]+, 187 (20), 181 (10), 179 (26), 140 (33), 
139 (11), 138 (100), 103 (38), 102 (10), 77 (13). HRMS (EI): calcd. for C12H11O2Cl [(M+, 
Cl35])+: 222.04421; found: 222.044214.  
 
2-(3-Chlorophenyl)-6-methyl-2H-pyran-4(3H)-one (11b). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10b (0.70 g, 5.0 mmol) 
in THF (15 mL), 11b was isolated as a solid (0.78 g, 70%), mp 54-55 
°C. 1H NMR (300 MHz, CDCl3):  = 2.02 (s, 3 H, CH3), 2.52 (dd, J = 
3.5, 16.8 Hz, 1 H, HA), 2.74 (dd, J = 13.9 Hz, 1 H, HB), 5.28 (dd, J = 
3.6, 13.9 Hz, 1 H, CH), 5.37 (s, 1 H, CHOlf), 7.27 (t, J = 6.7 Hz, 1 H, ArH), 7.29 (d, J = 8.7 
Hz, 1H, ArH), 7.32 (d, J = 8.4 Hz, 1 H, ArH), 7. 35 (s, 1 H, ArH). 13C NMR (62.8 MHz, 
CDCl3):  = 21.0 (CH3), 42.3 (CH2), 79.9 (CH), 105.4 (CHOlf), 124.1, 126.3, 128.9, 130.1 
(CH), 134.7, 140.2 (C), 174.0 (COlf), 191.7 (CO). IR (KBr): v = 3399, 3066, 2958, 2921, 
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2853, 1714 (w), 1663, 1607 (s), 1573, 1431 (m), 1391, 1325 (s), 1237, 1159, 1064, 1002, 879, 
783, 690, 582 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 224 ([M, 37Cl, 2)]+, 222 ([M, 35Cl, 
1)]+, 204 (10), 179 (24), 140 (32), 139 (10), 138 (100), 103 (33), 77 (13). HRMS (EI): calcd. 
for C12H11O2Cl [(M+, Cl35])+: 222.04421; found: 222.043856.  
 
2-(4-Chlorophenyl)-6-methyl-2H-pyran-4(3H)-one (11c). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10c (0.70 g, 5.0 mmol) 
in THF (15 mL), 11c was isolated as a colourless crystalline solid 
(0.84 g, 76%), mp 81-82 °C. 1H NMR (300 MHz, CDCl3):  = 2.09 (s, 
3 H, CH3), 2.59 (dd, J = 3.7, 16.7 Hz, 1 H, HA), 2.77 (dd, J = 14.0 Hz, 1 H, HB), 5.37 (dd, J = 
3.8, 14.0 Hz, 1 H, CH), 5.45 (s, 1 H, CHOlf), 7.33-7.37 (m, 2 H, CH), 7.39-7.42 (m, 2 H, CH). 
13C NMR (75.4 MHz, CDCl3):  = 21.0 (CH3), 42.3 (CH2), 80.0 (CH), 105.3 (CHOlf), 127.5, 
129.0 (CH), 134.6, 137.7 (C), 174.0 (COlf), 191.8 (CO). IR (KBr): v = 3037, 2965, 2808, 
2889, 1714 (w), 1600 (s), 1489, 1392, 1245, 1087, 1001 (m), 822 (s), 652, 547 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 224 ([M, 37Cl, 2)]+, 222 ([M, 35Cl, 3)]+, 204 (11), 179 (24), 140 
(33), 139 (10), 138 (100), 103 (23), 77 (10). HRMS (EI): calcd. for C12H11O2Cl ([M+, 35Cl]): 
222.04421; found: 222.044338. 
 
6-Methyl-2-m-tolyl-2H-pyran-4(3H)-one (11d). Starting with a THF solution of LDA (12.5 
mmol), 9a (0.50 g, 5.0 mmol) and 10d (0.60 g, 5 mmol) in THF (15 mL), 
11d was isolated as a colourless oil (0.77 g, 76%). 1H NMR (300 MHz, 
CDCl3):  = 2.08 (s, 3 H, CH3), 2.38 (s, 3 H, CH3Ar), 2.53 (dd, J = 3.5, 
16.8 Hz, 1 H, HA), 2.78 (dd, J = 14.1 Hz, 1 H, HB), 5.33 (dd, J = 3.5, 
14.1 Hz, 1 H, CH), 5.42 (s, 1 H, CHOlf), 7.17 (d, J = 7.8 Hz, 1 H, ArH), 7.20 (d, J = 7.2 Hz, 1 
H, ArH), 7.22 (s, 1 H, ArH), 7.29 (t, J = 7.5 Hz, 1 H, ArH). 13C NMR (75.4 MHz, CDCl3):  
= 21.1 (CH3), 21.4 (CH3Ar), 42.3 (CH2), 80.9 (CH), 105.1 (CHOlf), 123.2, 126.9, 128.7, 129.5 
(CH), 138.1, 138.5 (C), 174.2 (COlf), 192.2 (CO). IR (KBr): v = 3317, 3028, 2918, 2734, 2610 
(w), 1664, 1604 (s), 1490, 1435 (w), 1359, 1256, 1183 (m), 1095 (w), 1025, 951, 886, 808, 
759, 699 (m), 660, 618, 551 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 202 (M+, 3), 184 (14), 
160 (15), 159 (41), 119 (10), 118 (100), 117 (60), 115 (17), 91 (17). HRMS (EI): calcd. for 
C13H14O2 [M]+: 202.09883; found: 202.098878. Anal. Calcd. C13H14O2: C, 77.20; H, 6.98. 
Found: C, 77.01; H, 6.794. 
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2-(2,3-Dimethoxyphenyl)-6-methyl-2H-pyran-4(3H)-one (11e). Starting with a THF 
solution of LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10e (0.83 g, 
5.0 mmol) in THF (15 mL), 11e was isolated as a solid (0.91 g, 73%), 
mp 86-87 °C. 1H NMR (300 MHz, CDCl3):  = 1.99 (s, 3 H, CH3), 
2.49 (dd, J = 3.5, 16.8 Hz, 1 H, HA), 2.66 (dd, J = 14.3, 1 H, HB), 3.79 
(s, 3 H, OCH3Ar), 3.81 (s, 3 H, OCH3Ar), 5.45 (s, 1 H, CHOlf), 5.65 (dd, J = 3.5, 14.3 Hz, 1 H, 
CH), 6.77 (d, J = 7.7 Hz, 1 H, ArH), 7.01 (t, J = 7.4 Hz, 1 H, ArH), 7.8 (d, J = 7.8, 1 H, ArH). 
13C NMR (62.8 MHz, CDCl3):  = 21.1 (CH3), 41.7 (CH2), 55.8, 60.0 (OCH3Ar), 76.1 (CH), 
105.0 (CHOlf), 111.6, 118.3, 124.3 (CH), 132.0, 146.2, 152.3 (CAr), 174.5 (COlf), 192.7 (CO). 
IR (KBr): v = 2962, 2937, 2835, 1721, 1664 (w), 1602, 1586, 1478, 1429, 1395, 1302, 1273, 
1219, 1082 (m), 999 (s), 927, 856, 785, 747, 629, 558 (m) cm-1. MS (EI, 70 eV): m/z (%) = 
248 (M+, 37), 230 (19), 217 (30), 206 (47), 205 (51), 175 (21), 174 (20), 164 (78), 150 (10), 
149 (100), 121 (75), 91 (29), 78 (20), 77 (21). HRMS (ESI-TOF): calcd. for C14H16O4 
[M+H]+: 249.11214; found: 249.1118. C, 50.19; Anal. Calcd. C14H16O4: C, 67.73; H, 6.50. 
Found: C, 67.70; H, 7.19. 
 
2-(3-Hydroxyhenyl)-6-methyl-2H-pyran-4(3H)-one (11f). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10f (0.61 g, 5.0 mmol) 
in THF (15 mL), 11f was isolated as a solid (0.68 g, 67%),  mp 140-
142 °C. 1H NMR (300 MHz, DMSO-d6):  = 2.10 (s, 3 H, CH3), 2.55 
(dd, J  = 3.7, 16.9 Hz, 1 H, HA), 2.81 (dd, J = 13.8 Hz, 1 H, HB), 5.40 
(dd, J  = 3.6, 13.8 Hz, CH, 1 H), 5.46 (s, 1 H, CHOlf), 6.78 (t, J = 7.4 Hz, 1 H, ArH), 6.89 (d, J 
= 7.8 Hz, 1 H, ArH), 6.91 (d, J = 7.3 Hz, 1 H, ArH), 7.24 (s, 1 H, ArH), 9.46 (b.s, 1 H, OHAr). 
13C NMR (75 MHz, DMSO-d6):  = 21.1 (CH3), 42.9 (CH2), 82.1 (CH), 105.3 (CHOlf), 114.1, 
116.6, 118.3, 130.8 (CH), 141.2, 158.9 (CAr), 177.5 (COlf), 195.4 (CO). IR (KBr): v = 3052, 
2957 (m), 2829, 2600 (w), 1633, 1596 (m), 1580, 1574 (s), 1484, 1397 (m), 1360, 1220 (s), 
1175, 1025, 1004, 939, 786, 697, 529 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 204 (M+, 12), 
186 (13), 161 (24), 120 (100), 91 (21). HRMS (EI): calcd. for C12H12O3 [M]+: 204.07810; 
found: 204.078399.  
2-(4-Nitrophenyl)-6-methyl-2H-pyran-4(3H)-one (11g). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10g (0.75 g, 5.0 mmol) 
in THF (15 mL), 11g was isolated as a colourless crystalline solid 
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(0.70 g, 60%), mp 128-130 °C. 1H NMR (300 MHz, CDCl3):  = 2.05 (s, 3 H, CH3), 2.58 (dd, 
J = 4.4, 16.7 Hz, 1 HA), 2.67 (dd, J = 13.1 Hz, 1 HB), 5.62 (s, 1 H, CHOlf), 5.45 (dd, J  = 4.5, 
13.1 Hz, 1 H, CH), 7.51-7.54 (m, 2 H, ArH), 8.20-8.23 (m, 2 H, ArH). 13C NMR (75.4 MHz, 
CDCl3):  = 21.0, (CH3), 42.3 (CH2), 79.4 (CH), 105.7 (CHOlf), 124.1, 126.7 (CH), 145.2, 
148.0 (C), 173.7 (COlf), 190.9 (CO). IR (KBr): v = 3074, 2905, 2847 (w), 1721 (m), 1651, 
1598, 1512 (s), 1494, 1436, 1396 (m), 1342, 1330 (s), 1296, 1234, 1184, 1161, 1104, 1071, 
1030, 1009, 950, 899 (m), 850, 833 (s), 747, 697, 682, 648 (m) cm-1. GC-MS (EI, 70 eV): m/z 
(%) = 233 (M+, 10), 200 (11), 191 (23), 174 (15), 149 (100), 119 (41), 103 (32), 102 (14), 91 
(28), 77 (42), 69 (10), 51 (11), 43 (19). HRMS HRMS (EI): calcd. for C12H11O4N [M]+: 
233.06826; found: 233.067763. 
 
6-Phenyl-2-(thiophen-2-yl)-2H-pyran-4(3H)-one (11h). Starting with a THF solution of 
LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 10h (0.56 g, 5.0 mmol) in 
THF (15 mL),  11h was isolated as a redish viscous oil (0.80 g, 82%). 1H 
NMR (300 MHz, CDCl3):  = 2.07 (s, 3 H, CH3), 2.77 (dd, J  = 4.0, 16.7 
Hz, 1 H, HA), 2.93 (dd, J = 12.6 Hz, 1 H, HB), 5.44 (s, 1 H, CH), 5.64 (dd, J 
= 4.0, 12.6 Hz, 1 H, CH), 7.04 (d, J = 3.5 Hz, 1 H, CHthienyl), 7.12 (t, J = 3.5 Hz, 1 H, 
CHthienyl), 7.39 (d, J = 5.0 Hz, 1 H, CHthienyl). 13C NMR (75.4 MHz, CDCl3):  = 21.1 (CH3), 
42.1 (CH2), 76.2 (CH), 105.4 (CH), 126.1, 126.6, 126.9 (CHthienyl), 140.8 (Cthienyl), 173.7 
(COlf), 191.5 (CO). IR (KBr): v = 3139, 3127, 3078, 2914 (w), 1657 (m), 1604 (s), 1503, 1439 
(m), 1387, 1322, 1183, 1147, 1000 (s), 900, 864, 841, 820 (m), 741 (s), 683, 597 (m) cm-1. 
MS (EI, 70 eV): m/z (%) = 194 (M+, 7), 176 (16), 161 (10), 151 (12), 110 (100), 109 (13). 
HRMS (EI): calcd. for C10H10O2S [M]+: 194.03960; found: 194.039943. 
 
2-(Phenyl)-6-phenyl-2H-pyran-4(3H)-one (11i).  Starting with a THF solution of LDA (12.5 
mmol), 9b (0.81 g, 5.0 mmol) and 10i (0.53 g, 5.0 mmol) in THF (15 
mL), 11i was isolated as a colourless crystalline solid (0.97 g, 78%),  
mp 93-94 °C. 1H NMR (300 MHz, DMSO-d6):  = 2.69 (dd, J = 3.4, 
16.6 Hz, 1 H, HA), 3.02 (dd, J = 13.6 Hz, 1 H, HB), 5.75 (dd, J = 3.4, 
13.6 Hz,  1 H, CH), 6.21 (s, 1 H, CHOlf), 7.40-7.88 (m, 10 H, Ph). 13C NMR (75 MHz, 
DMSO-d6): = 41.8 (CH2), 80.1 (CH), 101.9 (CHOlf), 126.4, 126.5, 128.54, 128.59, 128.8, 
131.7 (CH), 132.2, 138.5 (C), 168.7 (COlf), 192.0 (CO). IR (KBr): v = 3292, 3064, 3029, 2896 
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(w), 1710, 1650 (s), 1592, 1570, 1490, 1382, 1315, 1245, 1178, 1046, 937, 854 (m), 762, 692 
(s), 664, 614, 569 (m) cm-1. MS (EI, 70 eV): m/z (%) = 250 (M+, 6), 232 (11), 145 (25), 144 
(17), 105 (40), 104 (100), 103 (18), 78 (16), 77 (23). HRMS (EI): calcd. for C17H14O2 [M]+: 
250.09883; found: 250.099148. Anal. Calcd. C17H14O2: C, 81.58; H, 5.64. Found: C, 81.56; 
H, 5.72. 
 
2-(2-Chlorophenyl)-6-phenyl-2H-pyran-4(3H)-one (11j). Starting with a THF solution of 
LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10a (0.70 g, 5.0 mmol) 
in THF (15 mL), 11j was isolated as a colourless crystalline solid 
(0.88 g, 62%),  mp 96-98 °C. 1H NMR (300 MHz, DMSO-d6):  =  
2.68 (dd, J  = 3.3, 16.7 Hz, 1 H, HA), 3.07 (dd, J  = 14.0 Hz, 1 H, HB), 
5.95 (dd, 1 H, J = 3.2, 14.0 Hz, CH), 6.25 (s, 1 H, CHOlf), 7.47-7.89  (m, 9 H, ArH). 13C NMR 
(62.8 MHz, DMSO-d6):  = 40.2 (CH2), 77.2 (CH), 101.9 (CHOlf), 126.4, 127.7, 128.1, 128.8, 
129.7, 130.4, 131.8 (CH), 131.9, 132.0, 135.3 (C), 168.8 (COlf), 191.6 (CO). IR (KBr): v = 
3282, 3063, 3035, 2968, 2916 (w), 1651, 1595 (s), 1570, 1450 (m), 1378, 1327 (s), 1293, 
1233, 1131, 1071, 993, 941, 856, 805, 772 (m), 754, 685, 669 (s), 616, 567, 540 (m) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 286 ([M, 37Cl, 3]+), 284 ([M, 35Cl, 9]+), 249 (22), 179 (10), 
178 (10), 140 (34), 139 (10), 138 (100), 105 (48), 103 (35), 102 (11), 77 (29). HRMS (EI): 
calcd. for C17H13ClO2 [M+, 35Cl]: 284.05986; found: 284.059945. Anal. Calcd. C17H13O2Cl: 
C, 71.71; H, 4.60. Found: C, 71.74; H, 4.62. 
 
2-(4-Chlorophenyl)-6-phenyl-2H-pyran-4(3H)-one (11k). Starting with a THF solution of 
LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10c (0.70 g, 5.0 
mmol) in THF (15 mL), 11k was isolated as a colourless 
crystalline solid (0.94 g, 82%), mp 90-92 °C. 1H NMR (300 MHz, 
DMSO-d6):  = 2.72 (dd, J  = 3.4, 16.6 Hz, 1 H, HA), 3.05 (dd, J  
= 13.6 Hz, 1 H, HB), 5.78 (dd, 1 H, J = 3.4, 13.6, CH), 6.21 (s, 1 H, CHOlf), 7.35-7.56  (m, 5 
H, ArH), 7.62-7.65  (m, 2 H, ArH), 7.84-7.88  (m, 2 H, ArH). 13C NMR (62 MHz, DMSO-
d6):  = 41.6 (CH2), 79.3 (CH), 101.9 (CHOlf), 126.4, 128.4, 128.5, 128.8, 131.7 (CH), 132.1, 
133.1, 137.5 (C), 168.6 (COlf), 191.8 (CO). IR (KBr): v = 3281, 3089, 3058, 2965, 2895 (w), 
1651, 1595, 1568, 1492 (s), 1449, 1376, 1328, 1293, 1215, 1160, 1089, 993, 855, 835, 804 
(m), 768, 681, 664 (s), 615, 566, 540 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 286 ([M, 37Cl, 
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6]+), 284 ([M, 35Cl, 7]+), 179 (13), 178 (10), 140 (32), 139 (10), 138 (100), 105 (44), 103 (25), 
102 (10), 77 (24). HRMS (ESI-TOF): calcd. for C17H13ClO2 [M+, 37Cl]: 284.05986; found: 
284.060349. Anal. Calcd. C17H13ClO2: C, 71.71; H, 4.60. Found: C, 71.65; H, 4.95. 
 
2-(2,4-Dimethoxyphenyl)-6-phenyl-2H-pyran-4(3H)-one (11l). Starting with a THF 
solution of LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10j 
(0.83 g, 5.0 mmol) in THF (15 mL), 11l was isolated as a 
colourless crystalline solid (0.96 g, 73%),  mp 101-102 °C. 1H 
NMR (300 MHz, DMSO-d6):  = 2.67 (dd, J = 4.0, 16.8 Hz, 1 H,  
HA), 2.78 (dd, J = 13.5 Hz, 1 H, HB,), 3.77 (s, 6 H, 2CH3Ar), 5.80 (dd, J = 4.0, 13.5 Hz, 1 H, 
CH), 6.03 (s, 1 H, CHOlf), 6.45 (s, 1 H, ArH), 6.50 (d, J = 8.4 Hz, 1 H, ArH), 7.34-7.42 (m, 4 
H, ArH), 7.71 (d, J = 8.1 Hz, 1 H, ArH). 13C NMR (75 MHz, DMSO-d6):  = 41.9 (CH2), 55.4 
(2 x OCH3), 76.2, 98.5, 102.1, 104.4 (CH), 117.4, 124.7 (C), 126.6, 127.4, 128.6, 131.5 (CH), 
155.5, 159.1 (C), 168.9 (COlf), 192.0 (CO). IR (KBr): v = 3271, 3082, 2966, 2933, 2837 (w), 
1650, 1613, 1566, 1453, 1375, 1288, 1209, 1158, 1029, 954, 835 (m), 773, 695 (s) cm-1. MS 
(EI, 70 eV): m/z (%) = 310 (M+, 20), 205 (67), 165 (13.4), 164 (100), 149 (73), 121 (39.1), 
105 (24.8), 91 (11), 77 (20). HRMS (M+H): calcd. for C19H19O4 [M+H]+: 311.12779; found: 
311.12746. 
 
2-(3-Bromophenyl)-6-phenyl-2H-pyran-4(3H)-one (11m). Starting with a THF solution of 
LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10i (0.92 g, 5.0 
mmol) in THF (15 mL), 11m was isolated as a colourless 
crystalline solid (1.16 g, 72%),  mp 103-104 °C. 1H NMR (300 
MHz, DMSO-d6):  = 2.70 (dd, J  = 3.4, 16.7 Hz, 1 H, HA), 3.04 
(dd, J  = 13.7 Hz, 1 H, HB), 5.80 (dd, 1 H, J = 3.3, 13.7 Hz, 1 H, CH), 6.21 (s, 1 H, CHOlf), 
7.41-7.64 (m, 6 H, ArH), 7.81-7.88 (m, 3 H, ArH). 13C NMR (62.8 MHz, DMSO-d6):  = 41.2 
(CH2), 79.3 (CH), 102.0 (CHOlf), 121.8 (C), 125.6, 126.4, 128.8, 129.3, 130.8, 131.4, 131.7 
(CH), 132.1, 141.2 (C), 168.6 (COlf), 191.8 (CO). IR (KBr): v = 3291, 3057, 2976, 2910, 1722 
(w), 1651, 1593 (s), 1567, 1492, 1448, 1366, 1292, 1241, 1174, 1073, 991, 946, 880, 830, 783 
(m), 767, 684 (s), 661, 612, 586 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 330 ([M, 81Br, 4]+), 
328 ([M, 79Br, 5]+), 312 (13), 310 (12), 224 (12), 222 (11), 184 (85), 183 (10), 182 (88), 144 
(14), 106 (10), 105 (100), 103 (46), 102 (21), 77 (55), 51 (13). HRMS: calcd. for C17H13O2Br 
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[M+, 79Br]: 328.00934; found: 328.008852.; calcd. for C17H13O2Br [M+, 81Br]: 330.00730; 
found: 330.00730. Anal. Calcd.: C, 62.03; H, 3.98. Found: C, 62.01; H, 3.97. 
 
2-(3-Nitrophenyl)-6-phenyl-2H-pyran-4(3H)-one (11n) Starting with a THF solution of 
LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10k (0.75 g, 5.0 
mmol) in THF (15 mL), 11n was isolated as a colourless 
crystalline solid (1.0 g, 68 %),  mp 104-105 °C. 1H NMR (300 
MHz, DMSO-d6):  = 2.77 (dd, J  = 3.4, 16.5 Hz, 1 H, HA), 3.07 
(dd, J  = 13.8 Hz, 1 H,  HB), 5.93 (dd, J = 3.4, 13.7 Hz, 1 H, CH), 6.24 (s, 1 H, CHOlf), 7.46-
8.28 (m, 8 H, ArH), 8.46 (s, 1 H, ArH). 13C NMR (62.8 MHz, DMSO-d6):  = 41.7 (CH2), 
79.0, 102.1, 121.2, 123.3, 126.4, 128.8, 130.2, 131.7, 133.0 (CH), 140.7, 147.8 (C), 168.5 
(COlf), 191.5 (CO). IR (KBr): v = 3107, 3088, 3068, 2930, 2894 (w), 1613, 1573 (s), 1519, 
1494, 1458, 1393 (m), 1345 (s), 1285, 1237, 1185, 1147, 1060, 1019, 898, 874 818 (m), 764, 
684 (s), 616, 541 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 295 (M+, 2), 162 (34), 161 (27), 
151 (37), 150 (34), 147 (28), 120 (11), 105 (100), 104 (7), 78 (12), 77 (85), 76 (10), 69 (47), 
51 (37), 50 (13), 43 (18). HRMS (EI): calcd. for C17H13NO4 [M]+: 295.08391; found: 
295.084032. 
 
2-(4-Nitrophenyl)-6-phenyl-2H-pyran-4(3H)-one (11o) Starting with a THF solution of 
LDA (12.5 mmol), 9b (0.81 g, 5.0 mmol) and 10l (0.75 g, 5.0 
mmol) in THF (15 mL), 11o was isolated as a solid (0.98 g, 
67%), mp 118-119 °C. 1H NMR (300 MHz, DMSO-d6):  = 2.73 
(dd, J  = 4.2, 16.8 Hz, 1 H, HA), 2.82 (dd, J  = 13.2 Hz, 1 H,  
HB), 5.64 (dd, J = 4.1, 13.2 Hz, 1 H, CH), 6.09 (s, 1 H, CHOlf), 7.37-8.27 (m, 9 H, ArH). 13C 
NMR (75 MHz, DMSO-d6):  = 42.9 (CH2), 79.7 (CH), 102.6 (CHOlf), 124.2, 126.6, 126.8, 
128.8, 132.1 (CH), 135.4, 145.2 (C), 169.8 (COlf), 191.4 (CO). IR (KBr): v = 3108, 3089, 
3068, 2931, 2895 (w), 1611, 1573 (s), 1519, 1495, 1457, 1394 (m), 1346 (s), 1286, 1238, 
1185, 1147, 1060, 1019, 898, 874, 818 (m), 764, 684 (s), 616, 541 (m) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 295 (M+, 48), 294 (14), 176 (19), 173 (26), 144 (14), 115 (14), 106 (12), 105 
(100), 102 (15), 77 (36), 69 (22), 51 (11). HRMS (EI): calcd. for C17H13NO4 [M]+: 
295.08391; found: 295.084160. 
 
O
O
O2N
O
O
O2N
 103  
11.2.2 [3+3] Reaction of 2,3-dihydro-4H-pyran-4-ones 
To a stirred dichloromethane solution (2 mL per 1.0 mmol of 11c) of 11c (1.0 equiv.) and of 
1,3-bis(silyl enol ether) 3d (1.1 equiv.) was added TiCl4 (1.1 equiv.) at 78 °C under an argon 
atmosphere. The temperature of the reaction mixture was allowed to rise to 20 °C during 16 h. 
To the solution was added hydrochloric acid (10%, 3 mL per 1.0 mmol of 11c) and the 
mixture was extracted with dichloromethane (3 x 15 mL). The combined organic layers were 
dried (Na2SO4), filtered and the filtrate was concentrated under reduced pressure. The residue 
was purified by column chromatography (silica gel, heptanes  EtOAc/heptanes = 1:10). 
 
(E)-Methyl 6-(4-chlorostyryl)-3-ethyl-2-hydroxy-4-methylbenzoate (12). Starting with 11c 
(0.334 g, 1.5 mmol) and 3d (0.476 g, 1.65 mmol), 12 was isolated 
after chromatography (silica gel, n-heptane/EtOAc) as white solid 
crystal (0.23 g, 50%). 1H NMR (300 MHz, CDCl3):  = 1.07 (t, J = 
7.5 Hz, 3 H, CH3), 2.28 (s, 3 H, CH3), 2.64 (q, J = 7.5 Hz, 2 H, 
CH2), 3.88 (s, 3 H, OCH3), 6.66 (d, J = 16.0 Hz, 1 H, CH),  6.81 
(s, 1 H, ArH), 7.24-7.35 (m, 4 H, ArH), 7.56 (d, J = 16.0 Hz, 1 H, ArH), 11.44 (s, 1 H, OH). 
13C NMR (CDCl3, 75 MHz):  = 13.1, 19.6 (CH3), 19.7 (CH2), 52.4 (OCH3), 108.2 
(CCOOCH3), 121.4 (CH), 127.7 (2×CH), 128.6 (CH), 128.9 (2×CH), 130.7 (CH), 130.8, 
133.1, 136.3, 137.4, 143.0 (CAr), 160.5 (COH), 172.1 (CO). ). IR (KBr): v  = 3030, 2953, 
2931, 2872, 1786, 1724 (w), 1655 (s), 1603, 1557, 1490, 1436, 1394, 1357, 1318 (m), 1273, 
1233 (s), 1194 (m), 1152, 1090 (s), 1051, 962, 849 (m), 814 (s), 786, 731, 629, 596 (m). GC-
MS (EI, 70 eV): m/z (%) = 332 ([M, 37Cl, 29]+), 330 ([M, 35Cl, 100]+), 283 (42), 207 (22), 165 
(9), 131 (8), 91 (11), 69 (32), 44 (12). HRMS (EI): Calcd. for C19H19O3Cl [M+, 35Cl]: 
330.10172; found: 330.101981. 
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11.3 Synthesis of Fluorinated 2,3-Dihydro-4H-pyran-4-ones by Cyclocondensation of 
1,3-Dicarbonyl Dianions with Aldehydes 
 
11.3.1 Synthesis of Fluorinated 2,3-dihydro-4H-pyran-4-ones (14a-j) and (16a-f): A THF 
solution of LDA (12.5 mmol) was prepared by addition of nBuLi (5 ml, 12.5 mmol, 2.5 M 
solution in hexanes) to a THF solution (15 ml) of diisopropylamine (1.26 g, 12.5 mmol) at 
0°C. After stiring for 1 h, the solution was cooled to -78 °C and 1,1,1-trifluoro-pentane-2,4-
dione (0.77 g, 5.0 mmol) was added. After stirring for 1 h at -78 °C, aldehydes (5.0 mmol) 
was added and the solution was allowed to warm to 20 °C within 24 h. Hydrochloric acid 
(10%, 15 mL) was added and the mixture was allowed to stand for 15 min. Ethyl acetate (25 
mL) was added. The organic and aqueous layers were separated and the latter was extracted 
with ethyl acetate (3 x 50 mL). The combined organic layers were dried (Na2SO4), filtered 
and the filtrate was concentrated in vacuo. The residue was purified by chromatography 
(silica gel, heptanes/ethyl acetate = 2:1) to give the products (14a-j) and (16a-f). 
 
6-(Trifluoromethyl)-2-phenyl-2H-pyran-4(3H)-one (14a). Starting with a THF solution of 
LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10i (0.53 g, 5.0 mmol) in 
THF (15 mL), 14a was isolated as a slightly yellow oil (0.97 g, 80%). 1H 
NMR (300 MHz, CDCl3):  = 2.81 (ddd, J = 1.1, 3.6, 17.1 Hz, 1 H, HA), 
3.01 (dd, J = 13.6, 17.1 Hz, 1 H, HB), 5.61 (dd, J  = 3.6, 13.7 Hz, 1 H, 
CH), 5.98 (q, J = 1.0 Hz, 1 H, CHOlf), 7.41-7.47 (m, 5 H, ArH). 19F NMR 282.4 MHz, 
CDCl3):  = -73.3. 13C NMR (75.4 MHz, CDCl3):  = 42.7 (CH2), 82.6 (CH), 105.2 (q, JC,F = 
2.8 Hz, CHOlf), 118 (q, JC,F = 274.8 Hz, CF3), 126.1, 129.0, 129.4 (CH), 136.3 (CAr), 159.4 (q, 
JC,F = 37.3 Hz, COlf), 191.2 (CO). IR (KBr): v = 3368, 3093, 3067, 2976, 2901, 2707 (w), 
1687, 1638 (s), 1585 (m), 1498, 1455 (w), 1413 (m), 1367 (w), 1270 (s), 1243 (m), 1194, 
1142, 1067 (s), 986, 941, 877, 828, 756 (m), 695 (s), 620, 593, 533 (m)  cm-1. MS (EI, 70 eV): 
m/z (%) = 242 (M+, 5), 173 (7), 145 (9), 117 (9), 105 (12), 104 (100), 103 (20), 78 (15), 77 
(11), 69 (12), 51 (8). HRMS (ESI-TOF): calcd. for C12H8O2F3 [M-H]+: 241.04819 found: 
241.04775. Anal. Calcd. C12H9O2F3: C, 59.51; H, 3.75. Found: C, 59.75; H, 3.92. 
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2-(2-Chlorophenyl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14b). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10a (0.70 g, 
5.0 mmol) in THF (15 mL), 14b was isolated as a colourless oil (0.86 g, 
62%). 1H NMR (300 MHz, CDCl3):  = 2.81 (dd, J = 13.9, 17.1 Hz, 1 H, 
HA), 2.95 (ddd, J = 1.2, 3.6, 17.1 Hz, 1 H, HB), 5.97 (dd, J = 3.7, 14.0 
Hz, 1 H, CH), 6.02 (q, = 1.0 Hz, CHOlf ), 7.37-7.47 (m, 3 H, ArH), 7.61-7.64 (m, 1 H, ArH). 
19F NMR (282 MHz, CDCl3):  = -73.2. 13C NMR (75 MHz, CDCl3):  = 41.7 (CH2), 79.7 
(CH), 105.4 (q, JC,F = 3.0 Hz, CHOlf), 115.1 (q, JC,F = 275.2 Hz, CF3), 127.0, 127.6, 129.9, 
130.3 (CH), 131.7, 134.5 (C), 159.3 (q, JC,F = 36.9 Hz, COlf), 190.7 (CO). IR (KBr): v = 3034, 
2922 (w), 1678, 1631, 1410 (s), 1344 (m), 1261, 1167, 1152, 1069 (s), 994, 960, 938 (m), 811 
(s), 720, 710, 605 (m) cm-1. MS (EI, 70 eV): m/z (%) = 278 ([M, 37Cl, 1]+), 276 ([M, 35Cl, 
4]+), 241 (13), 118 (100), 117 (51), 91 (15), 69 (12). HRMS (ESI-TOF): calcd. for C12H9O2Cl 
F3 [M+H]+, (M+, [35Cl]): 277.02377; found: 277.02388. 
 
2-(4-Chlorophenyl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14c). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10c (0.70 
g, 5.0 mmol) in THF (15 mL), 14c was isolated as a colourless 
crystalline solid (1.04 g, 72%),  mp 76-77 °C. 1H NMR (300 MHz, 
CDCl3):  = 2.69 (ddd, J = 0.9, 3.8, 17.0 Hz, 1 H, HA), 2.87 (dd, J = 
13.3, 17.0 Hz, 1 H, HB), 5.48 (dd, J  = 3.8, 13.6 Hz, 1 H, CH), 5.88 (brs, 1 H, CHOlf), 7.25-
7.36  (m, 4 H, ArH).19F NMR 282 MHz, CDCl3):  = -73.3. 13C NMR (62.8 MHz, CDCl3):  
= 42.6 (CH2), 81.8 (CH), 105.3 (q, JC,F = 3.1 Hz, CHOlf ), 118.7 (q, JC,F = 275.0 Hz, CF3), 
127.5, 129.2 (CH), 135.4, 134.8 (C), 158.9 (q, JC,F = 37.0 Hz, COlf), 190.6 (CO). IR (KBr): v = 
3104, 2884 (w), 1680, 1634, 1494 (s), 1410, 1324 (m), 1274, 1175, 1141, 1068 (s), 993, 959, 
939, 877 (m), 835 (s), 719, 638, 548 (m) cm-1. MS (EI, 70 eV): m/z (%) = 278 ([M, 37Cl, 2]+), 
276 ([M, 35Cl, 6]+), 140 (33), 139 (12), 138 (100), 103 (23), 69 (13). HRMS (EI): calcd. for 
C12H8O2F3Cl [M+, 35Cl]: 276.01594; found: 276.015382. 
 
2-(3-Nitrophenyl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14d). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10k (0.75 
g, 5.0 mmol) in THF (15 mL), 14d was isolated as a solid (0.90 g, 
63%),  mp 102-103 °C. 1H NMR (300 MHz, CDCl3):  =  2.79 
(ddd, J = 1.2, 3.9, 16.9 Hz, 1 H, HA), 2.92 (dd, J = 13.4, 16.8 Hz, 1 
H, HB), 5.63 (dd, J = 4.4, 13.9 Hz, 1 H, CH), 5.95 (brs, 1 H, CHOlf), 7.57-7.62  (m, 1 H, ArH), 
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7.67-7.73 (m, 1 H, ArH), 8.21-8.26 (m, 2 H, ArH). 19F NMR 282 MHz, CDCl3):  = -73.1. 
13C NMR (75.4 MHz, CDCl3):  = 42.6 (CH2), 81.2, 105.7 (q, JC,F = 3.0 Hz, 1 H, CHOlf), 115 
(q, JC,F = 275.2 Hz, CF3), 121.2, 124.3, 130.3, 131.9 (CH), 138.4, 148.6 (C), 159.0 (q, JC,F = 
37.7 Hz, COlf), 189.8 (CO). IR (KBr): v = 3093, 3067, 2912, 2878 (w), 1688, 1640, 1531 (s), 
1417, 1353 (m), 1271, 1192, 1143, 1075 (s), 1005, 943, 912, 868 (m), 808 (s), 736 (m), 683 
(s), 626, 538 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 287 (M+, 43), 286 (6), 270 (8), 219 
(13), 218 (100), 200 (14), 190 (12), 176 (84), 173 (28), 172 (13), 171 (12), 165 (17), 144 (25), 
143 (20), 131 (12), 130 (10), 129 (17), 118 (11), 116 (19), 115 (64), 103 (17), 102 (33), 89 
(12), 77 (13), 76 (14), 75 (11), 69 (49), 63 (12), 51 (12). HRMS (ESI-TOF): calcd. for 
C12H7F3NO4 [M-H]+: 286.03327 found: 286.03353. Anal. Calcd C12H8F3NO4: C, 50.19; H, 
2.81; N, 4.88. Found: C, 50.18; H, 2.82; N, 4.87. 
 
2-(4-Nitrophenyl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14e). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10l (0.75 
g, 5.0 mmol) in THF (15 mL), 14e was isolated as a colourless 
crystalline solid (0.86 g, 60%),  mp 112 °C. 1H NMR (300 MHz, 
CDCl3):  =  2.79 (ddd, J = 0.8, 4.5, 17.0 Hz, 1 H, HA), 2.88 (dd, J 
= 12.7, 17.1 Hz, 1 H, HB), 5.64 (dd, J = 4.6, 12.7 Hz, 1 H, CH), 5.95 (brs, 1 H, CHOlf), 7.54-
7.57 (m, 2 H, ArH), 8.24-8.26 (m, 2 H, ArH). 19F NMR 282 MHz, CDCl3):  = -73.3. 13C 
NMR (62.8 MHz, CDCl3):  = 42.7 (CH2), 81.1 (CH), 105.7 (q, JC,F = 3.0 Hz, 1 H, CHOlf), 
118.8 (q, JC,F = 274.4 Hz, CF3), 124.1, 126.8 (CH), 143.8, 148.3 (C), 158.4 (q, JC,F = 37.6 Hz, 
COlf), 189.8 (CO). IR (KBr): v = 3094, 3068, 2912, 2879 (w), 1689, 1640, 1530 (s), 1418, 
1354 (m), 1270, 1193, 1144, 1075 (s), 1005, 944, 912, 868 (m), 807 (s), 737 (m), 684 (s), 626, 
539 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 287 (M+, 4), 218 (9), 162 (11), 150 (10), 149 
(100), 119 (31), 103 (31), 102 (11), 91 (24), 77 (38), 69 (19), 51 (10). HRMS (EI): calcd. for 
C12H8O2F3 [M]+: 287.04054 found: 287.040243. 
 
2-(Biphenyl-4-yl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14f). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10m 
(0.91 g, 5.0 mmol) in THF (15 mL), 17f was isolated as a 
colourless crystalline solid (1.29 g, 81 %), mp 124 °C. 1H NMR 
(300 MHz, CDCl3):  = 2.75 (ddd, J = 1.0, 3.6, 17.1 Hz, 1 H, 
HA), 2.96 (dd, J = 13.6, 17.1 Hz, 1 H, HB), 5.56 (dd, J = 3.5, 13.6 
Hz, 1 H, CH), 5.90 (q, J = 1.0 Hz, 1 H, CHOlf), 7.36-7.43  (m, 4 H, ArH), 7.51-7.61  (m, 5 H, 
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ArH). 19F NMR 282 MHz, CDCl3):  = -73.2. 13C NMR (75.4 MHz, CDCl3):  = 42.6 (CH2), 
82.4 (CH), 105.2 (q, J C,F = 3.0 Hz, CHOlf), 118.5 (q, JC,F = 275.0 Hz, CF3), 126.6, 127.1, 
127.71, 127.7, 128.8 (CH), 135.1, 140.1, 142.5 (C), 159.7 (q, J C,F = 37.2 Hz, COlf), 191.1 
(CO). IR (KBr): v = 3057, 3028, 2991, 2837, 1712 (w), 1660, 1601 (s), 1485, 1432 (m), 1394, 
1332, 1235, 1000 (s), 950, 898, 873 (m), 762, 731, 701 (s) 657 (m)  cm-1. MS (EI, 70 eV): m/z 
(%) = 318 (M+, 32), 181 (16), 180 (100), 179 (13), 178 (18), 165 (10), 69 (10). HRMS (ESI-
TOF): calcd. for C18H14O2F3 [M+H]+: 319.09404; found: 319.09435.  
 
2-(Thien-2-yl)-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14g). Starting with a THF 
solution of LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10h (0.56 g, 5.0 
mmol) in THF (15 mL), 14g was isolated as a slight yellow oil (0.88 g, 
71%). 1H NMR (300 MHz, CDCl3):  = 2.88 (ddd, J = 0.9, 4.3, 17 Hz, 1 
H, HA), 3.03 (dd, J = 13.5, 17.0 Hz, 1 H, HB), 5.46 (brs, 1 H, CHOlf), 5.77 
(dd, J = 4.2, 11.4 Hz, 1 H, CH), 7.04 (d, J = 3.3 Hz, 1 H, CHthienyl), 7.12 (t, J = 3.5 Hz, 1 H, 
CHthienyl), 7.39 (d, J = 5.0 Hz, 1 H, CHthienyl).19F NMR 282 MHz, CDCl3):  = -73.2. 13C NMR 
(75.4 MHz, CDCl3):  = 42.3 (CH2), 76.2 (CH), 105.3 (q, J C,F = 3.0 Hz, CHOlf), 118.3 (q, J C,F 
= 273.0 Hz, CF3), 126.3, 126.6, 127.3 (CHthienyl), 140.8 (Cthienyl), 159.3 (q, J C,F = 37.2 Hz, 
COlf), 191.6 (CO). IR (KBr): v = 3086, 3070 (m), 1686 (s), 1637, 1410, 1358, 1317 (m), 1262, 
1193, 1145 (s), 1065, 965, 823 (m), 701 (s) 640 (m) cm-1. MS (EI, 70 eV): m/z (%) = 248 
(M+, 19), 111 (10), 110 (100), 109 (10), 69 (15). HRMS (ESI-TOF): calcd. for C10H7O2F3S 
[M]+: 248.01134; found: 248.010271. 
 
2-Heptyl-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14h). Starting with a THF solution of 
LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10n (0.64 g, 5.0 
mmol) in THF (15 mL), 14h  was isolated as a slight yellow 
oil (1.02 g, 78%). 1H NMR (300 MHz, CDCl3):  = 0.81 (t, J = 
7.0 Hz, 3 H, CH3(CH2)(CH2)5), 1.19-1.26 (m, 8 H, CH3(CH2)4(CH2)2), 1.34-1.42 (m, 2 H, 
CH3(CH2)4(CH2)(CH2)), 1.59-1.84 (m, 2 H), 2.50 (t, J = 7.1 Hz, 2 H, CH3(CH2)4(CH2)(CH2)), 
4.44-4.51 (m, 1 H, CH), 5.75 (brs, 1 H, CHOlf). 19F NMR (282 MHz, CDCl3):  = -73.6. 13C 
NMR (75.4 MHz, CDCl3):  = 13.0 (CH3), 21.5, 23.6, 28.0, 28.1, 30.7, 32.9, 40.3 (CH2), 80.7 
(CH), 103.6 (q, J = 3 Hz, CHOlf), 121.5 (q, J C,F = 276.5 Hz, CF3), 158.3 (q, J C,F = 36.9 Hz, C), 
190.8 (CO). IR (KBr): v = 2921, 2852 (m), 1688 (s), 1465, 1417 (m), 1340 (w), 1270, 1197, 
1156 (s), 1073, 909, 820 (m), 720 (w) cm-1. MS (EI, 70 eV): m/z (%) = 264 (M+, 16), 195 
(29), 193 (10), 167 (16), 165 (100), 139 (68), 110 (17), 109 (10), 98 (11), 97 (23), 95 (10), 85 
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(12), 84 (22), 83 (18), 82 (12), 81 (14), 70 (22), 69 (86), 68 (13), 67 (16), 56 (30), 55 (41), 54 
(15), 43 (30), 42 (13), 41 (48), 39 (17), 29 (17). HRMS: calcd. for C13H19O2F3 [M]+: 
264.3371; found: 264.33711. 
 
2-Octyl-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14i). Starting with a THF solution of 
LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10o (0.71 g, 
5.0 mmol) in THF (15 mL), 14i was isolated as a slight 
yellow oil (1.10 g, 79%). 1H NMR (300 MHz, CDCl3):  = 
0.81 (t, J = 7.0 Hz, 3 H, CH3(CH2)(CH2)6), 1.19-1.46 (m, 12 H, CH3(CH2)6(CH2)), 1.58-1.88 
(m, 2 H), 2.47-2.51 (m, 2 H, CH2), 4.43-4.52 (m, 1 H, CH), 5.74 (s, 1 H, CHOlf). 19F NMR 
(282 MHz, CDCl3):  = -73.6. 13C NMR (75.4 MHz, CDCl3):  = 13.0 (CH3), 21.5, 23.6, 28.0, 
28.1, 28.2, 30.7, 32.9, 40.2 (CH2), 80.6 (CH), 103.4 (q, J = 3 Hz, CHOlf), 121.9 (q, J C,F = 
276.4 Hz, CF3), 158.2 (q, J C,F = 36.7 Hz, C), 190.7 (CO). IR (KBr): v = 2925, 2855 (m), 1691 
(s), 1466, 1417 (m), 1339 (w), 1269, 1194, 1149 (s), 1073, 909, 819 (m), 720 (w) cm-1. MS 
(EI, 70 eV): m/z (%) = 278 (M+, 2), 209 (18), 167 (13), 165 (100), 139 (45), 97 (14), 83 (15), 
82 (12), 81 (10), 70 (18), 69 (52), 67 (10), 57 (12), 56 (17), 55 (30), 54 (10), 43 (19), 41 (33), 
39 (10), 29 (11). HRMS: calcd. for C14H21F3O2 [M]+: 278.14882; found: 278.149378. 
 
2-Nonyl-6-(trifluoromethyl)-2H-pyran-4(3H)-one (14j). Starting with a THF solution of 
LDA (12.5 mmol), 13 (0.77 g, 5.0 mmol) and 10p (0.78 
g, 5.0 mmol) in THF (15 mL), 14j was isolated as a 
colourless crystalline solid (1.21 g, 83%). 1H NMR (300 
MHz, CDCl3):  = 0.80 (t, J = 7.0 Hz, 3 H, CH3(CH2)8), 1.17-1.26 (m, 12 H, 
CH2(CH2)6(CH2)2), 1.35-1.43 (m, 2 H, CH3(CH2)6(CH2)(CH2)), 1.60-1.87 (m, 2 H, CH2), 
2.47-2.51 (m,  2 H, CH2), 4.46-4.52 (m, 1 H, CH), 5.75 (brs, 1 H, CHOlf). 19F NMR (282 
MHz, CDCl3):  = -73.6. 13C NMR (75.4 MHz, CDCl3):  = 14.0 (CH3), 22.6, 24.5, 29.1, 
29.3, 29.4, 31.8, 32.3, 33.8, 41.3 (CH2), 81.6 (CH), 106.6 (q, J = 3 Hz, CHOlf), 118.5 (q, J C,F = 
277.9 Hz, CF3), 159.2 (q, J C,F = 36.5 Hz, COlf), 191.8 (CO). IR (KBr): v = 2924, 2854 (m), 
1691 (s), 1466, 1418 (m), 1340 (w), 1269, 1195, 1150 (s), 1073, 912, 820 (m), 720 (w) cm-1. 
MS (EI, 70 eV): m/z (%) = 292 (M+, 1), 223 (14), 165 (100), 139 (30), 97 (11), 83 (12), 70 
(12), 69 (35), 56 (10), 55 (22), 43 (15), 41 (25), 29 (10). HRMS: calcd. for C15H23O2F3 [M]+: 
319.09404; found: 319.09435. 
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6-Methyl-2-(2-(trifluoromethyl)phenyl)-2H-pyran-4(3H)-one (16a).  Starting with a THF 
solution of LDA (12.5 mmol), 9 (0.50 g, 5.0 mmol) and 15a (0.87 g, 5.0 
mmol) in THF (15 mL), 16a was isolated as a colourless crystalline solid 
(0.94 g, 73%), mp 127 °C. 1H NMR (300 MHz, CDCl3):  = 2.00 (s, 3 H, 
CH3), 2.2.49 (ddd, J = 0.7, 3.7, 16.8 Hz, 1 H, HA), 2.64 (dd, J = 14.1, 16.9 
Hz, 1 H, HB), 5.38 (s, 1 H, CHOlf),  5.69 (dd, J = 3.7, 14.0 Hz, 1 H, CH), 7.38-7.43  (m, 1 H, 
ArH), 7.55-7.62 (m, 2 H, ArH), 7.71-7.74 (m, 1 H, ArH). 19F NMR 282 MHz, CDCl3):  = -
58.4. 13C NMR (75.4 MHz, CDCl3):  = 21.0 (CH3), 43.1 (CH2), 77.1 (q, J C,F = 2.3 Hz, CH), 
105.3 (CHOlf), 125.9 (q, J = 5.6 Hz, ArH), 128.0, 128.7, 132.5 (ArH), 123.9 (q, J C,F = 274.3 
Hz, CF3), 127.0 (q, J C,F = 32.1 Hz, CAr), 137.2 (q, J C,F = 1.0 Hz, ArH), 174.2 (COlf), 191.3 
(CO). IR (KBr): v = 3078, 3017, 2970 (w), 1660, 1613 (s), 1486, 1396, 1359 (m), 1310 (s), 
1288, 1240 (m), 1152, 1100 (s), 1060, 1035, 1000, 948, 879, 810 (m), 770 (s), 751, 652, 548 
(m) cm-1. MS (EI, 70 eV): m/z (%) = 256 (M+, 5), 213 (23), 173 (11), 172 (100), 171 (40), 151 
(24). HRMS (ESI-TOF): calcd. for C13H12O2F3 [M+H]+: 257.0784; found: 257.0787. 
 
2-(2-Chloro-3-(trifluoromethyl)phenyl)-6-methyl-2H-pyran-4(3H)-one (16b). Starting 
with a THF solution of LDA (12.5 mmol), 9a (0.50 g, 5.0 mmol) and 15b 
(1.04 g, 5.0 mmol) in THF (15 mL), 16b was isolated as a colourless 
crystalline solid (1.03 g, 71%), mp 137 °C. 1H NMR (300 MHz, CDCl3):  
= 2.00 (s, 3H, CH3), 2.45-2.64 (m, 2 H, HA,B), 5.38 (s, 1 H, CHOlf), 5.63 
(dd, J = 4.2, 13.6 Hz, 1 H, CH), 7.35-7.39  (m, 1 H, ArH), 7.54 (d, 1 H, J = 
8.3 Hz, 1 H, ArH), 7.71-7.73 (m, 1 H, ArH). 19F NMR 282 MHz, CDCl3):  = -58.4. 13C 
NMR (75.4 MHz, CDCl3):  = 20.9 (CH3), 43.0 (CH2), 76.6 (q, J C,F = 5.7 Hz, CH), 105.4 
(CHOlf), 121.7 (q, J C,F = 273 Hz, CF3), 125.6 (q, J C,F = 31.3 Hz, CH), 127.4 (q, J C,F = 5.7 Hz, 
CH), 128.6 (q, J C,F = 42.0 Hz, CH), 139.1 (q, J C,F = 28.1 Hz, CAr), 173.8 (COlf), 190.6 (CO). 
IR (KBr): v = 3117, 2976, 2926, 1660 (w), 1601 (s), 1575, 1440, 1392, 1330, 1234 (m), 1557 
(s), 1126 (m), 1105 (s), 1042, 1000, 958, 880, 848, 770, 706, 596 (m)  cm-1. MS (EI, 70 eV): 
m/z (%) = 292 ([M, 37Cl, 1]+), 290 ([M, 35Cl, 6]+), 255 (16), 247 (16), 208 (49), 207 (15), 206  
(100), 171 (39), 151 (14), 43 (13). HRMS (ESI-TOF): calcd. for C13H11ClO2F3 [M+H]+, (M+, 
[35Cl]): 291.09305; found: 291.093056. 
 
 
 
O
O
CF3
O
O
Cl
CF3
 110
2-(2-Chloro-4-(trifluoromethyl)phenyl)-6-methyl-2H-pyran-4(3H)-one (16c). Starting 
with a THF solution of LDA (12.5 mmol), 9 (0.50 g, 5.0 mmol) and 
15c (1.04g, 5.0 mmol) in THF (15 mL), 16c was isolated as a 
colourless crystalline solid (1.09 g, 75%), mp 143 °C. 1H NMR (300 
MHz, CDCl3):  = 2.03 (s, 3 H, CH3), 2.47 (dd, J = 14.1, 14.1 Hz, 1 
H, HA), 2.68 (ddd, J = 1.1, 3.5, 14.1 Hz, 1 H, HB), 5.40 (s, 1 H, CHOlf), 5.71 (dd, J = 3.5, 14.1 
Hz, CH), 7.54 (d, J = 8.1 Hz, 1 H, ArH), 7.58  (s, 1 H, ArH), 7.69 (d, J = 8.3 Hz, 1 H, ArH). 
19F NMR 282 MHz, CDCl3):  = -62.8. 13C NMR (75.4 MHz, CDCl3):  = 20.5 (CH3), 40.8 
(CH2), 77.3 (CH), 105.6 (CHOlf), 127.1 (q, J C,F = 272 Hz, CF3), 131.8 (q, J C,F = 33.8 Hz, CAr), 
124.2 (q, J C,F = 3.8 Hz, CH), 126.7 (q, J C,F = 3.8 Hz, CH), 127.7 (q, J C,F = 3.8 Hz, CH), 131.8 
(q, J C,F = 33.8 Hz, C), 140.2 (C), 173.8 (COlf), 190.9 (CO). IR (KBr): v = 3092, 2966, 2848 
(w), 1666, 1613 (s), 1388 (m), 1319 (s), 1240 (m), 1118 (s), 1064, 1006, 945, 846, 815, 713, 
649, 538 (m) cm-1. MS (EI, 70 eV): m/z (%) = 292 ([M, 37Cl, 5]+),  290 ([M, 35Cl, 4]+), 255 
(13), 247 (15), 208 (32), 207 (11), 206 (100), 171 (27), 151 (17), 43 (10). HRMS: calcd. for 
C13H10ClO2F3 [M+, 35Cl]: 290.09404; found: 319.09435. 
 
2-(2-Fluorophenyl)-6-methyl-2H-pyran-4(3H)-one (16d).  Starting with a THF solution of 
LDA (12.5 mmol), 9 (0.50 g, 5.0 mmol) and 15d (0.62 g, 5.0 mmol) in THF 
(15 mL), 16d was isolated as a slight yellow oil (0.69 g, 67%). 1H NMR 
(250 MHz, CDCl3):  = 1.98 (s, 3 H, CH3), 2.51 (dd, J = 3.2, 16.8 Hz, 1 H, 
HB), 2.69 (dd, J = 14.1, 16.8 Hz, 1 H, HB), 5.35 (s, 1 H, CHOlf), 5.58 (dd, J 
= 3.6, 14.1 Hz, 1 H, CH), 6.96-7.03 (m, 1 H, CH), 7.09-7.14 (m, 1 H, CH), 7.22-7.29 (m, 1 H, 
ArH), 7.39-7.45 (m, 1 H, ArH). 19F NMR (282 MHz, CDCl3):  = -118.2. 13C NMR (75.4 
MHz, CDCl3):  = 21.0 (CH3), 41.3 (CH2), 75.1 (d, JF,C = 3.1 Hz, CH), 105.2 (CHOlf), 115.8 
(d, JF,C = 21.7 Hz, CH), 124.5 (d, JF,C = 3.6 Hz, CH), 125.5 (d, JF,C = 12.7 Hz, CH), 127.5 (d, 
JF,C = 3.4 Hz, Cr), 130.4 (d, JF,C = 8.3 Hz, CAr), 159.7 (d, JF,C = 247.8 Hz, C), 174.2 (COlf), 
191.8 (CO). IR (KBr): v = 3067, 296, 1722 (w), 1660 (m), 1605 (s), 1491, 1436, 1360, 1330, 
1230, 1151, 1065, 1001, 950, 871, 810 (m), 755 (s), 657, 553 (m) cm-1. GC-MS (EI, 70 eV): 
m/z (%) = 206 (M+, 2), 163 (20), 123 (10), 122 (100), 121 (14), 96 (11). HRMS: calcd. for 
C12H11O2F [M] +: 206.07376; found: 206.07373. Anal. Calcd. C12H11O2F: C, 69.89; H, 5.38. 
Found: C, 69.86; H, 5.51. 
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2-(3-Fluorophenyl)-6-methyl-2H-pyran-4(3H)-one (16e). Starting with a THF solution of 
LDA (12.5 mmol), 9 (0.50 g, 5.0 mmol) and 15e (0.62 g, 5.0 mmol) in 
THF (15 mL), 16e was isolated as a slight yellow oil (0.75 g, 72%). 1H 
NMR (300 MHz, CDCl3):  = 2.02 (d, 3 H, CH3), 2.53 (ddd, J = 1.0, 
3.8, 16.7 Hz, 1 H, HA), 2.68 (dd, J = 13.8, 16.8 Hz, 1 H, HB), 5.31 (dd, J 
= 3.8, 13.8 Hz, 1 H, CH), 5.36 (s, 1 H, CHOlf), 6.96-7.03 (m, 1 H, ArH), 7.05-7.11 (m, 2 H, 
ArH), 7.28-7.36 (m, 1 H, ArH). 19F NMR (282 MHz, CDCl3):  = -115.4. 13C NMR (62.8 
MHz, CDCl3):  = 21.0 (CH3), 42.3 (CH2), 79.9 (CH), 105.3 (CHOlf), 113.0 (d, JF,C = 23.0 Hz, 
CH), 115.6 (d, JF,C = 21 Hz, CH), 121.6 (d, JF,C = 3.7 Hz, CH), 130.8 (d, JF,C = 8.7 Hz, CH), 
140.6 (d, JF,C = 7.5 Hz, C), 162.1 (d, JF,C = 246.5, C), 174.1 (COlf), 191.8 (CO). IR (KBr): 
v = 3067, 2921, 1722 (w), 1666 (m), 1607, 1590 (s), 1488, 1448 (m), 1392, 1392 (s), 1359 
(m), 1326, 1237 (s), 1041 (m), 1003 (s), 890 (m), 785, 691 (s), 627), 592 (w) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 206 (M+, 6), 188 (7), 173 (6), 163 (22), 122 (100), 121 (14), 96 (13). 
HRMS: calcd. for C12H11O2F [M+]: 206.07376; found: 206.07469. Anal. Calcd. C12H11O2F: 
C, 69.89; H, 5.38. Found: C, 69.74; H, 5.66. 
 
2-(4-Fluorophenyl)-6-methyl-2H-pyran-4(3H)-one (16f). Starting with a THF solution of 
LDA (12.5 mmol), 9 (0.50 g, 5.0 mmol) and 15f (0.62 g, 5.0 mmol) in 
THF (15 mL), 16f was isolated as a colourless crystalline solid (0.80 g, 
78%),  mp 61-62 °C. 1H NMR (300 MHz, CDCl3):  = 1.99 (s, 3 H, 
CH3), 2.50 (dd, J = 3.4, 16.8 Hz 1 H, HA), 2.70 (dd, J = 14.0, 16.6 Hz, 1 
H, HB), 5.29 (dd, J = 3.8, 13.9 Hz, 1 H, CH), 5.36 (s, 1 H, CHOlf), 6.95-7.06 (m, 2 H, ArH), 
7.28-7.34 (m, 2 H, ArH). 19F NMR (282 MHz, CDCl3):  = -112.7. 13C NMR (75.4 MHz, 
CDCl3):  = 21.1 (CH3), 42.3 (CH2), 80.1 (CH), 105.3 (CHOlf), 115.7 (d, JF,C = 21.8 Hz, CH), 
128.1 (d, JF,C = 7.2 Hz, CH), 134.0 (d, JF,C = 3 Hz, C), 162.8 (d, JF,C = 247.0, C), 174.2 (COlf), 
192.0 (CO). IR (KBr): v = 3295, 3119, 2966, 2849, 1898 (w), 1651 (m), 1600 (s), 1511, 1426, 
1396, 1335, 1248 (m), 1219 (s), 1159, 1024, 997, 903 (m), 818 (s), 659, 554 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 206 (M+, 4), 188 (10), 163 (17), 122 (100), 121 (15), 96 (10), 
HRMS: calcd. for C12H11O2F [M+]: 206.07376; found: 206.073710. Anal. Calcd. C12H11O2F: 
C, 69.89; H, 5.38. Found: C, 69.88; H, 5.56. 
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11.4 Synthesis of 2,4-Diarylbenzophenones by Site-Selective Suzuki-Miyaura 
Reactions of 2,4-Bis(trifluoromethylsulfonyloxy)benzophenone 
 
11.4.1 Synthesis of 2,4-Bis(trifluoromethylsulfonyloxy)benzophenone (18):  To a CH2Cl2 
solution (10 mL/mmol) of 17 (1.0 equiv.) was added pyridine (4.0 
equiv) at – 78 C under argon atmosphere. After 10 min, Tf2O (2.4 
equiv.) was added at -78 C. The mixture was allowed to warm to 0 
C during 4 h with stirring. The reaction mixture was filtered and the 
filtrate was concentrated in vacuo. The product was isolated by rapid 
column chromatography (flash silica gel, heptanes/EtOAc). Starting 
with 20 (214 mg, 1.0 mmol), pyridine (0.32 ml, 4.0 mmol) and  Tf2O (0.40 ml, 2.4 mmol), 21 
was isolated as a highly viscous oil (420 mg, 88%). 1H NMR (300 MHz, CDCl3):  = 6.54-
6.55 (m, 1 H, ArH), 6.59-6.69 (m, 3H, ArH), 7.79-6.87 (m, 2 H, ArH), 6.93-6.96 (m, 2 H, 
ArH). 13C NMR (62.8 MHz, CDCl3):  = 114.0 (q, JF,C = 320 Hz, CF3), 122.9 (q, JF,C = 320 
Hz, CF3), 116.5, 121.2, 128.8, 130.1, 132.5 (CH), 132.7 (CAr), 134.3 (CH), 135.7, 147.0, 
150.5 (CAr), 190.9 (CO). 19F NMR (282 MHz, CDCl3):  = -73.7, -73.0 (CF). IR (KBr):  = 
3303, 3092 (w), 1657 (s), 1600, 1597, 1493, 1433, 1427(m), 1319 (w), 1295, 1274, 1242, 
1216 (m), 1189, 1133 (s), 1087, 966, 936, 923, 892, 859, 854, 795, 752, 693, 664, 603, 584, 
570 (m) cm-1. GC-MS (EI, 70 eV): m/z (%): 478 (M+, 50), 401 (22), 184 (19), 156 (10), 128 
(8), 105 (100), 77 (34), 69 (27), 51 (10). HRMS (EI, 70 eV): calcd for C15H8F6O7S2 [M+]: 
477.96101; found 477.961098.  
 
11.4.2 Synthesis of diaryl-substituted benzophenones (20a-d), (21a-j) and (22a-d)  
 
The reaction was carried out in a pressure tube. To a dioxane suspension (5 mL) of 18 or 5 ( 
1.0 mmol), Pd(PPh3)4 (5-10 mol-%) and of the arylboronic acid (1.3 mmol per Br), K3PO4 
was added. The mixture was stirred at 110 °C under argon atmosphere for the indicated period 
of time (6-8 h). The reaction mixture was diluted with water and extracted with CH2Cl2 (3 x 
25 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate was 
concentrated in vacuo. The residue was purified by flash chromatography (silica gel, EtOAc / 
heptanes). 
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11.4.3 Synthesis of symmetrical diaryl benzophenones 
 
 (2,4-Bis(phenyl)phenyl)(phenyl)methanone (20a) Starting with 18 (220 mg, 0.46 mmol), 
K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (32 mg, 6 mol%), 
phenylboronic acid (146 mg, 1.2 mmol) and 1,4-dioxane (5 mL per 
1 mmol of 18), 20a was isolated as a white solid (125 mg, 82%). 1H 
NMR (300 MHz, CDCl3):  = 7.06-7.09 (m, 2 H, ArH), 7.11-7.15 
(m, 2 H, ArH), 7.17-7.23 (m, 3 H, ArH), 7.27-7.33 (m, 3 H, ArH), 
7.35-7.40 (m, 2 H, ArH), 7.49-7.51 (m, 1 H, ArH), 7.56-7.61 (m, 5 H, ArH). 13C NMR 
(CDCl3, 75.4 MHz):  = 125.7, 127.3, 127.4, 128.0, 128.1, 128.3, 128.9, 129.0, 129.1, 129.6, 
129.9, 132.8 (CH), 137.5, 137.7, 140.1, 140.2, 141.9, 143.3 (C), 198.5 (CO). IR (KBr): 
v = 3050, 3026, 2923, 2853 (w), 1657 (s), 1595 (m), 1552, 1496 (w), 1441, 1393, 1315 (m), 
1279 (s), 1234, 1158, 1132, 1073, 1025, 960, 936, 922, 902, 843, 800, 773 (m), 760, 742, 690 
(s), 638, 584 (m) cm-1. MS (EI, 70 eV): m/z (%) = 334 (M+, 100), 333 (73), 258 (18), 257 
(85), 229 (14), 228 (35), 227 (15), 226 (21), 105 (12), 77 (18). HRMS (EI): calcd. for 
C25H18O [M]+: 334.13522; found: 334.134518. 
 
(2,4-Bis(p-tolyl)phenyl)(phenyl)methanone (20b). Starting with 18 (220 mg, 0.46 mmol), 
K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (32 mg, 6 mol%), P-
tolylboronic acid (163 mg, 1.2 mmol) and 1,4-dioxane (5 mL per 
1 mmol of 18), 20b was isolated as a white solid (139 mg, 84%). 
1H NMR (300 MHz, CDCl3):  = 2.16 (s, 3 H, CH3), 2.33 (s, 3 
H, CH3), 6.93-6.96 (m, 2 H, ArH), 7.04-7.13 (m, 2 H, ArH), 
7.19-7.25 (m, 4 H, ArH), 7.27-7.37 (m, 2 H, ArH), 7.45-7.51 (m, 
3 H, ArH), 7.53-7.65 (m, 3 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 127.1, 128.1, 128.6, 
128.7, 128.8, 129.0, 129.5, 129.6, 129.9, 130.0 (CH), 137.5, 137.7, 140.1, 140.2, 141.9, 143.3 
(C), 198.5 (CO). ). IR (KBr): v = 3079, 3032, 1661, 1596, 1490, 1445, 1426, 1314, 1283, 
1242, 1178, 1138, 1069, 999, 914, 835, 751 (s), 698 (m), 785 (s) 621 (m) cm-1. MS (EI, 70 
eV): m/z (%) = 362 (M+, 100), 333 (73), 258 (18), 257 (85), 229 (14), 228 (35), 227 (15), 226 
(21), 105 (12), 77 (18). HRMS (EI): calcd. for C27H22O [M]+: 362.13522; found: 362.134518. 
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(2,4-Bis(m-chlorophenyl)phenyl)(phenyl)methanone (20c) Starting with 18 (220 mg, 
0.46mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (32 mg, 6 
mol%), m-chlorophenylboronic acid (187 mg, 1.2 mmol) and 1,4-
dioxane (5 mL per 1 mmol of 18), 20c was isolated as a white solid 
(138 mg, 75%). 1H NMR (300 MHz, CDCl3):  = 7.06-7.08 (m, 2 H, 
ArH), 7.23-7.40 (m, 6 H, ArH), 7.45-7.53 (m, 2 H, ArH), 7.54-7.61 
(m, 6 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 125.4, 126.1, 
127.2, 127.4, 127.6, 128.1, 128.2, 128.4, 128.7, 128.9, 129.5, 129.7, 130.2, 133.0 (CH), 
133.0, 134.2, 134.9, 137.2, 137.7, 138.1, 140.5, 141.6, 142.0 (C), 197.9 (CO). ). IR (KBr): v = 
3080, 3034 (w), 1665 (s), 1595, 1545, 1494, 1443, 1430, 1316, 1285, 1244, 1180, 1135, 1071, 
1002, 915, 837 (m), 753 (s), 700 (m), 787 (s), 671, 667, 624, 530 (m) cm-1. MS (EI, 70 eV): 
m/z (%) = 404 ([M, 37Cl2, 63]+), 402 ([M, 35Cl2, 100]+), 401 (49), 369 (12), 368 (10),  367 
(36), 329 (10), 328 (11), 327 (55), 326 (20), 325 (85), 290 (12), 264 (14), 263 (10), 262 (44), 
227 (13), 226 (54), 225 (10), 224 (14), 184 (20), 105 (39), 77 (33). HRMS (EI): calcd. for 
C25H16Cl2O [(M+, Cl35,Cl37])+: 402.05727; found: 402.056201.  
 
(2,4-Bis(p-methoxyphenyl)phenyl)(phenyl)methanone (20d): Starting with 18 (220 mg, 
0.46 mmol), K3PO4 (292 mg, 1.38 mmol), Pd(PPh3)4 (32 mg, 6 
mol%), p-methoxyphenylboronic acid (182 mg, 1.2 mmol) and 
1,4-dioxane (5 mL per 1 mmol of 18), 20d was isolated as a 
white solid (128 mg, 71%). 1H NMR (300 MHz, CDCl3):  = 
3.65 (s, 3 H, OCH3), 3.80 (s, 3 H, OCH3), 6.66-6.69 (m, 1 H, 
ArH), 6.92-6.97 (m, 2 H, ArH), 7.13-7.18 (m, 2 H, ArH), 7.41-
7.53 (m, 9 H, ArH), 7.75-7.78 (m, 2 H, ArH). 13C NMR (CDCl3, 
62.8 MHz):  = 55.3, 55.4 (OCH3), 114.3, 114.6, 12.7, 128.0, 128.3, 129.4, 128.5, 130.1, 
130.9, 133.6 (CH), 136.7, 137.5, 141.4, 142.7, 145.9, 147.4, 158.9, 159.6 (C), 197.8 (CO). ). 
IR (KBr): v = 3061, 2937 (w), 2842 (m), 1657, 1601 (s), 1526, 1490, 1443, 1425 (m), 1396 
(s), 1296, 1246, 1211, 1139, 1062, 971, 910 (m), 832, 694 (s), 611, 539 (m) cm-1. MS (EI, 70 
eV): m/z (%) = 394 (M+, 100), 333 (73), 258 (18), 257 (85), 229 (14), 228 (35), 227 (15), 226 
(21), 105 (12), 77 (18). HRMS (EI): calcd. for C25H18O [M]+: 394.04522; found: 394.044518. 
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11.4.4 Synthesis of monoaryl-benzophenones 
 
4-Benzoyl-4'-methylbiphenyl-3-yl trifluoromethanesulfonate (21a). Starting with 18 (220 
mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 (32 mg, 
3 mol%), p-tolylboronic acid (81 mg, 0.6 mmol) and 1,4-dioxane 
(5 mL per 1 mmol of 18), 21a was isolated as a white solid (141 
mg, 73%). 1H NMR (300 MHz, CDCl3):  = 2.33 (s, 3 H, CH3), 
7.20-7.23 (m, 2 H, ArH), 7.39-7.43 (m, 4 H, ArH), 7.49-7.56 (m, 
4 H, ArH), 7.74-7.77 (m, 2 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 21.2 (CH3), 120.5 (q, J 
= 321 Hz), 120.7, 126.1, 127.0, 128.5, 130.0, 130.1 (CH), 130.3 (C), 131.9, 133.6 (CH), 
135.2,  136.7, 139.2, 146.3, 147.4 (C), 192.5 (CO). 19F NMR (282 MHz, CDCl3):  = -73.3. 
IR (KBr): v = 3026, 2950, 2857 (w), 1657, 1615, 1598 (m), 1548, 1448 (w), 1422 (s), 1286, 
1242 (m), 1206, 1136 (s), 1085 (m), 1018 (w), 945, 899 (m), 814 (s), 746, 703, 622, 604, 540 
(m) cm-1. MS (EI, 70 eV): m/z (%) = 420 (M+, 100), 343 (36), 287 (23), 210 (10), 105 (32), 77 
(17). HRMS (EI): calcd. for C21H15O4F3S [M]+: 420.06377; found: 420.063866. 
 
4-Benzoyl-4'-ethylbiphenyl-3-yl trifluoromethanesulfonate (21b). Starting with 18 (220 
mg, 0.46 mmol), K3PO4 (32 mg, 146 mg, 0.69 mmol), 
Pd(PPh3)4 (3 mol%), 4-ethylphenylboronic acid (90 mg, 0.6 
mmol) and 1,4-dioxane (5 mL per 1 mmol of 18), 21b was 
isolated as a white solid (150 mg, 75%). 1H NMR (300 MHz, 
CDCl3):  = 1.20 (t, J = 7.6Hz, 3 H, CH2CH3), 2.64 (q, J = 
7.6Hz, 3 H, CH2CH3), 7.16-7.27 (m, 2 H, ArH), 7.38-7.47 (m, 4 H, ArH), 7.50-7.60 (m, 4 H, 
ArH), 7.75-7.78 (m, 2 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 15.4 (CH3), 28.6 (CH2), 
118.5 (q, J = 319.1Hz), 120.7, 126.1, 127.1, 128.5, 128.8, 130.1 (CH), 131.6 (CAr), 131.8, 
133.6 (CH), 135.4, 136.7, 145.5, 146.3, 147.3 (C), 192.5 (CO). 19F NMR (282 MHz, CDCl3): 
 = -73.3. IR (KBr): v = 3025, 2961, 2918, 2854 (w), 1655, 1615 (m), 1523, 1448 (w), 1422 
(s), 1322, 1285, 1240 (m), 1205, 1137 (s), 1086 (m), 1018, 979 (w), 930, 898 (m), 828 (s), 
798, 703, 603, 534 (m) cm-1. MS (EI, 70 eV): m/z (%) = 434 (M+, 100), 419 (10), 357 (31), 
301 (16), 105 (33), 77 (16). HRMS (EI): calcd. for C22H17F3O4S [M]+: 434.07942; found: 
434.078943. 
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4-Benzoyl-3',4'-dimethylbiphenyl-3-yl trifluoromethanesulfonate (21c). Starting with 18 
(220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 
(32 mg, 3 mol%), 3,4-dimethylphenylboronic acid (90 mg, 0.60 
mmol) and 1,4-dioxane (5 mL per 1 mmol of 18), 21c was 
isolated as a white solid (135 mg, 68%). 1H NMR (300 MHz, 
CDCl3):  = 2.23 (s, 3 H, CH3), 2.26 (s, 3 H, CH3), 7.14-7.27 (m, 
3 H, ArH), 7.36-7.41 (m, 2 H, ArH), 7.48-7.58 (m, 3 H, ArH), 
7.73-7.76 (m, 2 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 19.5 (CH3), 19.9 (CH3), 118.5 (q, J 
= 320.5Hz), 120.7, 124.5, 126.1, 128.3, 128.5, 130.1, 130.5, 131.8, 133.6  (CH), 135.6,  
136.7, 137.6, 139.0, 146.5, 147.3, 153.8 (C), 192.5 (CO). 19F NMR (282 MHz, CDCl3):  = -
73.3. IR (KBr): v = 3022, 2946, 2858, 2659 (w), 1655, 1614, 1598, 1513, 1447 (m), 1421 (s), 
1319, 1280, 1242 (m), 1208, 1138 (s), 1084, 953, 862, 822, 742, 701, 651, 607, 572 (m) cm-1. 
MS (EI, 70 eV): m/z (%) = 434 (M+, 100), 357 (29), 301 (22), 258 (10), 105 (29), 77 (15). 
HRMS (EI): calcd. for C22H17O4F3S [M]+: 434.07942; found: 434.079871. 
 
4-Benzoyl-3', 5'-dimethylbiphenyl-3-yl trifluoromethanesulfonate (21d). Starting with 18 
(220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 
(32 mg, 3 mol-%), 3,5-dimethylphenylboronic acid (81 mg, 0.6 
mmol) and 1,4-dioxane (5 mL per 1 mmol of 18), 21d was 
isolated as a white solid (133 mg, 67%). 1H NMR (300 MHz, 
CDCl3):  = 2.29 (s, 3 H, CH3), 6.98 (s, 1 H, ArH), 7.11 (s, 2 H, 
ArH), 7.34-7.39 (m, 2 H, ArH), 7.48-7.56 (m, 4 H, ArH), 7.72-
7.75 (m, 2 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 21.3 (2CH3), 120.6 (q, J = 319Hz), 
121.0, 125.1, 126.4, 128.5, 130.1 (CH), 130.4 (CAr), 130.7, 131.8, 133.7 (CH), 136.7, 138.1, 
138.9, 146.7, 147.3 (C), 192.5 (CO). 19F NMR (282 MHz, CDCl3):  = -73.3. IR (KBr): 
v = 3028, 2952, 2859 (w), 1667, 1612, 1597 (m), 1553 (w), 1423 (s), 1389, 1315, 1285, 1246 
(m), 1204, 1135 (s), 1069 (m), 1000 (w), 955, 899 (m), 836 (s), 755, 696, 602, 544 (m) cm-1. 
MS (EI, 70 eV): m/z (%) = 434 (M+, 100), 357 (37), 301 (23), 258 (10), 152 (10), 105 (33), 77 
(17). HRMS (EI): calcd. for C22H17O4F3S [M]+: 434.07942; found: 434.079065. 
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4-Benzoyl-4'-tert-butylbiphenyl-3-yl trifluoromethanesulfonate (21e). Starting with 18 
(220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 
(32 mg, 3 mol%), 4-tert-butylphenylboronic acid (106 mg, 
0.60 mmol) and 1,4-dioxane (5 mL per 1 mmol of 18), 21e 
was isolated as a white solid (161 mg, 76%). 1H NMR (300 
MHz, CDCl3):  = 1.28 (s, 9 H, CH3), 7.37-7.42 (m, 2 H, 
ArH), 7.45-7.51 (m, 5 H, ArH), 7.52-7.60 (m, 3 H, ArH). 13C 
NMR (CDCl3, 75 MHz):  = 31.2 (3CH3), 34.7 (C), 120.7, 120.6 (q, J = 319Hz), 121.7, 126.2, 
126.3, 126.9,  128.5, 130.1 (CH), 130.3 (C), 131.9, 133.6 (CH), 136.7, 146.2, 147.4, 152.4 
(C), 192.5 (CO). 19F NMR (282 MHz, CDCl3):  = -73.3. IR (KBr): v = 3060, 2959, 2866 (w), 
1660, 1614, 1596 (m), 1554 (w), 1462, 1415, 1318, 1241 (m), 1207, 1137 (s), 1089, 948, 895 
(m), 810 (s), 696, 603, 569 (m) cm-1. MS (EI, 70 eV): m/z (%) = 462 (M+, 33), 447 (100), 313 
(15). HRMS (EI): calcd. for C24H21O4F3S [M]+: 462.11072; found: 462.110339. 
 
4-Benzoyl-3'-chlorobiphenyl-3-yl trifluoromethanesulfonate (21f). Starting with 18 (220 
mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 (32 mg, 3 
mol%), 3-chlorophenylboronic acid (93 mg, 0.60 mmol) and 1,4-
dioxane (5 mL per 1 mmol of 18), 21f was isolated as a white solid 
(131 mg, 65%). 1H NMR (300 MHz, CDCl3):  = 6.83-6.93 (m, 5 
H, ArH), 6.98-7.07 (m, 5 H, ArH), 7.24-7.27 (m, 2 H, ArH). 13C 
NMR (CDCl3, 75 MHz):  = 118.5 (q, J = 319.1Hz), 121.0, 125.4, 
126.5, 127.3, 128.6, 129.0, 130.1, 130.5, 131.9, 133.8 (CH), 135.2, 136.5, 139.9, 144.7, 
147.2, 160.2 (C), 192.3 (CO). 19F NMR (282 MHz, CDCl3):  = -73.9. IR (KBr): v = 3085, 
3034 (w), 1665 (s), 1593, 1545, 1493, 1447, 1429, 1317, 1286, 1245, 1182, 1141, 1071, 997, 
915, 833 (m), 746 (s), 696 (m), 783 (s), 671, 666, 621, 527 (m) cm-1. MS (EI, 70 eV): m/z (%) 
= 442 ([M, 37Cl, 40]+), 440 (M+, 100), 365 (20), 363 (52), 309 (10), 307 (27), 244 (21), 230 
(13), 215 (19), 139 (27), 105 (76), 77 (31). HRMS (EI): calcd. for C20H12ClF3O4S [M+, 35Cl]: 
440.06021; found: 440.060214. 
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4-Benzoyl-3'-methoxybiphenyl-3-yl trifluoromethanesulfonate (21g). Starting with 18 
(220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 (32 
mg, 3 mol%), 3-methoxyphenylboronic acid (91 mg, 0.60 mmol) 
and 1,4-dioxane (5 mL per 1 mmol of 18), 21g was isolated as a 
white solid (128 mg, 64%). 1H NMR (300 MHz, CDCl3):  = 3.79 
(s, 3 H, OCH3), 6.88-7.11 (m, 3 H, ArH), 7.30-7.42 (m, 3 H, ArH), 
7.49-7.60 (m, 4 H, ArH), 7.74-7.77 (m, 1 H, ArH). 13C NMR 
(CDCl3, 75 MHz):  = 55.4 (OCH3), 113.2, 114.1, 119.6 (CH), 120.7 (q, J = 319.7 Hz, C), 
121.0, 126.5, 128.5, 130.1, 130.3 (CH), 130.8 (C), 131.8, 133.7 (CH), 136.6, 139.5, 146.2, 
147.2, 160.2 (C), 192.4 (CO). 19F NMR (282 MHz, CDCl3):  = -73.3. IR (KBr): v = 3078, 
3030 (w), 1663 (s), 1596, 1540, 1492, 1443, 1428, 1316, 1285, 1244, 1180, 1140, 1071, 998, 
913, 833 (m), 753 (s), 697 (m), 783 (s), 667, 529 (m) cm-1. MS (EI, 70 eV): m/z (%) = 436 
(M+, 100), 359 (24), 303 (14), 260 (14), 226 (11), 105 (28), 77 (16). HRMS (EI): calcd. for 
C21H15O5S [M]+: 436.05868; found: 436.058189. 
 
4-Benzoyl-4'-methoxybiphenyl-3-yl trifluoromethanesulfonate (21h). Starting with 18 
(220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), Pd(PPh3)4 
(32 mg, 3 mol%), 4-methoxyphenylboronic acid (91 mg, 0.60 
mmol) and 1,4-dioxane (5 mL per 1 mmol of 18), 21h was 
isolated as a white solid (126 mg, 63%). 1H NMR (300 MHz, 
CDCl3):  = 3.78 (s, 3 H, OCH3), 6.92-6.96 (m, 2 H, ArH), 
7.37-7.43 (m, 2 H, ArH), 7.46-7.52 (m, 4 H, ArH), 7.54-7.55 (m, 2 H, ArH). 13C NMR 
(CDCl3, 62.8 MHz):  = 55.4 (OCH3), 114.6, 118.4 (q, J = 319Hz), 120.3, 125.7, 128.4, 128.5 
(CH), 129.8 (CAr), 130.1, 131.9, 133.6 (CH), 136.7, 145.9, 147.4, 160.5 (C), 192.5 (CO). 19F 
NMR (282 MHz, CDCl3):  = -73.3. IR (KBr): v = 3082, 2962, 2867 (w), 1662, 1613, 1599 
(m), 1556 (w), 1463, 1414, 1317, 1243 (m), 1209, 1136 (s), 1092, 947, 893 (m), 809 (s), 697, 
605, 570 (m) cm-1. MS (EI, 70 eV): m/z (%) = 436 (M+, 100), 359 (14), 303 (15), 226 (15), 
105 (35), 77 (16). HRMS (EI): calcd. for C21H15O5F3S [M]+: 436.05868; found: 436.058078. 
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4-Benzoyl-3',4',5'-trimethoxybiphenyl-3-yl trifluoromethanesulfonate (21i). Starting with 
18 (220 mg, 0.46 mmol), K3PO4 (146 mg, 0.69 mmol), 
Pd(PPh3)4 (32 mg, 3 mol%), 3,4,5-trimethoxyphenylboronic 
acid (127 mg, 0.60 mmol) and 1,4-dioxane (5 mL per 1 mmol 
of 18), 21i was isolated as a white solid (132 mg, 58%). 1H 
NMR (300 MHz, CDCl3):  = 3.82 (s, 3 H, OCH3), 3.85 (s, 6 
H, OCH3), 6.70 (s, 2 H, OCH3), 7.36-7.46 (m, 3 H, CH), 7.50-
7.55 (m, 3 H, CH), 7.73-7.75 (m, 2 H, CH). 13C NMR (CDCl3, 75 MHz):  = 56.3 (2xOCH3), 
60.9 (OCH3), 104.6 120.9 (CH), 122.5 (q, J = 319.5Hz, C), 126.4, 128.5, 130.1, 131.8, 133.7 
(CH), 133.9,  136.6, 139.0, 146.4, 147.2, 153.8 (C), 192.3 (CO). 19F NMR (282 MHz, 
CDCl3):  = -73.3. IR (KBr): v = 3062 (w), 2923 (m), 2851 (w), 1665, 1611, 1585, 1515, 
1487, 1412, 1316, 1272 (m), 1204, 1138, 1095, 965, 913, 854, 824, 756, 700, 646, 597 (m) 
cm-1. MS (EI, 70 eV): m/z (%) = 496 (M+, 100), 481 (28), 105 (17), 77 (10). HRMS (EI): 
calcd. for C23H19F3O7S [M]+: 496.07981; found: 496.079565. 
 
11.4.5 Synthesis of unsymmetrical diaryl benzophenones 
 
Phenyl(4-(p-tolyl)-2-(p-methoxyphenyl)phenyl)methanone (22a). Starting with 21a (147 
mg, 0.35 mmol), K3PO4 (111 mg, 0.52 mmol), Pd(PPh3)4 (13 
mg, 3 mol%), 4-methoxyphenylboronic acid (68 mg, 0.45 mmol) 
and 1,4-dioxane (5 mL per 1 mmol of 21), 22a was isolated as a 
white solid (92 mg, 70%). 1H NMR (300 MHz, CDCl3):  = 2.16 
(s, 3 H, CH3), 2.33 (s, 3 H, CH3), 6.93-6.96 (m, 2 H, ArH), 7.04-
7.13 (m, 2 H, ArH), 7.19-7.25 (m, 4 H, ArH), 7.27-7.37 (m, 2 H, 
ArH), 7.45-7.51 (m, 3 H, ArH), 7.53-7.65 (m, 3 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 
127.1, 128.1, 128.6, 128.7, 128.8, 129.0, 129.5, 129.6, 129.9, 130.0 (CH), 137.5, 137.7, 
140.1, 140.2, 141.9, 143.3 (C), 198.5 (CO). IR (KBr): v = 3086, 3035 (w), 1663 (s), 1598, 
1544, 1495, 1443, 1425, 1311, 1280, 1239, 1176, 1138, 1069, 999, 924, 836 (m), 753 (s), 698 
(m), 783 (s), 671, 667, 623, 530 (m) cm-1. MS (EI, 70 eV): m/z (%) = 379 (29), 378 (100), 347 
(16), 301 (11), 287 (26), 273 (10), 105 (39), 91 (26). HRMS (EI): calcd. for C25H18O [M]+: 
379.06870; found: 379.068576. 
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Phenyl(4-(p-tert-butylphenyl)-2-(p-methoxyphenyl)phenyl)methanone (22e) Starting with 
21e (161 mg, 0.35 mmol), K3PO4 (111 mg, 0.52 mmol), 
Pd(PPh3)4 (13 mg, 3 mol%), 4-methoxyphenylboronic acid (68 
mg, 0.45 mmol) and 1,4-dioxane (5 mL per 1 mmol of 21e), 
22e was isolated as a white solid (104 mg, 71%). 1H NMR 
(250 MHz, CDCl3):  = 1.30 (s, 9 H, 3CH3), 3.65 (s, 3 H, 
OCH3), 6.65-6.69 (m, 2 H, ArH), 7.13-7.24 (m, 5 H, ArH), 
7.41-7.49 (m, 4 H, ArH), 7.53-7.61 (m, 5 H, ArH), 7.64-7.65 
(m, 1 H, ArH). 13C NMR (CDCl3, 62.8 MHz):  = 31.3 (CH3), 55.1 (OCH3), 113.7, 125.1, 
125.8, 126.9, 128.0, 128.6, 129.4, 129.9, 130.1, 132.7 (CH), 137.2, 137.3, 137.5, 139.1, 
141.3, 143.0, 151.0, 158.9 (C), 198.3 (CO). IR (KBr): v = 3081, 3033 (w), 1663 (s), 1596, 
1541, 1492, 1447, 1428, 1316, 1285, 1243, 1179, 1140, 1072, 1006, 913, 832, 698 (m), 785 
(s), 670, 621, 529 (m) cm-1. MS (EI, 70 eV): m/z (%) = 421 (30), 420 (100), 419 (19), 406 
(24), 405 (79), 443 (10), 105 (17). HRMS (EI): calcd. for C30H28O2 [M]+: 421.07981; found: 
421.079910. 
 
Phenyl(4-(m-chlorophenyl)-2-(p-methoxyphenyl)phenyl)methanone (22f). Starting with 
21f (154 mg, 0.35 mmol), K3PO4 (111 mg, 0.52 mmol), 
Pd(PPh3)4 (13 mg, 3 mol%), 4-methoxyphenylboronic acid (68 
mg, 0.45 mmol) and 1,4-dioxane (5 mL per 1 mmol of 21f), 22f 
was isolated as a white solid (86 mg, 62%). 1H NMR (300 
MHz, CDCl3):  = 3.65 (s, 3 H, OCH3), 6.66-6.69 (m, 2 H, 
ArH), 7.08-7.38 (m, 9 H, ArH), 7.47-7.62 (m, 5 H, ArH). 13C 
NMR (CDCl3, 75 MHz):  = 55.2 (OCH3), 113.8, 114.0, 119.3, 125.3, 127.5, 128.1, 128.3, 
129.8, 130.0, 130.1 (C), 130.6 (CH), 132.3 (C), 132.9, 133.3 (CH), 136.5, 137.7, 138.8, 143.4, 
150.2 (CH), 159.6 (C), 197.1 (CO). IR (KBr): v = 3062, 3025 (w), 2871 (m), 1667 (s), 1605, 
1550, 1518, 1453, 1408, 1360, 1316, 1279, 1246, 1211, 1139, 1061, 976, 907, 850 (m), 833, 
726, 696 (s), 660, 610, 536 (m) cm-1. MS (EI, 70 eV): m/z (%) = 398 ([M, 37Cl, 45]+), 396 
([M, 35Cl, 100]+), 363 (26), 287 (11). 105 (36), 91 (10) HRMS (EI): calcd. for C26H19Cl2O 
[M+, 35Cl]: 398.06872; found: 398.0687210. 
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11.4.6 Synthesis of symmetrical and unsymmetrical dialkynyl-benzophenones 
(24a-d), (25a-c). 
 
 In a pressure tube (glass bomb) a suspension of Pd(PPh3)4 (3-5.0 mol%), 18 (0.50 mmol), 
alkyne (0.50-1.10 mmol), (Bu)4NI (27 mg, 15 mol%), CuI (10-20mol%), Et3N (0.62-1.25 
mmol) in DMF (5 mL) was purged with argon and stirred at 20 °C for 10 min. The reaction 
mixture was stirred at 60 -80 °C for 2-4 h. The reaction mixture was cooled to 20 °C, poured 
into H2O and CH2Cl2 (25 mL each), and the organic and the aqueous layer were separated. 
The latter was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were washed 
with H2O (3 x 20 mL), dried (Na2SO4), concentrated in vacuo and the residue was purified by 
chromatography (flash silica gel, heptanes/EtOAc) to give 24a-d and 25a-c. 
 
11.4.7 Synthesis of symmetrical dialkynyl-benzophenones (24a-d) 
 
 (2,4-Bis(phenylethynyl)phenyl)(phenyl)methanone (24a). Starting with 18 (238 mg, 0.50 
mmol), Pd (PPh3)2Cl2 (20mg, 6 mol%), dry CuI (19 mg, 20 
mol%), (Bu)4NI (27 mg, 15 mol-%), triethylamine (252 mg, 
2.5 mmol), 1-ethynylbenzene (112 mg, 1.1 mmol) was added  
in DMF (5mL per 1 mmol of 18), 24a was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a colourless 
oil (149 mg, 78%). 1H NMR (300 MHz, CDCl3):  = 6.94-6.97 
(m, 2 H, ArH), 7.08-7.15 (m, 3 H, ArH), 7.26-7.29 (m, 3 H, 
ArH), 7.34-7.48 (m, 7 H, ArH), 7.69-7.80 (m, 3 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 
86.8, 87.9, 91.9, 95.7, 122.4,  125.9 (C), 126.1, 128.4, 128.6, 128.8 (CH), 129.3 (C), 129.0, 
130.2, 131.0 (CH), 131.3 (C), 131.5, 131.8, 131.9, 133.2, 135.5 (CH),  137.2, 140.6 (C), 196.4 
(CO). IR (KBr): v = 3079, 3032 (w), 1661, 1596, 1541, 1490, 1445, 1426, 1314, 1283, 1242, 
1178, 1138, 1069, 999, 914, 835 (m), 751 (s), 698 (m), 785 (s), 669, 666, 621, 528 (m) cm-1. 
MS (EI, 70 eV): m/z (%) = 382 (M+, 100), 381 (57), 365 (19), 353 (13), 352 (20), 351 (11), 
350 (14), 276 (28), 274 (19), 77 (10). HRMS (EI): calcd. for C29H18O [M]+: 382.02323; 
found: 382.023235. 
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(2,4-Bis(m-tolylethynyl)phenyl)(phenyl)methanone (24b). Starting with 18 (238mg, 0.50 
mmol), Pd(PPh3)2Cl2 (20 mg, 6 mol%), dry CuI (19 mg, 20 
mol%), (Bu)4NI (27 mg, 15 mol-%), triethylamine (252 mg, 
2.5 mmol), 1-ethynyl-3-methylbenzene (128mg, 1.1mmol) 
was added  in DMF (5mL per 1 mmol of 18), 24b was 
isolated after chromatography (silica gel, n-heptane/EtOAc) 
as a colourless oil (151mg, 71%). 1H NMR (300 MHz, 
CDCl3):  = 2.14 (s, 3 H, CH3), 2.26 (s, 3 H, CH3), 6.71-
6.78 (m, 2 H, ArH), 6.93-7.18 (m, 4 H, ArH), 7.26-7.50 (m, 7 H, ArH), 7.66-7.80 (m, 3 H, 
ArH). 13C NMR (CDCl3, 62.8 MHz):  = 21.1, 21.2 (2xCH3), 86.5, 87.6, 92.1, 96.0 (C), 
122.2, 122.4,  126.0 (C), 128.0 (CH), 128.1 (C), 128.4, 128.8, 129.0, 129.5, 129.7, 130.2, 
130.9, 132.1, 132.3, 133.2, 135.4 (CH), 137.2, 137.8, 138.1, 140.5 (C), 196.4 (CO). IR (KBr): 
v = 3055, 2918, 2858, 1660, 1594, 1579, 1539, 1485, 1447, 1314, 1283, 1243, 1192, 1154, 
1093, 1039, 999, 962, 922, 834 (m), 780 (s), 748, 700, 686 (s), 669, 624, 584 (m) cm-1. MS 
(EI, 70 eV): m/z (%) = 410 (M+, 100), 409 (33), 408 (15), 395 (29), 393 (12), 289 (16), 181 
(10), 77 (10). HRMS (EI): calcd. for C33H42O [M]+:. 
 
 (2,4-Bis(p-tolylethynyl)phenyl)(phenyl)methanone (24c): Starting with 18 (238mg, 0.50 
mmol), Pd(PPh3)2Cl2 (20 mg, 6 mol%), dry CuI (19 mg, 20 
mol%), (Bu)4NI (27 mg, 15 mol-%), triethylamine (252 mg, 
2.5 mmol), 1-ethynyl-4-methylbenzene (128 mg, 1.1 mmol) 
was added  in DMF (5mL per 1 mmol of 18), 24c was 
isolated after chromatography (silica gel, n-heptane/EtOAc) 
as a colourless oil (159mg, 75%). 1H NMR (300 MHz, 
CDCl3):  = 2.22 (s, 3 H, CH3), 2.31 (s, 3 H, CH3), 6.84-
6.95 (m, 4 H, ArH), 7.10-7.18 (m, 3 H, ArH), 7.37-7.51 (m, 
6 H, ArH), 7.68-7.82 (m, 3 H, ArH). 13C NMR (CDCl3, 75 MHz):  = 21.4, 21.5 (2xCH3), 
86.2, 86.8, 87.3, 92.1, 119.3, 119.5, 122.5, 126.0 (C), 128.4, 128.8, 129.0, 129.2, 130.1, 
130.7, 131.3, 131.6, 133.1, 135.3 (CH),  137.3, 138.7, 139.0, 140.3 (C), 196.5 (CO). IR 
(KBr): v = 3055, 3025, 2916, 2860 (w), 1659, 1591, 1555, 1477, 1445, 1406, 1316, 1286, 
1241, 1178, 1116, 1088, 1037, 999, 917, 836 (m), 812 (s), 699 (m), 686 (s), 651, 621, 596 (m) 
cm-1. MS (EI, 70 eV): m/z (%) = 410 (M+, 100), 409 (17), 408 (15), 396 (12), 395 (28), 366 
(14), 204 (14), 197 (10), 196 (23), 191 (10), 190 (18), 182 (59), 181 (16), 176 (33), 170 (17), 
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144 (13), 143 (14), 131 (12), 77 (13). HRMS (EI): calcd. for C31H22O [M]+: 410.32359; 
found: 410.324468. 
 
 (2,4-Di(dec-1-ynyl)phenyl)(phenyl)methanone (24d): Starting with 18 (238mg, 0.30 
mmol), Pd(PPh3)2Cl2 (20 mg, 6 mol%), dry CuI (19 mg, 10 
mol%), (Bu)4NI (27 mg, 15 mol%), triethylamine (126 mg, 
1.25 mmol), 1-decyne (45mg, 0.33 mmol) was added  in 
DMF (5mL per 1 mmol of 18), 24d was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (100mg, 74%). 1H NMR (500 MHz, CDCl3): 
 = 0.78-0.82 (m, 6 H, 2xCH3), 1.16-1.28 (m, 20 H, 
10×CH2), 1.36-1.44 (m, 4 H, 2×CH2), 1.51-1.60 (m, 4 H, 
2xCH2), 7.37-7.41 (m, 3 H, ArH), 7.48-7.54 (m, 3 H, ArH), 
7.67-7.71 (m, 2 H, ArH). 13C NMR (CDCl3, 125 MHz):  = 
14.0 (CH3), 19.6, 19.8, 22.6, 28.6, 28.7, 28.9, 29.1, 29.2, 
31.8 (CH2), 78.8, 79.3, 95.3, 97.7, 126. 5 (C), 128.3, 128.4, 
129.9 (CH), 130.4 (C), 131.7, 132.4 133.3 (CH), 135.9, 137.3 (C), 195.4 (CO). IR (KBr): 
v = 3059 (w), 2952 (m), 2922 (s), 2852 (m), 2224 (w), 1659, 1593, 1543, 1481, 1446, 1404, 
1317, 1292, 1264, 1239, 1177, 1159, 1123, 1027, 939, 841, 793, 744 (m), 713 (s), 694, 666 
(m), 615 (w), 594 (m) cm-1. MS (EI, 70 eV): m/z (%) = 454 (M+, 6), 285 (10), 105 (100), 77 
(15). HRMS (EI): calcd. for C33H42O[M]+: 454.31347; found: 454.313394. 
 
11.4.8 Synthesis of mono-alkynyl-benzophenones (25a-c) 
 
2-Benzoyl-5-(hept-1-ynyl)phenyl (25a-ctrifluoromethanesulfonate (25a). Starting with 18 
(238mg, 0.50 mmol), Pd(PPh3)2Cl2 (10 mg, 3 mol%), dry 
CuI (10 mg, 10 mol-%), (Bu)4NI (27 mg, 15mol%), 
triethylamine (126 mg, 1.25 mmol), 1-pentyne (51mg, 
0.55 mmol) was added  in DMF (5mL per 1 mmol of 
18),  25a was isolated after chromatography (silica gel, 
n-heptane/EtOAc) as a colourless oil (165mg, 78%). 1H NMR (300 MHz, CDCl3):  = 0.85 (t, 
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J = 7.2 Hz, 3 H, CH2(CH2)3CH3), 1.25-1.36 (m, 4 H, CH2 CH2(CH2)2CH3), 1.51-1.58 (m, 2 H, 
CH2(CH2)(CH2)2CH3), 2.36 (t, J = 7.2 Hz, 2 H, CH2(CH2)3CH3), 7.31 (s,1 H, ArH), 7.38-7.41 
(m, 4 H, ArH), 7.50-7.53 (m, 1 H, ArH), 7.68-7.72 (m, 2 H, ArH). 19F NMR (282 MHz, 
CDCl3):  = -73.4. 13C NMR (CDCl3, 75 MHz):  = 13.9 (CH3), 19.4, 22.1, 28.0, 31.1 (CH2), 
78.4, 95.9 (C), 118.4 (q, J = 320 Hz, CF3), 125.2, 128.5 (CH), 129.3 (C), 130.1, 130.9 (CH), 
131.0 (C), 131.1, 133.7 (CH), 136.4, 146.6 (C), 192.2 (CO). IR (KBr): v  = 3065 (w), 2931 
(m), 2860 (w), 1668 (s), 1608, 1598 (m), 1493 (w), 1448 (s), 1317, 1283, 1236 (m), 1205, 
1136 (s), 1086 (m), 1000 (w), 941, 970, 839, 803, 762, 697, 602 (m) cm-1. MS (EI, 70 eV): 
m/z (%) = 424 (M+, 6), 295 (10), 105 (100), 77 (15), 29 (10). HRMS (EI): calcd. for 
C21H19F3O4S [M]+: 424.44556; found: 424.445487. 
 
2-Benzoyl-5-(dec-1-ynyl)phenyl trifluoromethanesulfonate (25b):Starting with 18 (238mg, 
0.50 mmol), Pd(PPh3)2Cl2 (10 mg, 3 
mol%),, dry CuI (10 mg, 10 mol%), 
(Bu)4NI (27 mg, 15 mol%), triethylamine 
(126 mg, 1.25 mmol), 1-decyne (72mg, 0.55 
mmol) was added  in DMF (5mL per 1 
mmol of 18), 25b was isolated after chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (188mg, 81%). 1H NMR (300 MHz, CDCl3):  = 0.80 (t, J = 7.3 Hz, 3 H, 
CH2(CH2)6CH3), 1.17-1.26 (m, 8 H, CH2(CH2)2(CH2)4CH3), 1.33-1.38 (m, 2 H, 
CH2(CH2)(CH2)5CH3), 1.50-1.55 (m, 2 H, CH2(CH2) (CH2)5CH3), 2.36 (t, J = 6.9 Hz, 2 H, 
CH2(CH2)6CH3), 7.32 (s,1 H, ArH), 7.37-7.42 (m, 4 H, ArH), 7.51-7.55 (m, 1 H, ArH), 7.69-
7.72 (m, 2 H, ArH). 19F NMR (282 MHz, CDCl3):  = -73.4. 13C NMR (CDCl3, 75 MHz):  = 
14.0 (CH3), 19.5, 22.6, 28.3, 28.9, 29.0, 29.1, 31.8 (CH2), 78.4, 95.9 (C), 114.2 (q, J = 320 
Hz, CF3), 125.2, 128.5 (CH), 129.3 (C), 130.1, 130.9 (CH), 131.0 (C), 131.1, 133.7 (CH), 
136.5, 146.6 (C), 192.2 (CO). IR (KBr): v = 2924 (m), 2854 (w), 1669 (s), 1608, 1542, 1465 
(m), 1426 (s), 1316, 1283, 1235 (m), 1206, 1138 (s), 1087, 1013, 970, 939, 884, 798, 698, 
661, 603 (m) cm-1. MS (EI, 70 eV): m/z (%) = 466 (M+, 9), 410 (14), 396 (10), 395 (10), 105 
(100), 77 (16). HRMS (EI): calcd. for C24H25F3O4S [M]+: 466.63943; found: 466.639334. 
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2-Benzoyl-5-((4-methoxyphenyl)ethynyl)phenyl trifluoromethanesulfonate (25c). Starting 
with 18 (238mg, 0.50 mmol), Pd(PPh3)2Cl2 (10 mg, 3 
mol%), dry CuI (10 mg, 10 mol%), (Bu)4NI (27 mg, 15 
mol%), triethylamine (126 mg, 1.25 mmol), 4-
methoxyphenylacetylene (72mg, 0.55 mmol) was added  in 
DMF (5mL per 1 mmol of 18), 25c was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (156mg, 68%). 1H NMR (300 MHz, CDCl3): 
 =  3.71 (s, 3 H, OCH3), 6.78-6.81 (m, 2 H, ArH), 7.34-7.50 (m, 8 H, ArH), 7.68-7.71 (m, 2 
H, ArH). 19F NMR (282 MHz, CDCl3):  = -73.3. 13C NMR (CDCl3, 75 MHz):  = 55.3 
(OCH3), 85.7, 94.3 (C), 114.2 (CH), 117.5 (q, J = 320 Hz, CF3), 124.8, 128.6 (CH), 128.8 (C), 
130.1, 130.7 (CH), 131.0 131.2 (C), 131.3, 133.4, 133.8 (CH), 136.4, 146.7, 160.4 (C), 192.2 
(CO). IR (KBr): v = 3085 (w), 2958 (m), 2837 (w), 1665 (s), 1596, 1539, 1513 (m), 1428 (s), 
1394, 1282, 1246 (m), 1207, 1139 (s), 1076, 1025, 968, 912, 849 (m), 829 (s), 801, 745, 695, 
653 (m), 600 (s) cm-1. MS (EI, 70 eV): m/z (%) = 460 (M+, 100), 327 (21), 312 (12), 105 (16), 
77 (11). HRMS (EI): calcd. for C23H15F3O5S [M]+: 460.32357; found: 460,323471. 
 
11.4.9 Synthesis of alkynyl-aryl-benzophenones 
 
(4'-tert-Butyl-5-((4-methoxyphenyl)ethynyl)biphenyl-2-yl)(phenyl)methanone (26c). 
Starting with 27c (92 mg, 0.20 mmol), K3PO4 (63 mg, 0.30 
mmol), Pd(PPh3)4 (7mg, 3 mol-%), 4-tert-
butylphenylboronic acid (46 mg, 0.26 mmol) and 1,4-
dioxane (5 mL per 1 mmol of 25c), 26c was isolated as a 
white solid (65 mg, 73%), mp. 131 °C. 1H NMR (300 
MHz, CDCl3):  = 1.14 (s, 9 H, 3CH3), 3.77 (s, 3 H, 
OCH3), 6.81-6.84 (m, 2 H, ArH), 7.11-7.31 (m, 6 H, ArH), 
7.40-7.56 (m, 8 H, ArH ). 13C NMR (CDCl3, 75 MHz):  = 
31.1 (3CH3), 34.3 (C), 55.3 (OCH3), 87.5, 91.2 (C), 114.0 (CH), 114.9 (C), 125.1 (CH), 125.8 
(C), 127.9, 128.6, 129.0, 129.7, 132.6, 132.9, 133.2 (CH), 136.4, 137.4, 138.0, 141.5, 150.4, 
159.9 (C), 198.3 (CO). IR (KBr): v = 3057, 3031 (w), 2957 (m), 2903, 2866, 2837 (w), 2220, 
2201, 1713 (m), 1663 (s), 1593, 1543 (m), 1509 (s), 1462 (m), 1446 (w), 1412, 1362, 1280 
O
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(m), 1245 (s), 1217, 1173, 1105, 1027, 927, 887 (m), 829 (s), 802, 762 (m), 701 (s), 655, 621, 
536 (m) cm-1. MS (EI, 70 eV): m/z (%) = 444 (M+, 100), 430 (17), 429 (42), 387 (10), 105 
(24), 77 (13). HRMS (EI): calcd. for C32H28O2 [M]+: 444.20838; found: 444.208616. 
 
11.5 Synthesis of Bis(diaryl)sulfones by Site-Selective Suzuki-Miyaura Cross-Coupling 
Reactions of 2,4-Bis(trifluoromethylsulfonyloxy)-diphenylsulfone 
 
11.5.1 Regioselective Suzuki reactions. Synthesis of (29a-d). 
 A 1,4-dioxane solution of the arylboronic acid 19 (1.1-2.2 equiv.), K3PO4 (3.0 equiv.), 
Pd(PPh3)4 and 28 or 30 was stirred at 60-90 °C for 4 h under argon atmosphere. After cooling 
to 20 °C, a saturated aqueous solution of NH4Cl was added. The organic and the aqueous 
layer were separated and the latter was extracted with CH2Cl2. The combined organic layers 
were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography. 
 
2-(4'-Methylbiphenyl-4-ylsulfonyl)phenyl trifluoromethanesulfonate (29a) Starting with 
with 28 (257 mg, 0.5 mmol), K3PO4 (159 mg, 0.75 mmol), 
Pd(PPh3)4 (26 mg, 3 mol%), 4-methylphenylboronic acid (75 
mg, 0.55 mmol) and 1,4-dioxane (5 mL per 1 mmol of 28), 
29a was isolated as a white solid (164 mg, 77%). 1H NMR 
(300 MHz, CDCl3):  = 2.33 (s, 3H, CH3), 7.19-7.22 (d, J = 
8.0 Hz, 2H, ArH), 7.32-7.35 (m, 1H, 2CH2), 7.41 (d, J = 8.2 Hz, 2H, ArH), 7.47-7.53 (m, 1H, 
ArH), 7.58-7.61 (m, 1H, ArH), 7.63-7.66 (m, 2H, ArH), 7.95 (d, J = 8.6 Hz, 2H, ArH), 8.23-
8.27 (m, 1H, ArH). 19F NMR (282MHz, CDCl3):  = -73.1.  13C NMR (62.8 MHz, CDCl3):  
= 21.1 (CH3), 122.2 (CH), 124.0 (q, J = 321.7 Hz, CF3), 127.2, 127.5, 128.5, 128.9, 129.7, 
130.9 (CH), 134.4 (C), 135.5 (CH), 136.0, 138.3, 138.8, 146.5, 146.8 (C). IR (KBr): v = 2959, 
2928, 2869 (w), 1590, 1514, 1467, 1392, (m), 1313, 1151 (s), 1093, 1003 (m), 820 (s), 752, 
623, 565 (m) cm_1. GC-MS (EI, 70 eV): m/z (%) = 426 ([M]+, 100), 333 (19), 332 (21), 305 
(10), 304 (14), 198 (28), 197 (23), 180 (18), 178 (14), 166 (26), 165 (83), 152 (25). HRMS 
(EI, 70 eV): calcd for C17H13O: 312.01443; found 312.013869: calcd for C28H26O2: 
426.16480; found 426.164948. 
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2-(4'-Ethylbiphenyl-4-ylsulfonyl)phenyl trifluoromethanesulfonate (29b) Starting with 
with 28 (257 mg, 0.5 mmol), K3PO4 (159 mg, 0.75 mmol), 
Pd(PPh3)4 (26 mg, 3 mol%), 4-ethylphenylboronic acid (82 
mg, 0.55 mmol) and 1,4-dioxane (5 mL per 1 mmol of 28), 
29b was isolated as a white solid (190 mg, 81%). 1H NMR 
(300 MHz, CDCl3):  = 1.19 (d, J = 7.6 Hz, 3H, CH3), 7.22 
(d, J = 8.4 Hz, 2H, ArH), 7.32-7.35 (m, 1H, ArH), 7.44 (d, J = 8.2 Hz, 2H, ArH), 7.47-7.53 
(m, 1H, ArH), 7.58-7.62 (m, 1H, ArH), 7.65 (d, J = 8.7 Hz, 2H, ArH), 7.94 (d, J = 8.7 Hz, 2H, 
ArH), 8.23-8.24 (m, 1H, ArH). 19F NMR (282 MHz, CDCl3):  = -73.1. 13C NMR (62.8 MHz, 
CDCl3):  = 15.4 (CH3), 28.5 (CH2), 122.2 (CH), 123.5 (q, J = 322.0 Hz, CF3), 127.3, 127.5, 
128.5, 128.6, 128.8, 130.9 (CH), 134.4 (C), 135.5 (CH), 136.3, 138.3, 145.1, 146.5, 146.9 (C). 
IR (KBr): v = 3108, 3023, 2965, 2852 (w), 1591, 1468 (m), 1433, 1332, 1200, 1157, 1128, 
870 (s), 786, 728, 619, 561 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 470 ([M]+, 100), 455 
(12), 258 (15), 257 (33), 245 (38), 244 (42), 229 (16), 227 (12), 197 (24), 165 (28), 152 (15). 
HRMS (ESI M+H, 70 eV): calcd for C21H18F3O5S2: 471.05423; found 471.05405. 
 
2-(4'-tert-Butylbiphenyl-4-ylsulfonyl)phenyl trifluoromethanesulfonate (31c) Starting 
with with 28 (257 mg, 0.5 mmol), K3PO4 (159 mg, 0.75 
mmol), Pd(PPh3)4 (26 mg, 3 mol%), 4-tert-
butylphenylboronic acid (98 mg, 0.55 mmol) and 1,4-
dioxane (5 mL per 1 mmol of 28), 29c was isolated as a 
white solid (206 mg, 83%). 1H NMR (300 MHz, CDCl3): 
 = 1.28 (s, 9H, 3CH3),  7.34 (d, J = 8.2 Hz, 1H, ArH), 7.44 (d, J = 7.0 Hz, 2H, ArH), 7.47-
7.48 (m, 1H, ArH), 7.52 (d, J = 7.7 Hz, 2H, ArH), 7.60 (d, J = 8.1 Hz, 1H, ArH), 7.64 (d, J = 
8.7 Hz, 2H, ArH), 7.95 (d, J = 8.6 Hz, 2H, ArH), 8.25 (d, J = 7.8 Hz, 1H, ArH). 19F NMR 
(282MHz, CDCl3):  = -73.1.  13C NMR (62.8 MHz, CDCl3):  = 31.2 (3CH3), 34.6 (C), 
122.2 (CH), 123.5 (q, J = 322.3 Hz, CF3), 126.0, 127.0, 127.5, 128.5, 128.8, 130.9 (CH), 
134.4 (C), 135.5 (CH), 136.0, 138.3, 146.5, 146.7, 152.0 (C). IR (KBr): v = 3023, 2959, 2862 
(w), 1592, 1467 (m), 1433, 1331 (s), 1247, 1215, 1200 (m), 1156, 1128, 870 (s), 821, 786, 
723, 709, 613, 580, 566, 554 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 498 ([M]+, 35), 485 
(13), 484 (25), 483 (100), 285 (18), 271 (25). HRMS (ESI M+H, 70 eV): calcd for 
C21H18F3O5S2: 471.05423; found 471.05405. 
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2-(4'-Methoxybiphenyl-4-ylsulfonyl)phenyl trifluoromethanesulfonate (29d) Starting with 
28 (257 mg, 0.4 mmol), K3PO4 (159 mg, 0.75 mmol), 
Pd(PPh3)4 (26 mg, 3 mol%), 4-methoxyphenylboronic acid 
(83 mg, 0.55 mmol) and 1,4-dioxane (5 mL per 1 mmol of 
28), 29d was isolated as a white solid (115 mg, 74%). 1H 
NMR (300 MHz, CDCl3):  = 3.76 (s, 3H, OCH3), 6.90 (d, 
J = 7.0 Hz, 2H, ArH), 7.30-7.33 (m, 1H, ArH), 7.45 (d, J = 7.0 Hz, 2H, ArH), 7.48-7.51 (m, 
1H, ArH), 7.57-7.63 (m, 3H, ArH), 7.92 (d, J = 8.7 Hz, 2H, ArH), 8.21-8.24 (m, 1H, ArH). 
19F NMR (282MHz, CDCl3):  = -73.2.  13C NMR (62.8 MHz, CDCl3):  = 55.3 (OCH3), 
114.5, 122.2, 122.3 (CH), 123.5 (q, J = 322.0 Hz, CF3), 128.5, 128.6, 128.9, 130.9 (CH), 
131.2, 134.5 (C), 135.5 (CH), 137.9, 146.4, 146.5, 160.3 (C). IR (KBr): v = 3070, 2964, 2838 
(w), 1589 (m), 1426, 1331 (s), 1229 (m), 1200, 1157, 1128 (s), 1093, 1034 (m), 881 (m), 827, 
774, 738, 684, 618, 564 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 426 ([M]+, 100), 333 (19), 
332 (21), 305 (10), 304 (14), 198 (28), 197 (23), 180 (18), 178 (14), 166 (26), 165 (83), 152 
(25). HRMS (EI, 70 eV): calcd for C17H13O: 312.01443; found 312.013869: calcd for 
C28H26O2: 426.16480; found 426.164948. 
 
11.5.2 Synthesis of unsymmetrical Bis(diaryl)sulfones  (30a-e) 
 
2-(4'-Methylbiphenyl-4-ylsulfonyl)biphenyl (30a) Starting with 29a (228 mg, 0.50 mmol), 
K3PO4 (159 mg, 0.75 mmol), Pd(PPh3)4 (18 mg, 3 mol%), 
phenylboronic acid (67 mg, 0.55 mmol) and 1,4-dioxane (5 
mL per 1 mmol of 29a), 30a was isolated as a solid (165 mg, 
86%). 1H NMR (300 MHz, CDCl3):  = 2.32 (s, 3H, CH3), 
6.91 (d, J = 7.0 Hz, 2H, ArH), 7.08-7.14 (m, 3H, ArH), 7.16-7.20 (m, 5H, ArH), 7.29-7.33 
(m, 1H, ArH), 7.28 (d, J = 8.0 Hz, 2H, ArH), 7.34 (d, J = 8.2 Hz, 2H, ArH), 7.49-7.53 (m, 2H, 
ArH), 8.36-8.39 (m, 1H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.1 (CH3), 126.6, 127.0, 
127.2, 127.5, 127.6, 128.1, 128.4, 129.7, 130.0, 132.6, 132.8 (CH), 136.4, 138.1, 138.5, 
139.0, 139.9, 142.1, 145.2 (C). IR (KBr): v = 3052, 2918, 2852 (w), 1591, 1464 (m), 1297, 
1147 (s), 1090, 1005, 813, 757, 702, 690 (m), 625, 582 (s), 541 (m) cm-1. GC-MS (EI, 70 eV): 
m/z (%) = 384 ([M]+, 100), 320 (28), 304 (19), 289 (19), 215 (13), 183 (43), 165 (26), 152 
(75). HRMS (EI, 70 eV): calcd for C25H20O2S: 384.11785; found 384.117575. 
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4'-Ethyl-2-(4'-methylbiphenyl-4-ylsulfonyl)biphenyl (30b) Starting with 29a (228 mg, 0.50 
mmol), K3PO4 (159 mg, 0.75 mmol), Pd(PPh3)4 (18 mg, 3 
mol%), 4 -ethylphenylboronic acid (82 mg, 0.55 mmol) and 
1,4-dioxane (5 mL per 1 mmol of 29a), 30b was isolated as a 
solid (187 mg, 91%). 1H NMR (300 MHz, CDCl3):  = 1.18 
(t, J = 7.7 Hz, 3 H, CH2CH3), 2.31 (s, 3 H, CH3), 2.61 (q, J = 
7.6Hz, 2 H,  CH2CH3), 6.80-6.82 (m, 2 H, ArH),  6.89-6.93 (m, 2 H, ArH), 7.07-7.20 (m, 5 H, 
ArH), 7.23-7.36 (m, 4 H, ArH), 7.44-7.48 (m, 2 H, ArH), 8.32-8.36 (m, 1 H, ArH) . 13C NMR 
(75 MHz, CDCl3):  = 15.4, 21.1 (CH3), 28.5 (CH2), 127.1 (C), 127.2, 127.3, 127.5, 127.6, 
128.6, 128.9, 129.8, 130.9, 135.5, 136.1 (CH), 138.3, 138.8, 139.7, 145.1, 146.5, 146.7, 146.9 
(C). IR (KBr): v = 3104 (w) 3058 (w), 2967 (w), 2920 (w), 2873 (w), 1592 (m), 1555 (w), 
1484 (w), 1450 (w), 1423 (s), 1406 (w), 1333 (s), 1297 (m), 1228 (m), 1209 (s), 1157 (s), 
1128 (s), 1089 (m), 1054 (m), 1003 (m), 958 (w), 884 (s), 781 (m), 717 (m), 685 (m), 622 
(m), 595 (s), 560 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 412 ([M]+, 100), 348 (12), 333 
(22), 318 (26), 197 (26), 165 (50), 152 (32). HRMS (EI, 70 eV): calcd for C27H24O2S: 
412.14973; found: 412.14882. 
 
4'-Methoxy-2-(4'-methylbiphenyl-4-ylsulfonyl)biphenyl (30c) Starting with 29a (228 mg, 
0.5 mmol), K3PO4 (159 mg, 0.75 mmol), Pd(PPh3)4 (18 mg, 3 
mol%), 4-methoxyphenylboronic acid (83 mg, 0.5 mmol) and 
1,4-dioxane (5 mL per 1 mmol of 29a), 30c was isolated as a 
solid (151 mg, 73%). 1H NMR (300 MHz, CDCl3):  = 2.32 
(s, 3H, CH3), 3.75 (s, 3H, OCH3), 6.91 (d, J = 7.0 Hz, 2H, 
ArH), 7.08-7.14 (m, 3H, ArH), 7.16-7.20 (m, 4H, ArH), 7.29-7.33 (m, 1H, ArH), 7.28 (d, J = 
8.0 Hz, 2H, ArH), 7.34 (d, J = 8.2 Hz, 2H, ArH), 7.49-7.53 (m, 1H, ArH), 8.36-8.39 (m, 1H, 
ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.1 (CH3), 55.3 (OCH3), 112.7, 126.5, 127.0, 
127.2, 127.4, 128.1, 128.5, 129.7 (CH), 130.5 (C), 131.2, 132.9 (CH), 135.3, 136.4, 137.3, 
139.1, 140.0, 142.3, 145.1, 151.7 (C). IR (KBr): v = 3056, 2952, 2921, 2851 (w), 1612, 1574, 
1514, 1462, 1391, 1309, 1245, 1032, 832 (m), 758 (s), 672 (m), 625 (s), 538 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 414 ([M]+, 100), 335 (14), 305 (10), 168 (14), 167 (10), 152 (26), 
140 (14), 139 (24). HRMS (EI, 70 eV): calcd for C26H22O2S: 414.12842; found 414.128525.  
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2-(4'-Methylbiphenyl-4-ylsulfonyl)-4'-(trifluoromethyl)biphenyl (30d) Starting with 29a 
(228 mg, 0.50 mmol), K3PO4 (159 mg, 0.75 mmol), 
Pd(PPh3)4 (18 mg, 3 mol%), 4 (trifluoromethyl) 
phenylboronic acid (104 mg, 0.55 mmol) and 1,4-dioxane (5 
mL per 1 mmol of 29a), 30c was isolated as a solid (183 mg, 
81%). 1H NMR (300 MHz, CDCl3):  = 2.33 (s, 3H, CH3), 
7.04 (d, J = 7.9 Hz, 2H, ArH), 7.10-7.13 (m, 1H, ArH), 7.16-7.21 (m, 4H, ArH), 7.28-7.33 
(m, 3H, ArH), 7.36 (d, J = 7.2 Hz, 2H, ArH). 19F NMR (282 MHz, CDCl3):  = -62.8. 13C 
NMR (62.8 MHz, CDCl3):  = 21.1 (CH3), 122.6 (q, J = 274 Hz, C), 124.1 (d, J = 3.8 Hz, 
CH), 126.7, 127.0, 128.0, 128.3, 128.5 (CH), 129.6 (C), 129.8 (CH), 130.1 (C), 130.4, 132.0, 
133.0 (CH), 136.1, 138.7, 140.1 (q, J = 36.5 Hz, CH), 140.5, 141.7, 145.5 (C). IR (KBr): v = 
3062, 2849 (w), 1591, 1470, 1392 (m), 1313, 1152 (s), 1107, 1062 (m), 811 (s), 756, 626 (m), 
582 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 452 ([M]+, 100), 215 (10), 201 (15), 183 (55), 
167 (12), 155 (15), 152 (46). HRMS (EI, 70 eV): calcd for C26H19O2F3S: 452.10524; found 
452.104506. 
 
2-(4'-tert-Butylbiphenyl-4-ylsulfonyl)-4'-methylbiphenyl (29e) Starting with 29c (249 mg, 
0.40 mmol), K3PO4 (127 mg, 0.60 mmol), Pd(PPh3)4 
(14 mg, 3 mol%), 4 -methylphenylboronic acid (72 mg, 
0.44 mmol) and 1,4-dioxane (5 mL per 1 mmol of 29c), 
30e was isolated as a solid (153 mg, 87%). 1H NMR 
(300 MHz, CDCl3):  = 1.28 (s, 9H, 3CH3), 2.32 (s, 
3H, CH3), 6.91 (d, J = 7.0 Hz, 2H, ArH), 7.08-7.14 (m, 3H, ArH), 7.16-7.20 (m, 5H, ArH), 
7.29-7.33 (m, 1H, ArH), 7.28 (d, J = 8.0 Hz, 2H, ArH), 7.34 (d, J = 8.2 Hz, 2H, ArH), 7.49-
7.53 (m, 2H, ArH), 8.34-8.37 (m, 1H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.2, 31.2 
(CH3), 34.6 (C), 125.9, 126.5, 126.9, 127.5, 127.9, 128.2, 128.4, 129.8, 132.7, 132.8 (CH), 
135.3, 136.4, 137.3, 139.1, 140.0, 142.3, 145.1, 151.7 (C). IR (KBr): v = 3051, 2954, 2864 
(w), 1591, 1463, 1312 (m), 1153 (s), 1109, 1002 (m), 813 (s), 761, 739, 708 (m), 603, 559, 
535 (s)cm-1. GC-MS (EI, 70 eV): m/z (%) = 440 ([M]+, 48), 426 (31), 425 (100), 166 (11), 
165 (23), 152 (17). HRMS (EI, 70 eV): calcd for C29H28O2S: 440.18045; found 440.180674. 
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11.6 Site-Selective Sonogashira Reactions of 2,4-
Bis(trifluoromethylsulfonyloxy)diphenylsulfone 
 
11.6.1 Synthesis of dialkynyl-diphenylsulfones  
 
In a pressure tube (glass bomb) a suspension of Pd(PPh3)2Cl2 (2.5-5.0 mol%), 28 (257 mg, 0.5 
mmol), alkyne (0.50-1.10 mmol),  (Bu)4NI (27 mg, 15 mol%), CuI (10mol%), Et3N (0.62-
1.25 mmol) in DMF (5 mL) was purged with argon and stirred at 20 °C for 10 min. The 
reaction mixture was stirred at 60 -80 °C for 2-4 h. The solution was cooled to 20 °C, poured 
into H2O and CH2Cl2 (25 mL each), and the organic and the aqueous layer were separated. 
The latter was extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were washed 
with H2O (3 x 20 mL), dried (Na2SO4), concentrated in vacuo and the residue was purified by 
chromatography (flash silica gel, heptanes/EtOAc) to give (31a-e) and (32a-e). 
 
11.6.1 Synthesis of symmetrical dialkynyl-diphenylsulfones (31a-31e)  
 
2,4'-Sulfonylbis((phenylethynyl)benzene) (31a). Starting with 28 (257mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (18 mg, 5 mol%), (Bu)4NI (27 mg, 15 mol%), CuI 
(10 mg, 10 mol%), triethylamine (0.18 mL, 1.25 mmol), 
ethynylbenzene (0.12 mL, 1.1 mmol) and DMF (4 mL), 
following the general procedure 31a was prepared as a 
colourless soild  (184 mg, 88%). 1H NMR (300 MHz, CDCl3): 
 = 7.02-7.17 (m, 4H, ArH), 7.15-7.26 (m, 3H, ArH), 7.29-
7.31 (m, 2H, ArH), 7.33-7.39 (m, 1H, ArH), 7.45-7.48 (d, 1 H, J = 1.8, 7.8 Hz, ArH). 13C 
NMR (62.8 MHz, CDCl3):  = 85.8, 87.8, 93.0, 98.2, 122.3, 122.4, 122.7 (C), 128.3, 128.4, 
128.5, 129.0, 129.1, 129.2, 131.6, 131.7, 131.8, 132.3, 133.1, 134.8 (CH), 135.2, 139.7, 141.0 
(C). IR (KBr): v = 3060, 2924, 2853 (w), 1780, 1597, 1587, 1491, 1465, 1441, 1395, 1359 
(m), 1319 (s), 1279, 1249, 1220, 1155 (s), 1123, 1086, 916, 834 (m), 746, 688, 673, 622, 583 
(s), 548 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 418 ([M]+, 21), 352 (33), 313 (100), 284 
(21), 213 (10). HRMS (EI, 70 eV): calcd for C28H18O2S: 418.10220; found: 418.102241. 
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2,4'-Sulfonylbis((p-tolylethynyl)benzene) (31b) Starting with 28 (257mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (18 mg, 5 mol%), (Bu)4NI (27 mg, 15 mol%), 
CuI (10 mg, 10 mol%), triethylamine (0.18 mL, 1.25 
mmol), 1-ethynyl-4-methylbenzene (0.14 mL, 1.1 mmol) 
and DMF (4 mL), following the general procedure 31b was 
prepared as a colourless oil (205 mg, 92%). 1H NMR (300 
MHz, CDCl3):   = 7.25-7.27 (m, 4H, ArH), 7.31-7.34 (m, 
3H, ArH), 7.40-7.56 (m, 8H, ArH), 7.77-7.80 (m, 2H, ArH), 8.18 (dd, 1H, J = 1.8, 7.8 Hz, 
ArH).  13C NMR (62.8 MHz, CDCl3):  = 19.2, 19.3 (CH3), 82.9, 85.0, 91.0, 96.2, 116.9, 
117.0, 120.6 (C), 125.9, 126.0, 126.4, 126.9, 127.0, 129.2, 129.3, 129.4, 130.7 (CH), 132.5, 
136.9, 137.1, 137.2, 138.6 (C). IR (KBr): v = 3060, 2924, 2853 (w), 2216, 1780, 1597, 1587, 
1491, 1465, 1441, 1395, 1359 (m), 1319 (s), 1279, 1249, 1220, 1155 (s), 1123, 1086, 916, 
834 (m), 746, 688, 673, 622, 583 (s), 548 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 446 ([M]+, 
19), 382 (18), 366 (10), 350 (10), 328 (24), 327 (100), 189 (18), 176 (10), 119 (33). HRMS 
(EI, 70 eV): calcd for C30H22O2S: 446.13350; found: 446.133844. 
 
2,4'-Sulfonylbis(pent-1-ynylbenzene) (31c). Starting with 28 (257mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (18 mg, 5 mol%), (Bu)4NI (27 mg, 15 mol%), 
CuI (10 mg, 10 mol%), triethylamine (0.18 mL, 1.1 
mmol), 1-pentyne (0.10 mL, 1.1 mmol) and DMF (4 mL), 
following the general procedure 31c was prepared as a 
colourless oil (149 mg, 85%).1H NMR (250 MHz, CDCl3): 
 = 0.92-0.99 (m, 6H, 2CH3), 1.48-1.60 (m, 4H, CH2), 2.28-2.35 (m, 4H, 2CH2), 7.37-7.42 
(m, 4H, ArH), 7.74-7.79 (m, 2H, ArH), 8.16-8.20 (m, 1H, ArH). 13CNMR (75.4 MHz, 
CDCl3):  = 13.5, 13.6 (CH3), 21.4, 21.6, 21.8, 21.9 (CH2), 79.6, 79.7, 94.6, 100.3, 123.5 (C), 
127.6, 128.1, 128.9 (CH), 129.3 (CAr), 131.4, 132.9, 135.1 (CH), 139.1, 141.7 (CAr). IR 
(KBr): v = 3063 (w) 2961 (m), 2870 (w), 1590, 1467, 1317 (m), 1153 (s), 1128, 1089, 835 
(m), 748, 611 (s), 580 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 350 ([M]+, 4), 323 (22), 322 
(100), 280 (17), 279 (83), 263 (12), 257 (31), 241 (10), 229 (11), 228 (16), 226 (16), 215 (14), 
171 (12), 136 (11), 128 (12), 115 (14). HRMS (EI, 70 eV): calcd for C22H22O2S: 350.10900; 
found: 350.109274. 
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2,4'-Sulfonylbis(hept-1-ynylbenzene) (31d) Starting with 28 (257mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (18 mg, 5 mol%), (Bu)4NI (27 mg, 15 
mol%), CuI (10 mg, 10 mol%), triethylamine (0.18 mL, 
1.25 mmol), 1-heptyne (0.14 mL, 1.1 mmol) and DMF 
(4 mL), following the general procedure 31d was 
prepared as a colourless oil (179 mg, 88%). 1H NMR 
(300 MHz, CDCl3):  = 0. 82-0.87 (m, 6H, 2CH3), 
1.23-1.36 (m, 8H, 4CH2), 1.48-1.55 (m, 4H, 2CH2), 2.29-2-35 (m, 4H, 2CH2), 7.36-7.42 (m, 
5H, ArH), 7.74-7.77 (m, 2H, ArH), 8.16-8.19 (m, 1H, ArH). 13CNMR (75 MHz, CDCl3):   = 
13.9, 14.0 (CH3), 19.4, 19.8, 22.1, 22.2, 27.8, 28.1, 31.0, 31.1 (CH2), 79.4, 79.5, 94.8, 100.5 
(C), 123.5 (CAr), 127.6, 128.1, 128.9 (CH), 129.3 (C), 131.4, 132.9, 135.1 (CH), 139.1, 140.7 
(C). IR (KBr): v = 3063 (w) 2927 (m), 2857 (w), 1590, 1467, 1319 (m), 1154 (s), 1128, 1090, 
835 (m), 755 (s), 667 (m), 612 (s), 581 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 406 ([M]+, 
1), 351 (10), 350 (42), 323 (39), 308 (10), 307 (40), 228 (10), 226 (11), 221 (14), 220 (14), 
219 (100), 215 (11), 207 (10), 163 (15), 137 (10), 129 (10), 128 (11), 115 (16), 81 (10). 
HRMS (ESI+): calcd for C26H31O2S: 407.2039; found: 407.2048. 
 
2,4'-Sulfonylbis(dec-1-ynylbenzene) (31e) Starting with 28 (257mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (18 mg, 5 mol%), (Bu)4NI (27 mg, 15 
mol%), CuI (10 mg, 10 mol%), triethylamine (0.2 
mL, 1.25 mmol), 1-decyne  (0.20 mL, 1.1 mmol) 
and DMF (4 mL), following the general 
procedure 31e was prepared as a colourless oil 
(220 mg, 90%). 1H NMR (300 MHz, CDCl3):  = 
0.78-0.83 (m, 6H, 2CH3), 1.19-1.24 (m, 16H, 
8CH2), 1.30-1.39 (m, 4H, 2CH2), 1.45-1.54 (m, 4 H, 2CH2), 2.29-2.35 (m, 4 H, 2CH2), 7.35-
7.42 (m, 5 H, ArH), 7.73-7.77 (m, 2 H, ArH), 8.16-8.19 (m, 1 H, ArH). 13CNMR (75 MHz, 
CDCl3):   = 14.0, 14.1 (CH3), 19.4, 19.9, 22.6, 23.1, 23.3, 22.7, 28.1, 28.4, 28.9, 29.0, 29.1, 
29.2, 31.8, 31.9 (CH2), 79.4, 79.5, 94.8, 100.5, 123.5 (C), 127.6, 128.1, 128.9 (CH), 129.3 
(C), 131.4, 132.9, 135.0 (CH), 139.1, 140.7 (C). IR (KBr): v = 3060, 2924, 2853 (w), 2216, 
1780, 1597, 1587, 1491, 146, 1441, 1395, 1359 (m), 1319 (s), 1279, 1249, 1220 (m), 1155 (s), 
1123, 1086, 916, 834, 746, 688, 673 (m), 622, 583 (s), 548 (m) cm-1. GC-MS (EI, 70 eV): m/z 
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(%) = 490 ([M]+, 1), 392 (28), 366 (10), 365 (37), 350 (13), 349 (38), 262 (16), 261 (100), 
207 (25), 123 (15), 115 (10). HRMS (EI, 70 eV): calcd for C32H42O2S: 490.29000; found: 
490.288484. 
 
11.6.2 Synthesis of alkynyl-diphenylsulfones 
 
2-(4-(m-Tolylethynyl)phenylsulfonyl)phenyl trifluoromethanesulfonate (32a) Starting 
with 28 (257 mg, 0.50 mmol), Pd (PPh3)2Cl2 (09 mg, 2.5 
mol%), (Bu)4NI (27 mg, 15 mol%), CuI (10 mg, 10 
mol%), triethylamine (0.09 mL, 0.62 mmol), 1-ethynyl-3-
methylbenzene 32a (0.06 mL, 0.5 mmol) and DMF (4 
mL), following the general procedure  32a was prepared 
as a colourless oil (180 mg, 75%). 1H NMR (300 MHz, CDCl3):  = 0.78 (t, 3H, J = 7.2 Hz, 
CH3), 1.16-1.26 (m, 8H, 4CH2), 1.30-1.38 (m, 2H, CH2), 1.46-1.55 (m, 2H, CH2), 2.32 (t, 2H, 
J = 7.0 Hz, CH2),  7.28-7.31 (m, 2H, ArH), 7.40-7.62 (m, 3H, ArH), 7.78-7.81 (m, 2H, ArH), 
8.17-8.20 (m, 1H, ArH) . 19FNMR (282 MHz, CDCl3):  = -73.1. 13CNMR (75.4 MHz, 
CDCl3):  = 13.0 (CH3), 18.4, 21.6, 27.3, 27.8, 28.0, 28.1, 30.7 (CH2), 78.3, 94.8 (C), 119.8 
(q, JC,F = 321.0 Hz, CF3), 121.4 (C), 121.4, 127.2, 127.6 (CH), 129.5 (C), 129.8, 131.2, 134.7 
(CH), 137.4, 145.4 (C). IR (KBr): v = 3080, 2956 (w), 2875, 2855, 1596, 1469 (m), 1433 (s), 
1335, 1223, 1189, 1156 (m), 1129 (s), 1090, 884 (s), 783, 765, 688 (m), 619, 576 (s) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 480 (100), 348 (12), 282 (49), 268 (77), 255 (22), 252 (13), 
239 (62), 207 (47), 192 (25), 189 (46), 176 (15), 152 (12), 115 (24), 64 (15). HRMS (EI, 70 
eV): calcd for C22H15O5F3S2: 480.03075; found: 480.029308. 
 
2-(4-(p-tolylethynyl)phenylsulfonyl)phenyl trifluoromethanesulfonate (32b) Starting with 
28 (257 mg, 0.50 mmol), Pd (PPh3)2Cl2 (09 mg, 2.5 
mol%), (Bu)4NI (27 mg, 15 mol%), CuI (10 mg, 10 
mol%), triethylamine (0.09 mL, 0.62 mmol), 1-
ethynyl-4-methylbenzene (0.06 mL, 0.5 mmol) and 
DMF (4 mL), following the general procedure (32b) 
was prepared as a colourless oil (199 mg, 83%). 1H NMR (300 MHz, CDCl3):  = 2.30 (s, 3H, 
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CH3), 7.10 (d, J = 7.9 Hz, 2H, ArH), 7.31-7.36 (m, 3H, ArH), 7.48-7.55 (m, 2H, ArH), 7.57-
7.65 (m, 2H, ArH), 7.87 (d, J = 8.7 Hz, 2H, ArH), 8.21-8.25 (m, 1H, ArH). 19FNMR (282 
MHz, CDCl3):  = -73.1. 13CNMR (75.4 MHz, CDCl3):  = 21.5 (CH3), 87.1, 94.1 (C), 116.3, 
120.5 (C), 119.8 (q, JC,F = 321.0 Hz, CF3), 122.3, 128.3, 128.6, 129.2,130.9, 131.7, 132.0, 
135.7 (CH), 129.8, 131.2, 134.7 (CH), 135.7, 138.9, 139.5, 146.5 (C). IR (KBr): v = 3068, 
2919 (w), 1586 (m), 1426, 1332 (s), 1231, 1198, 1157 (m), 1127 (s), 1087 (m), 882 (s), 771, 
719, 608 (m), 572 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 480 (100), 282 (18), 268 (33), 239 
(27), 189 (16). HRMS (EI, 70 eV): calcd for C22H15O5F3S2: 480.03075; found: 480.030830. 
 
2-(4-((4-tert-Butylphenyl)ethynyl)phenylsulfonyl)phenyl trifluoromethanesulfonate (32c) 
Starting with 28 (258 mg, 0.50 mmol), Pd 
(PPh3)2Cl2 (9 mg, 2.5 mol%), (Bu)4NI (27 mg, 15 
mol%), CuI (10 mg, 10 mol%), triethylamine (0.09 
mL, 0.62 mmol), 4-tert-butylphenylacetylene (0.09 
mL, 0.5 mmol) and DMF (4 mL), following the 
general procedure  32c was prepared as a colourless oil (211 mg, 88%). 1H NMR (300 MHz, 
CDCl3):  = 1.31 (s, 9H, 3CH3), 7.29-7.34 (m, 3H, ArH), 7.39 (d, J = 8.4 Hz, 2H, ArH), 7.47-
7.55 (m, 2H, ArH), 7.58-7.65 (m, 2H, ArH), 7.87 (d, J = 8.6 Hz, 2H, ArH), 8.21-8.24. 
19FNMR (282 MHz, CDCl3):  = -73.1. 13CNMR (75.4 MHz, CDCl3):  = 31.1 (3CH3), 34.9, 
87.1, 94.1 (C), 119.1 (C), 114.2 (q, JC,F = 320.0 Hz, CF3), 122.3, 125.5, 128.3, 128.6 (CH), 
129.7 (C), 130.9, 131.6, 132.0 (CH), 134.1 (C), 135.8 (CH), 138.9, 146.4, 152.6 (C). IR 
(KBr): v = 3068, 2919 (w), 1586 (m), 1426, 1332 (s), 1231, 1198, 1157 (m), 1127 (s), 1087 
(m), 882 (s), 771, 719, 608 (m), 572 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 522 ([M]+, 2), 
(2), 507 (4), 309 (4), 57 (10), 43 (100), 42 (43), 41 (53). HRMS (EI, 70 eV): calcd for 
C22H15O5F3S2: 480.03075; found: 480.030830. 
 
2-(4-(Hept-1-ynyl)phenylsulfonyl)phenyl trifluoromethanesulfonate (32d) Starting with 
28 (257 mg, 0.50 mmol), Pd (PPh3)2Cl2 (9 mg, 2.5 
mol%), (Bu)4NI (27 mg, 15 mol%), CuI (10 mg, 10 
mol%), triethylamine (0.09 mL, 0.62 mmol), hept-1-
yne 32d (0.06 mL, 0.5 mmol) and DMF (4 mL), 
following the general procedure 32d was prepared as a 
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colourless oil (197 mg, 86 %). 1H NMR (300 MHz, CDCl3):  = 0.83 (t, 3H, J = 7.0 Hz, CH3), 
1.22-1.36 (m, 8H, 4CH2), 1.47-1.53 (m, 2H, CH2), 2.33 (t, 2H, J = 7.0 Hz, CH2),  7.28-7.32 
(m, 2H, ArH), 7.40-7.44 (m, 2H, ArH), 7.46-7.51 (m, 1H, ArH), 7.80 (d, J = 7.0 Hz, 2H, 
ArH), 8.18-8.22 (m, 1H, ArH) . 19FNMR (282 MHz, CDCl3):  = -73.2. 13CNMR (62.8 MHz, 
CDCl3):  = 13.9 (CH3), 19.4, 22.1, 28.0, 31.0 (CH2), 79.3, 95.8 (C), 121.0 (q, JC,F = 322.0 
Hz, CF3), 121.4 (C), 122.2, 128.2, 128.6 (CH), 130.4 (C), 130.9, 132.1 (CH), 134.1 (C), 135.7 
(CH), 138.4, 146.4 (C). IR (KBr): v = 3079, 2954 (w), 2873, 2858, 1591, 1465 (m), 1430 (s), 
1332, 1219, 1199, 1154 (m), 1127 (s), 1088 (m), 880 (s), 782, 763, 686 (m), 617, 574 (s) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 460 (51), 446 (44), 445 (10), 433 (11), 432 (25), 431 (100), 
406 (15), 273 (23), 234 (13), 233 (45), 219 (23), 206 (17), 205 (68), 181 (23), 178 (17), 143 
(20), 142 (46), 141 (30), 129 (65), 128 (41), 116 (46), 115 (48), 81 (15), 69 (16). HRMS (EI, 
70 eV): calcd for C20H19O5F3S2: 460.06205; found: 460.062589. 
 
2-(4-(Dec-1-ynyl)phenylsulfonyl)phenyl trifluoromethanesulfonate (32e) Starting with 28 
(257 mg, 0.50 mmol), Pd (PPh3)2Cl2 (9 mg, 2.5 
mol%), (Bu)4NI (27 mg, 15 mol%), CuI (10 mg, 
10 mol%), triethylamine (0.09 mL, 0.62 mmol), 
dec-1-yne (0.09 mL, 0.5 mmol) and DMF (4 
mL), following the general procedure A 32e was 
prepared as a colourless oil (228 mg, 91%). 1H 
NMR (300 MHz, CDCl3):  = 0.78 (t, 3H, J = 7.2 Hz, CH3), 1.16-1.26 (m, 8H, 4CH2), 1.30-
1.38 (m, 2H, CH2), 1.46-1.55 (m, 2H, CH2), 2.32 (t, 2H, J = 7.0 Hz, CH2), 7.28-7.31 (m, 2H, 
ArH), 7.40-7.62 (m, 3H, ArH), 7.78-7.81 (m, 2H, ArH), 8.17-8.20 (m, 1H, ArH) . 19FNMR 
(282 MHz, CDCl3):  = -73.2. 13CNMR (75.4 MHz, CDCl3):  = 13.0 (CH3), 18.4, 21.6, 27.3, 
27.8, 28.0, 28.1, 30.7 (CH2), 78.3, 94.8 (C), 119.8 (q, JC,F = 274.0 Hz, CF3), 121.4 (C), 121.4, 
127.2, 127.6 (CH), 129.5 (C), 129.8, 131.2, 134.7 (CH), 137.4, 145.4 (C). IR (KBr): v = 3083, 
2957 (w), 2922, 2852, 1591, 1465 (m), 1431, 1332 (s), 1246, 1218, 1200 (m), 1128 (s), 1088, 
879 (s), 784, 724, 686 (m), 618, 576 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 502 (21), 446 
(44), 445 (29), 433 (12), 432 (41), 431 (28), 406 (20), 277 (19), 273 (18), 262 (37), 233 (19), 
207 (12), 205 (27), 183 (23), 181 (14), 170 (17), 157 (24), 156 (39), 155 (19), 143 (29), 142 
(32), 141 (20), 131 (12), 129 (45), 128 (28), 123 (14), 117 (20), 116 (29), 115 (28), 81 (14), 
69 (12), 67 (10), 57 (13), 55 (19), 43 (100). HRMS (EI, 70 eV): calcd for C23H25O5F3S2: 
502.10900; found: 502.109274.  
S
O
O O
FF
F
S
O
O
 137  
11.6.3 Synthesis of unsymmetrical dialkynyl diphenylsulfone 
 
1-(4-(Hept-1-ynyl)phenylsulfonyl)-2-(pent-1-ynyl)benzene (33a). Starting with 32d (230 
mg, 0.5 mmol), Pd(PPh3)2Cl2 (9 mg, 2.5 mol%), CuI 
(10 mg, 10 mol%), triethylamine (0.09 mL, 0.62 
mmol), 1-pentyne (38 mg, 0.55 mmol)  and DMF (5 
mL) following the general procedure, 33a was 
prepared as a colourless oil (170 mg, 87%). 1H NMR 
(300 MHz, CDCl3):   = 0.77-0.93 (m, 6H, 2CH3), 1.18-1.24 (m, 8H, 4CH2), 1.29-1.61 (m, 
8H, 4CH2), 2.30-2.36 (m, 4H, 2CH2), 7.36-7.42 (m, 5H, ArH), 7.74-7.78 (m, 2H, ArH), 8.16-
8.19 (m, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 13.6, 14.0 (CH3), 19.4, 19.5, 22.1, 
22.6, 28.4, 28.9, 29.1, 30.2, 31.8 (CH2), 78.1, 79.5, 94.8, 100.4, 123.5 (C), 127.6, 128.1, 128.9 
(CH), 129.3 (C), 131.4, 132.9, 135.1 (CH), 139.1, 140.7 (C). IR (KBr): v = 3063, 2924 (w), 
2929, 2859, 1590, 1467 (m), 1318, 1153 (s), 1089, 835, 754, 730 (m), 612, 581 (s) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 392 ([M]+, 100), 365 (17), 350 (16), 349 (56), 228 (10), 205 (38), 
163 (12), 115 (12). HRMS (EI, 70 eV): calcd for C25H28O2S: 392.18045; found: 392.180237. 
 
1-(4-(Dec-1-ynyl)phenylsulfonyl)-2-(phenylethynyl)benzene (33b) Starting with 32e (252 
mg, 0.5 mmol), Pd(PPh3)2Cl2 (9 mg, 2.5 mol-%), 
CuI (10 mg, 10 mol%), triethylamine (0.09 mL, 
0.62 mmol), ethynylbenzene (56 mg, 0.55 mmol)  
and DMF (5 mL) following the general 
procedure, 33b was prepared as a colourless oil 
(188 mg, 83%). 1H NMR (300 MHz, CDCl3):   
= 0.79 (t, J = 7.3 Hz, CH3), 1.16-1.24 (m, 8H, 
4CH2), 1.24-1.36 (m, 4H, 2CH2), 1.43-1.52 (m, 2H, CH2), 2.30 (t, J = 6.9 Hz, CH2), 7.29-7.33 
(m, 4H, ArH), 7.42-7.54 (m, 6H, ArH), 7.79 (d, J = 7.4 Hz, 2H, ArH), 8.21-8.24 (m, 1H, 
ArH). 13C NMR (75.4 MHz, CDCl3):   = 14.0 (CH3), 19.4, 22.6, 28.4, 28.8, 29.0, 29.1, 31.7 
(CH2), 79.4, 85.8, 94.9, 98.0, 122.4, 122.6 (C), 128.2, 128.4, 128.5, 129.1, 129.2 (CH), 129.4 
(C), 131.6, 131.7, 133.0, 134.8 (CH), 139.0, 141.1 (C). IR (KBr): v = 3059 (w), 2922, 2852 
(m), 1590, 1490 (m), 1321, 1154 (s), 1124, 1088, 835 (m) 753 (s), 689, 673 (m), 612, 582 (s) 
cm-1. GC-MS (EI, 70 eV): m/z (%) = 454 ([M]+, 3), 350 (24), 350 (25), 349 (100), 289 (13), 
207 (10), 105 (12). HRMS (EI, 70 eV): calcd for C30H30O2S: 454.19610; found: 454.197202. 
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1-((4-tert-Butylphenyl)ethynyl)-2-(4-(dec-1-ynyl)phenylsulfonyl)benzene (33c) Starting 
with 32e (252 mg, 0.5 mmol), Pd(PPh3)2Cl2 
(9mg, 2.5 mol-%), CuI (10 mg, 10 mol%), 
triethylamine (0.09 mL, 0.62 mmol), 4-tert-
butylphenylacetylene (87 mg, 0.55 mmol)  and 
DMF (5 mL) following the general procedure, 
33c was prepared as a colourless oil (201 mg, 
79%). 1H NMR (250 MHz, CDCl3):   = 0.78 (t, 
J = 7.1 Hz, CH3), 1.16-1.29 (m, 18H, 4CH2), 
1.16 (s, 9H, 3CH3), 1.22-1.30 (m, 4H, 2CH2), 1.43-1.54 (m, 2H, CH2), 2.29 (t, J = 7.3 Hz, 
CH2), 7.29-7.35 (m, 4H, ArH), 7.39-7.53 (m, 5H, ArH), 7.81 (d, J = 8.5 Hz, 2H, ArH), 8.19-
8.23 (m, 1H, ArH).  13C NMR (62.8 MHz, CDCl3):  = 14.0 (CH3), 19.4, 22.6, 28.4, 28.8, 
29.0, 29.1 (CH2), 31.1 (CH3), 31.7 (CH2), 79.5, 85.2, 94.9, 98.4, 119.4, 122.9 (C), 125.5, 
128.2, 128.3, 129.1 (CH), 129.4 (C), 131.3, 131.6, 132.9, 134.8 (CH), 139.0, 141.0, 152.5 (C). 
IR (KBr): v = 3055 (w), 2920, 2845 (m), 1585, 1485 (m), 1316, 1150 (s), 1115, 1077, 830 (m) 
751 (s), 685, 670 (m), 607, 584 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 510 ([M]+, 16), 495 
(15), 350 (25), 349 (100), 161 (36). HRMS (EI, 70 eV): calcd for C34H38O2S: 510.19610; 
found: 510.197202. 
 
11.6.4 Synthesis of alkynyl-aryl-diphenylsulfone (34a-34e) 
 
2-(4-(Dec-1-ynyl)phenylsulfonyl)biphenyl (34a) Starting with 32e (252 mg, 0.50 mmol), 
Pd(PPh3)4 (15 mg, 2.5 mol%), phenylboronic 
acid (67 mg, 0.55 mmol) was added in dioxane 
(5mL) and K3PO4 (159 mg, 0.75 mmol) 
following the general procedure, 34a was 
prepared as colourless oil (189 mg, 88%). 1H 
NMR (300 MHz, CDCl3):  = 0.80 (t, J = 7.1 Hz, 
3H, CH3), 1.19-1.27 (m, 8 H, 4(CH2), 1.32-1.39 (m, 2 H, CH2), 1.47-1.54 (m, 2 H, CH2), 2.33 
(t, J = 7.4 Hz, 2 H, CH2), 6.87-6.90 (m, 2 H, ArH), 7.01-7.16 (m, 5 H, ArH), 7.21-7.26 (m, 1 
H, ArH), 7.36-7.52 (m, 3 H, ArH), 7.74-7.77 (m, 1 H, ArH), 8.32-8.35 (m, 1 H, ArH). 13C 
NMR (75.4 MHz, CDCl3):  = 14.0 (CH3), 19.4, 22.6, 28.4, 28.9, 29.0, 29.1, 31.8 (CH2), 79.5, 
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94.8 (C), 127.3, 127.5 (CH), 127.6 (C), 127.9, 128.5, 130.0, 131.2, 131.4, 132.5, 132.9 (CH), 
135.0, 137.9, 139.3, 142.3 (C). IR (KBr): v = 2951, 2922, 2853 (m), 2852 (w), 1591, 1464, 
1316 (m), 1152 (s), 1128, 1090, 1007, 835 (m), 758 (s), 698 (m), 610 (s), 576 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 430 ([M]+, 84), 374 (16), 373 (15), 360 (20), 359 (19), 334 (19), 
295 (13), 281 (13), 267 (13), 266 (13), 265 (27), 253 (30), 252 (36), 241 (14), 239 (11), 228 
(10), 217 (79), 207 (38), 201 (16), 185 (15), 184 (50), 183 (30), 169 (15), 168 (38), 157 (14), 
156 (19), 155 (17), 153 (96), 152 (100), 151 (22), 143 (19), 142 (18), 141 (26), 129 (40),128 
(31), 127 (15), 117 (27), 115 (31), 114 (16), 91 (12), 43 (11), 41 (14). HRMS (EI, 70 eV): 
calcd for C28H30O2S: 430.19610; found: 430.196883. 
 
2-(4-(Dec-1-ynyl)phenylsulfonyl)-4'-ethylbiphenyl (34b) Starting with 32e (252 mg, 0.50 
mmol), Pd(PPh3)4 (15 mg, 2.5 mol%), 4-
ethylphenylboronic acid (82 mg, 0.55 mmol) was 
added in dioxane (5mL) and K3PO4 (159 mg, 
0.75 mmol) following the general procedure, 
34b was prepared as colourless oil (208 mg, 
91%). 1H NMR (300 MHz, CDCl3):  = 0.79-
0.83 (m, 6H, 2CH3), 1.18-1.26 (m, 8 H, 4CH2), 
1.26-1.39 (m, 2 H, CH2), 1.47-1.55 (m, 2 H, CH2), 2.32 (t, J = 7.0 Hz, 2 H,CH2), 2.60 (t, J = 
7.5 Hz, 2 H, CH2), 6.79-6.82 (m, 1 H, ArH), 6.95-7.14 (m, 7 H, ArH), 7.36-7.45 (m, 2 H, 
ArH), 7.47-7.53 (m, 3 H, ArH), 7.74-7.77 (m, 1 H, ArH), 8.31-8.34 (m, 1 H, ArH). 13C NMR 
(75 MHz, CDCl3):  = 14.0, 15.9 (CH3), 19.4, 22.6, 28.4, 28.6, 28.9, 29.0, 29.1, 31.8 (CH2), 
79.5, 94.5 (C), 126.8, 127.5 (CH), 127.6 (C), 128.1, 128.4, 129.9, 131.1, 132.7, 132.9 (CH), 
139.3, 139.7, 142.3, 143.9 (C). IR (KBr): v = 3056 (w) 2923 (m), 2853 (w), 1591, 1464, 1315 
(m), 1153 (s), 1090, 831 (m), 756, 614 (s), 572 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 458 
([M]+, 100), 387 (11), 277 (32), 269 (13), 268 (77), 265 (10), 255 (22), 252 (13), 240 (34), 
239 (62), 208 (10), 207 (47), 192 (25), 190 (11), 189 (46), 178 (10), 176 (15), 165 (11), 152 
(12), 115 (24), 69 (14), 64 (15). HRMS (ESI+): calcd for C30H35O2S: 459.2352; found: 
459.2358. 
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2-(4-(Dec-1-ynyl)phenylsulfonyl)-4'-(trifluoromethyl)biphenyl (34c) Starting with 32e 
(252 mg, 0.50 mmol), Pd (PPh3)4 (15 mg, 2.5 
mol%), 4-(trifluoromethyl)phenylboronic acid 
(104 mg, 0.50 mmol) was added in dioxane 
(5mL) and K3PO4 (159 mg, 0.75 mmol) 
following the general procedure, 34c was 
prepared as colourless oil (211 mg, 85%). 1H 
NMR (300 MHz, CDCl3):   = 0.81 (t, 3H, J = 7.2 Hz, CH3), 1.19-1.27 (m, 8H, 4CH2), 1.27-
1.41 (m, 2H, CH2), 1.48-1.58 (m, 2H, CH2), 2.33 (t, 2H, J = 7.0 Hz, CH2), 7.01-7.06 (m, 4H, 
ArH), 7.09-7.14 (m, 3H, ArH), 7.39-7.42 (m, 2H, ArH), 7.54-7.57 (m, 2H, ArH), 8.33-8.36 
(m, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 14.0 (CH3), 19.4, 22.6, 28.4, 28.8, 29.0, 
29.1, 31.7 (CH2), 79.2, 95.1 (C), 116.8, 127.5, 127.6, 128.4, 128.6, 129.2, 131.1, 131.6, 132.9, 
133.0 (CH), 139.3, 139.8, 142.1, 159.3 (CAr).  IR (KBr): v = 3059 (w), 2924 (m), 2854 (w), 
1591, 1466 (m), 1317, 1153, 1124, 1106 (s), 1061, 836 (m), 757, 613, 574 (s) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 498 ([M]+, 36), 443 (18), 429 (18), 428 (58), 403 (13), 376 (12), 285 
(43), 269 (20), 265 (10), 252 (45), 249 (26), 236 (32), 222 (12), 207 (36), 201 (100), 170 (22), 
169 (14), 157 (18), 142 (41). HRMS (EI, 70 eV): calcd for C29H29F3O2S: 498.18404; found: 
498.18324. 
 
4'-tert-Butyl-2-(4-(p-tolylethynyl)phenylsulfonyl)biphenyl (34d) 
Starting with 32b (240 mg, 0.50 mmol), Pd (PPh3)4 (15 mg, 
2.5 mol%), 4-tert-butylphenylboronic acid (98 mg, 0.55 
mmol) was added in dioxane (5mL) and K3PO4 (137 mg, 
0.65 mmol) following the general procedure, 34d was 
prepared as colourless oil (219 mg, 88%). 1H NMR (300 
MHz, CDCl3):  = 1.23 (s, 3H, CH3), 1.25 (s, 9H, 3CH3), 
6.83 (d, J, 8.1 Hz, 2H, ArH), 6.97 (d, J, 8.2 Hz, 2H, ArH), 7.07-7.21 (m, 5H, ArH), 7.31 (d, J, 
8.6 Hz, 2H, ArH), 7.38 (d, J, 8.6 Hz, 2H, ArH), 7.48-7.52 (m, 2H, ArH), 8.33-8.36 (m, 1H, 
ArH). 13C NMR (75.4 MHz, CDCl3):  = 15.9 (CH3), 28.6 (CH2), 31.1 (3CH3), 34.8, 87.4, 
93.0, 119.3 (C), 125.4, 126.8, 127.5, 127.6, 128.4 (CH), 128.8 (C), 130.0, 131.0, 131.5, 132.7, 
133.0 (ArH), 135.2, 139.6, 139.8, 142.3, 144.0, 152.4 (CAr).  IR (KBr): v = 3059 (w), 2924 
(m), 2854 (w), 1591, 1466 (m), 1317, 1153, 1124, 1106 (s), 1061, 836 (m), 757, 613, 574 (s) 
cm-1. GC-MS (EI, 70 eV): m/z (%) = 498 ([M]+, 36), 443 (18), 429 (18), 428 (58), 403 (13), 
376 (12), 285 (43), 269 (20), 265 (10), 252 (45), 249 (26), 236 (32), 222 (12), 207 (36), 201 
S
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(100), 170 (22), 169 (14), 157 (18), 142 (41). HRMS (EI, 70 eV): calcd for C29H29F3O2S: 
498.18404; found: 498.18324. 
 
4'-Methoxy-2-(4-(p-tolylethynyl)phenylsulfonyl)biphenyl (34e) 
Starting with 32b (240 mg, 0.50 mmol), Pd (PPh3)4 (15 mg, 
2.5 mol%), 4-methoxyphenylboronic acid (74 mg, 0.55 
mmol) was added in dioxane (5mL) and K3PO4 (137 mg, 
0.65 mmol) following the general procedure, 34e prepared 
as colourless oil (175 mg, 80%). 1H NMR (300 MHz, 
CDCl3):  = 2.29 (s, 3H, CH3), 3.77 3.77 (s, 3H, OCH3), 6.68 (d, J = 7.1 Hz, 2H, ArH), 6.83 
(d, J = 7.6 Hz, 2H, ArH), 7.08-7.13 (m, 6H, ArH), 7.23 (d, J = 7.4 Hz, 2H, ArH), 7.34 (d = J, 
7.6 Hz, 2H, ArH), 7.47-7.51 (m, 2H, ArH), 8.32-8.35 (m, 1H, ArH). 13C NMR (75.4 MHz, 
CDCl3):  = 21.5 (CH3), 29.7 (CH2), 55.3 (OCH3), 87.4, 93.1 (C), 112.8 (CH), 119.2 (C), 
127.5, 127.6, 128.6, 129.2 (CH), 130.3 (C), 131.1, 131.3, 131.6, 132.9, 133.0 (ArH), 135.2, 
139.6, 139.8, 142.3, 144.0, 152.4 (CAr).  IR (KBr): v = 3030, 2953, 2848 (w), 1609, 1511, 
1463 (m), 1316 (s), 1235 (m), 1154, 1111, 1033, 1016 (m), 832 (s), 753, 736, 704 (m), 610, 
559 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 438 ([M]+, 100), 189 (10), 168 (8), 140 (10), 139 
(15). HRMS (EI, 70 eV): calcd for C28H22O3S: 438.12842; found: 438.127933. 
 
11.7 One-Pot Synthesis of 2,3-Diarylindenones by Site-Selective Suzuki-Miyaura 
Sonogashira cross coupling Reactions Reactions of 2,3-Dibromoindenone 
 
11.7.1 Synthesis of Arylindenones (36a-e) and (37a-e)  
The reaction was carried out in a pressure tube. To a suspension of 35 (144 mg, 0.5 mmol), 
Pd(PPh3)4 (2.5-3.0 mol% per cross-coupling) and boronic acid 19 (0.5 to 0.55 mmol per 
cross-coupling) in dioxane (5 mL) was added a 2M solution of K2CO3 (1 mL). The 
mixture was heated at the indicated temperature (40-70 °C) under Argon atmosphere for 4-
6 h. The reaction was diluted with water and extracted with CH2Cl2 (3 x 25 mL). The 
combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The resulting residue was purified by column chromatography (silica gel, EtOAc / 
heptanes). 
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11.7.2 Synthesis of 3-Arylindenones (36a-d) 
 
2-Bromo-3-(4-ethylphenyl)-1H-inden-1-one (36a) Starting with 35 (144 mg, 0.5 mmol), 
Pd(PPh3)4 (18 mg, 3 mol%) and 4-ethylphenylboronic acid (75 mg, 0.5 
mmol), 36a was isolated as a colourless crystalline solid (145 mg, 93%). 
Reaction temperature: 40 °C. 1H NMR (300 MHz, CDCl3):  = 0.72 (t, J = 
7.8 Hz, CH3), 2.16 (q, J = 7.5 Hz, CH2), 6.57-6.55 (m, 1H, ArH), 6.63-6.68 
(m, 2H, ArH), 6.78 (d, J = 6.9 Hz, 2H, ArH), 6.95-6.97 (m, 1H, ArH), 7.01 
(d, J = 6.9 Hz, 2H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 15.2 (CH3), 
28.9 (CH2), 117.4 (C), 121.3, 123.5, 128.2, 128.3, 128.4 (C), 128.8, 130.1 (C), 133.6 (CH), 
144.6, 147.0, 156.9, 189.9 (C). IR (KBr): v = 3066 (w), 2962 (m), 2928, 2871 (w), 1712 (s), 
1606, 1596, 1503, 1455, 1284, 1183, 1101, 1018, 918, 843, 759 (m), 704 (s), 627, 545 (m) 
cm-1. GC-MS (EI, 70 eV): m/z (%) = 314 ([M, 81Br]+, 100), 312([M, 79Br]+, 99), 299 (58), 297 
(56), 202 (14), 190 (16), 189 (43), 176 (10), 109 (12), 95 (10). HRMS (EI, 70 eV): calcd for 
C17H13OBr (M+, [79Br]): 312.01443; found 312.013869, calcd for (M+, [81Br]): 314.01238; 
found 314.012420. 
 
2-Bromo-3-(4-tert-butylphenyl)-1H-inden-1-one (36b) Starting with 35 144 mg, 0.5 
mmol), Pd(PPh3)4 (18 mg, 3 mol%) and 4-tert-butylphenylboronic acid (89 
mg, 0.5 mmol), 36b was isolated as a colourless crystalline solid (151 mg, 
89%). Reaction temperature: 40 °C. 1H NMR (300 MHz, CDCl3):  = 1.31 
(s, 9H, 3CH3), 7.10-7.13 (m, 1H, ArH), 7.15-7.20 (m, 1H, ArH), 7.24-7.30 
(m, 2H, ArH), 7.47 (d, J = 8.5 Hz, 2H, ArH), 7.55 (d, J = 8.5 Hz, 2H, ArH). 
13C NMR (75.4 MHz, CDCl3):  = 31.2 (CH3), 35.0, 117.4 (C), 121.4, 123.5, 
125.6, 128.1 (CH), 128.2 (C), 128.8 (CH), 130.1 (C), 133.6 (CH), 144.5, 153.8, 156.8, 189.9 
(C). IR (KBr): v = 3066 (w), 2959 (m), 2902, 2865 (w), 1713 (s), 1606, 1556, 1407, 1362, 
1267, 1099, 1015, 919, 800, 764 (m), 704 (s), 626, 533 (m) cm-1. GC-MS (EI, 70 eV): m/z 
(%) = 342 ([M]+, 81Br, 52), 340 ([M]+, 79Br, 51), 327 (96), 325 (100), 299 (16), 297 (15), 231 
(12), 202 (23), 189 (12), 176 (14), 109 (29), 95 (16). HRMS (EI, 70 eV): calcd for C19H17OBr 
(M+, [79Br]): 340.04573; found 340.045511, calcd for (M+, [81Br]): 342.04368; found 
342.043848. 
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2-Bromo-3-(4-(trifluoromethyl)phenyl)-1H-inden-1-one (36c) Starting with 35 (144 mg, 
0.5 mmol), Pd(PPh3)4 (18 mg, 3 mol%) and 4-
(trifluoromethyl)phenylboronic acid (95 mg, 0.5 mmol), 36c was isolated as 
a colourless crystalline solid (155 mg, 88%). Reaction temperature: 40 °C. 
1H NMR (300 MHz, CDCl3):  = 6.24 (d, J = 7.2 Hz, 1H, ArH), 6.41-6.47 
(m, 1H, ArH), 6.51-6.56 (m, 1H, ArH), 6.74 (d, J = 7.0 Hz, 1H, ArH), 6.91-
6.93 (m, 2H, ArH), 6.96-6.99 (m, 2H, ArH). 19F NMR (282 MHz, CDCl3):  
= -63.4. 13C NMR (62.8 MHz, CDCl3):  = 120.2 (CH), 118.8, 119.5 (CH), 120.2 (q, J = 275 
Hz, C), 122.4 (C), 126.7 (q, J = 1 Hz, C),  132.6 (q, J = 8 Hz, CH), 128.9 (q, J = 3 Hz, CH), 
132.6 (q, J = 8 Hz, CH), 135.2 (C), 138.1 (CH), 152.5 (q, J = 36.1 Hz, C), 157.8 (CH), 163.2, 
165.7, 196.7 (C). IR (KBr): v = 3080, 2929 (w), 1718 (s), 1598, 1407 (m), 1318 (s), 1156 (m), 
1109, 1099, 1064 (s), 1014, 850, 761 (m), 704 (s), 622 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) 
= 354 ([M]+, 81Br, 100), 352 ([M]+, 79Br, 99), 274 (11), 274 (61), 245 (28), 225 (27), 176 (34), 
112 (10). HRMS (EI, 70 eV): calcd for C16H8OBr: (M+, [81Br]): 351.97051; found 
351.970583, calcd for (M+, [79Br]): 353.96847; found 353.968672. (M+, [79Br]): 
 
2-Bromo-3-(4-methoxyphenyl)-1H-inden-1-one (36d) Starting with 35 (144 mg, 0.5 mmol), 
Pd(PPh3)4 (18 mg, 3 mol%) and 4-methoxyphenylboronic acid (76 mg, 0.5 
mmol), 36d was isolated as a colourless crystalline solid (133 mg, 85%). 
Reaction temperature: 40 °C. 1H NMR (300 MHz, CDCl3):  = 7.10-7.13 (m, 
1H, ArH), 7.15-7.20 (m, 1H, ArH), 7.24-7.30 (m, 2H, ArH), 7.47 (d, J = 8.5 
Hz, 2H, ArH), 7.55 (d, J = 8.5 Hz, 2H, ArH). 13C NMR (75.4 MHz, CDCl3): 
 = 15.2 (CH3), 28.6 (CH2), 55.3 (OCH3), 121.4, 123.5, 125.6, 128.1 (CH), 
128.2 (C), 128.8 (CH), 130.1 (C), 133.6 (CH), 144.5, 153.8, 156.8, 189.9 (C). IR (KBr): v = 
3063, 2916, 2840 (w), 1715 (s), 1607, 1505, 1258, 1178, 1099, 1028, 830, 769 (m), 704 (s), 
624, 576 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 316 ([M]+, 81Br, 98), 314 ([M]+, 81Br, 100), 
235 (18), 207 (10), 164 (27), 163 (42), 117 (15). HRMS (EI, 70 eV): calcd for C16H11O279Br: 
313.99369; found 313.993877, calcd for C19H17O281Br: 315.99165; found 315.991975. 
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11.7.3 Synthesis of unsymmetrical 2,3-diarylindenones (37a-c) 
 
3-(4-Ethylphenyl)-2-(4-methoxyphenyl)-1H-inden-1-one (37a)  
Starting with 36a (156 mg, 0.5 mmol), Pd(PPh3)4 (17 mg, 3 mol%), 
4-methoxyphenylboronic acid (76 mg, 0.5 mmol), 37a was isolated 
as a colourless crystalline solid (158 mg, 93%). Reaction 
temperature: 70 °C. 1H NMR (300 MHz, CDCl3):  = 1.14 (t, J = 
7.8 Hz, 3H, CH3), 2.54 (q, J = 7.8 Hz, 3H, CH2), 3.77 (s, 3H, 
OCH3), 6.86 (d, J = 6.9 Hz,  2H, ArH), 7.03 (d, J = 8.2 Hz, 2H, 
ArH), 7.10 (d, J = 8.3 Hz, 2H, ArH), 7.13-7.23 (m, 3H, ArH), 7.28 (d, J = 8.4 Hz, 2H, ArH), 
7.47-7.50 (m, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 15.2 (CH3), 28.6 (CH2), 55.3 
(OCH3), 114.1, 121.0, 122.7 (CH), 125.0 (C), 127.6 (CH), 128.3 (C), 128.7, 129.9, 130.2 
(CH), 131.0, 131.7 (C), 133.2 (CH), 143.7, 145.4, 154.5, 160.3, 196.7 (C). IR (KBr): v = 
3000, 2956, 2927, 2840 (w), 1695 (s), 1605, 1497, 1456, 1339, 1289, 1240, 1171 (s), 1032, 
952, 922, 854, 802, 734, 680, 581 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 340 ([M]+, 100), 
325 (26), 311 (23), 252 (12), 239 (12). HRMS (EI, 70 eV): calcd for C24H20O2: 340.14578; 
found 340.145705. 
 
2-Phenyl-3-(4-(trifluoromethyl)phenyl)-1H-inden-1-one (37b) Starting with 36c (176 mg, 
0.5 mmol), Pd(PPh3)4 (17 mg, 3 mol%), phenylboronic acid (61 mg, 0.5 
mmol), 37b was isolated as a colourless crystalline solid (152 mg, 87%). 
Reaction temperature: 70 °C. 1H NMR (300 MHz, CDCl3):  = 7.01 (d, 
J = 7.0 Hz, 1H, ArH), 7.13-7.21 (m, 5H, ArH), 7.28-7.33 (m, 2H, ArH), 
7.42 (d, J = 8.0 Hz, 2H, ArH), 7.51-7.54 (m, 1H, ArH), 7.59 (d, J = 7.0 
Hz, 2H, ArH). 19F NMR (282 MHz, CDCl3):  = -62.7. 13C NMR (62.8 
MHz, CDCl3):  = 120.9, 122.7 (q, J = 274.5 Hz, C), 123.3, 125.8 (q, J = 3.8 Hz, CH), 128.1, 
128.2, 128.9, 129.2 (CH), 129.9 (q, J = 8 Hz, CH), 130.1 (q, J = 33.5 Hz, C), 132.4, 132.6, 
135.5 (C), 133.6 (CH), 143.7, 152.3, 194.9 (C). IR (KBr): v = 3070, 2961, 2855 (w), 1707 (s), 
1596, 1455, 1408 (m), 1318 (s), 1165 (m), 1108, 1063, 1013 (s), 858, 801 (m), 752, 699 (s), 
656, 599 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 350 ([M]+, 81Br, 100), 349 (40), 333 (10), 
281 (38), 253 (14), 252 (39), 250 (12), 126 (13). HRMS (EI, 70 eV): calcd for C22H13OF3: 
350.09130; found 350.091245. 
O
CF3
O
O
 145  
 
2-(4-Ethylphenyl)-3-(4-methoxyphenyl)-1H-inden-1-one (37c) Starting with 36d (158 mg, 
0.5 mmol), Pd(PPh3)4 (17 mg, 3 mol%), 4-ethylphenylboronic acid 
(75 mg, 0.5 mmol), 37b was isolated as a colourless crystalline 
solid (146 mg, 86%). Reaction temperature: 70 °C. 1H NMR (300 
MHz, CDCl3):  = 1.20 (t, J = 7.7 Hz, CH3), 2.62 (q, J = 7.2 Hz, 
CH2), 3.70 (s, 3H, OCH3), 6.72 (d, J = 8.4 Hz, 2H, ArH), 7.05 (d, J 
= 7.2 Hz, 1H, ArH), 7.14-7.19 (m, 5H, ArH), 7.22-7.28 (m, 3H, 
ArH), 7.45-7.48 (m, 1H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 15.2 (CH3), 28.7 (CH2), 
55.1 (OCH3), 113.6, 121.0, 122.7 (CH), 123.3, (C), 128.2, 128.5, 128.6 (CH), 130.1, 130.8 
(C), 131.2 (CH), 131.5 (C), 133.3 (CH), 145.5, 154.0, 159.1, 197.0 (C). IR (KBr): v = 2968, 
2933, 2841 (w), 1706 (s), 1603, 1583, 1513, 1453, 1338, 1296 (m), 1250, 1175 (s), 1149, 
1066 (m), 1028 (s), 919, 832, 808, 764, 733, 713, 630, 562, 532 (m) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 340 ([M]+, 100), 325 (11), 311 (11), 268 (12), 239 (14). HRMS (EI, 70 eV): 
calcd for C24H20O2: 340.14577; found 340.145895. 
 
11.7.4 Synthesis of alkynylindenones (38a-f), (39a-d).  
In a pressure tube (glass bomb) a suspension of Pd(PPh3)2Cl2 (5-15 mol%), 35 and 38 ( 0.5 
mmol), alkyne (0.50-1.10 mmol),  CuI (10-20 mol%), (iPr)2NH (1.5 equiv) in DMF (5 mL) 
was purged with argon and stirred at 20 °C for 10 min. The reaction mixture was stirred at 
room temperature for 6-8 h. The solution was cooled to 20 °C, poured into H2O and CH2Cl2 
(25 mL each), and the organic and the aqueous layer were separated. The latter was extracted 
with CH2Cl2 (3 x 25 mL). The combined organic layers were washed with H2O (3 x 20 mL), 
dried (Na2SO4), concentrated in vacuo and the residue was purified by chromatography (flash 
silica gel, heptanes/EtOAc) to give 38a-f and 39a-d. 
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11.7.5 Synthesis of 3-aryl-2-alkynylindenones 
 
3-(4-Ethylphenyl)-2-(phenylethynyl)-1H-inden-1-one (38a) Starting with 36a (156 mg, 
0.50 mmol), Pd(PPh3)2Cl2 (18 mg, 5 mol%), dry CuI (10 mol%), 
di-isopropylamine (1ml/0.1 mmol of 36a), ethynylbenzene (56 
mg, 0.55 mmol) was added  at room temperature, 38a was isolated 
after chromatography (silica gel, n-heptane/EtOAc) as a colourless 
oil (142 mg, 85%). 1H NMR (300 MHz, CDCl3):  = 6.94-7.10 (m, 
2H, ArH), 7.22-7.25 (m, 3H, ArH), 7.30-7.32 (m, 3H, ArH), 7.40-
7.43 (m, 2H, ArH), 7.47-7.50 (m, 1H, ArH), 7.61-7.65 (m, 1H, ArH), 7.75-7.78 (m, 1H, ArH). 
13C NMR (62.8 MHz, CDCl3):  = 15.2 (CH3), 28.9 (CH2), 82.3, 99.6 (C), 117.1, 122.2, 
123.3, 126.9 (C), 128.1, 128.2, 128.5, 128.6, 131.8, 133.5 (CH), 144.2, 151.9, 159.5, 161.4, 
193.5 (C). IR (KBr): v = 3053, 2961, 2870 (w), 1712 (s), 1596, 1487, 1356, 1232, 1184, 1067, 
911, 825 (m), 753, 687 (s), 617 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 334 ([M]+, 100), 333 
(17), 319 (17), 305 (23), 289 (22), 276 (18), 144 (14). HRMS (EI, 70 eV): calcd for C25H18O: 
334.13522; found 334.135337. 
 
2-(Phenylethynyl)-3-(4-(trifluoromethyl)phenyl)-1H-inden-1-one (38b) Starting with 36c 
(176 mg, 0.50 mmol), Pd(PPh3)2Cl2 (18 mg, 5 mol%), dry CuI (10 
mol%), di-isopropylamine (1ml/0.1 mmol of 38b), ethynylbenzene 
(56 mg, 0.55 mmol) was added  at room temperature, 38b was 
isolated after chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (164 mg, 88%). 1H NMR (300 MHz, CDCl3):  = 
7.17-7.22 (m, 2H, ArH), 7.24-7.29 (m, 4H, ArH), 7.32-7.35 (m, 
1H, ArH), 7.37-7.41 (m, 1H, ArH), 7.50-7.53 (m, 1H, ArH), 7.73 (d, J = 8.3 Hz, 2H, ArH), 
7.90 (d, J = 8.3 Hz, 2H, ArH). 19F NMR (282 MHz, CDCl3):  = -62.7. 13C NMR (62.8 MHz, 
CDCl3):  = 80.4, 99.8 (C), 120.7 (CH), 121.4 (C), 122.6 (q, J = 273 Hz, C), 122.8, 124.5 (q, 
J = 3.9 Hz, CH), 127.3, 127.6, 128.0, 128.8 (CH), 129.3 (C), 129.9 (d, J = 32.9 Hz, C), 130.9, 
132.8 (CH), 134.6, 142.7, 156.9, 191.7 (C). IR (KBr): v = 3062, 2961 (w), 1715 (s), 1595, 
1488, 1455, 1409 (m), 1320 (s), 1165 (m), 1122, 1064, 1014 (s), 925, 855, 795 (m), 750, 716 
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(m), 686 (s), 591(m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 374 ([M]+, 100), 373 (34), 305 
(10), 276 (29). HRMS (EI, 70 eV): calcd for C24H13OF3: 374.09130; found 374.090996. 
 
2-((4-Tert-butylphenyl)ethynyl)-3-(4-methoxyphenyl)-1H-inden-1-one (38c) Starting with 
36d (157 mg, 0.50 mmol), Pd(PPh3)2Cl2 (18 mg, 5 mol%), 
dry CuI (10 mol%), di-isopropylamine (1ml/0.1 mmol of 
36c), 1-tert-butyl-4-ethynylbenzene (87 mg, 0.55 mmol) was 
added  at room temperature, 38c was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (157 mg, 80%). 1H NMR (300 MHz, CDCl3): 
 = 6.98 (d, J = 9.0 Hz, 2H, ArH), 7.20-7.32 (m, 4H, ArH), 7.36 (d, J = 6.9 Hz, 2H, ArH), 
7.47 (d, J = 9.0 Hz, 2H, ArH), 7.85 (d, J = 8.6 Hz, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  
= 31.4 (CH3), 34.8 (C), 55.4 (OCH3), 81.9, 99.7 (C), 114.0, 116.5, 120.0 (C), 122.0, 123.2 
(CH), 124.8 (C), 125.3, 129.4, 130.3 (CH), 131.1 (C), 131.5, 133.4 (CH), 144.2, 151.9, 159.5, 
161.4, 193.5 (C). IR (KBr): v = 3080, 2929 (w), 1718 (s), 1598, 1407 (m), 1318 (s), 1156 (m), 
1109, 1099, 1064 (s), 1014, 850, 761 (m), 704 (s), 622 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) 
= 392 ([M]+, 100), 378 (23), 377 (77),  207 (26), 144 (13), 32 (18). HRMS (EI, 70 eV): calcd 
for C28H24O2: 392.17708; found 392.177463. 
 
2-(Dec-1-ynyl)-3-(4-(trifluoromethyl)phenyl)-1H-inden-1-one (38d) Starting with 36c (176 
mg, 0.50 mmol), Pd(PPh3)2Cl2 (18 mg, 5 mol%), dry 
CuI (10 mol%), di-isopropylamine (1ml/0.1 mmol of 
36c), dec-1-yne (76 mg, 0.55 mmol) was added  at 
room temperature, 38d was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (182 mg, 89%). 1H NMR (300 MHz, CDCl3):  = 0.80 (t, j = 6.9 Hz, CH3), 
1.12-1.16 (m, 6H, CH2), 1.44-1.51 (m, 2H, CH2), 2.38 (t, J = 7.4 Hz, CH2), 7.14-7.34 (m, 3H, 
ArH), 7.46-7.50 (m, 1H, ArH), 7.69 (d, J = 7.9 Hz, 2H, ArH), 7.82 (d, J = 7.6 Hz, 2H, ArH). 
13C NMR (282 MHz, CDCl3):  = -62.8. 13C NMR (62.8 MHz, CDCl3):  = 14.0 (2CH3), 
20.1, 22.5, 28.3, 28.8, 29.0, 29.1, 31.8 (CH2), 72.3, 103.3 (C), 121.4 (CH), 122.2 (q, J = 273.1 
Hz, C), 123.7 (CH), 125.4 (q, J = 3.8 Hz, CH), 128.5, 129.5 (CH), 133.7 (q, J = 8.1 Hz, CH), 
135.7 (q, J = 36.3 Hz, C), 136.5, 143.8, 157.2, 193.3 (C). IR (KBr): v = 2954, 2925, 2855 (w), 
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1710 (s), 1596, 1461, 1410 (m), 1319 (s), 1161 (m), 1125, 1066 (s), 1016, 926, 827, 761, 717, 
681, 601 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 410 ([M]+, 58), 381 (18), 367 (41), 354 
(34), 353 (100), 339 (54), 325 (47), 313 (66), 311 (69), 287 (83), 262 (34), 243 (39), 231 (26), 
226 (32), 213 (63), 183 (11), 123 (39), 81 (42), 67 (28), 43 (23), 29 (10). HRMS (EI, 70 eV): 
calcd for C26H25OF3: 410.18520; found 410.185602. 
 
2-((6-Methoxynaphthalen-2-yl)ethynyl)-3-(4-methoxyphenyl)-1H-inden-1-one (39e) 
Starting with 36d (157 mg, 0.50 mmol), Pd(PPh3)2Cl2 (18 
mg, 5 mol%), dry CuI (10 mol%), di-isopropylamine 
(1ml/0.1 mmol of 36d), dec-1-yne (76 mg, 0.55 mmol) 
was added  at room temperature, 39e was isolated after 
chromatography (silica gel, n-heptane/EtOAc) as a 
colourless oil (162 mg, 78%). 1H NMR (300 MHz, 
CDCl3):  = 1H NMR (300 MHz, CDCl3):  = 0.79 (t, J = 7.0 Hz, CH3), 1.17-1.24 (m, 8H, 
4CH2), 1.31-1.36 (m, 2H, CH2), 2.39 (t, J = 7.0 Hz, CH3), 6.96 (d, J = 8.6 Hz, ArH), 7.17-
7.29 (m, 3H,  ArH), -7.01 (m, 2H, ArH), 7.13-7.21 (m, 5H, ArH), 7.22-7.33 (m, 2H, ArH), 
7.40-7.43 (m,  ArH), 7.43-7.51 (m, 2H, ArH), 7.77 (d, J = 8.7 Hz, 2H, ArH). 13C NMR (62.8 
MHz, CDCl3):  = 55.3, 55.4 (OCH3), 82.3, 100.2 (C), 105.8, 114.0 (CH), 116.5, 117.9 (C), 
119.4, 119.6, 122.0, 123.2 (CH), 124.8 (C), 126.7 (CH), 126.9, 128.4 (C), 129.0, 129.4, 130.3 
(CH), 131.2 (C), 131.7, 133.4 (CH), 144.2, 158.4, 159.4, 161.4, 193.5 (C). IR (KBr): v = 
3014, 2932, 2849 (w), 1704, 1599 (s), 1512, 1453, 1388, 1303, 1255 (s), 1162 (m), 1025 (s), 
947, 894 (m), 850 (s), 811, 728, 710, 661, 585 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 416  
([M]+, 100), 330 (6), 97 (5), 69 (12), 43 (10). HRMS (ESI+): calcd for C29H21O3: 417.1485; 
found 417.1484. 
 
11.7.6 Synthesis of 2,3-dialkynylindenones (39a-d) 
 
2,3-Bis(phenylethynyl)-1H-inden-1-one (39a) Starting with 35 (144 mg, 0.50 mmol), 
Pd(PPh3)2Cl2 (52 mg, 15 mol%), dry CuI (19 mg, 20 mol%), 
diisopropylamine (1ml/0.1 mmol of 35), ethynylbenzene (112 mg, 
1.1 mmol) was added  at room temperature, 39a was isolated after 
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chromatography (silica gel, n-heptane/EtOAc) as a colourless oil (147 mg, 89%). 1H NMR 
(300 MHz, CDCl3):  = 7.26-7.32 (m, 5H, ArH), 7.35-7.39 (m, 3H, ArH), 7.41-7.45 (m, 2H, 
ArH), 7.53-7.60 (m, 4H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 81.9, 83.1, 103.5, 111.3 
(C), 121.1 (CH), 121.9, 122.7 (C), 123.0, 128.3, 128.6, 129.0 (CH), 129.3 (C), 129.9, 130.1, 
132.0, 132.3, 134.3 (CH), 142.9, 143.1, 192.8 (C). IR (KBr): v = 3050, 2921, 2853 (w), 1708 
(s), 1596, 1489, 1442, 1358, 1219, 1157, 1069, 915, 868 (m), 754, 688 (s), 528 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 330 ([M]+, 100), 329 (17), 301 (16), 300 (45), 298 (12), 165 (15), 
150 (21), 140 (12). HRMS (EI, 70 eV): calcd for C26H28O2: 372.20838; found 372.208533. 
 
2,3-Bis(p-tolylethynyl)-1H-inden-1-one (39b) Starting with 35 (144 mg, 0.50 mmol), 
Pd(PPh3)2Cl2 (52 mg, 15 mol%), dry CuI (19 mg, 20 mol%),  
diisopropylamine (1ml/0.1 mmol of 35), 1-ethynyl-4-
methylbenzene (127 mg, 1.1 mmol) was added  at room 
temperature, 39b was isolated after chromatography (silica gel, 
n-heptane/EtOAc) as a colourless oil (166 mg, 93%). 1H NMR 
(300 MHz, CDCl3):  = 2.26 (s, 3H, CH3), 2.28 (s, 3H, CH3), 
7.06 (d, J = 8.4 Hz, 2H, ArH), 7.10 (d, J = 8.2 Hz, 2H, ArH), 
7.22 (d, J = 8.0 Hz, 2H, ArH),  7.30-7.39 (m, 4H, ArH), 7.42 (d, J = 8.0 Hz, 2H, ArH). 13C 
NMR (62.8 MHz, CDCl3):  = 20.5, 20.7 (CH3), 80.6, 82.0, 102.7, 110.9, 117.9, 118.8 (C), 
120.0, 121.7 (CH), 122.5 (C), 128.1 (CH), 128.3 (C), 128.4, 128.7, 130.8, 131.3, 133.2 (CH), 
138.2, 139.7, 141.7, 142.1, 191.1 (C). IR (KBr): v = 3083, 2930 (w), 1714 (s), 1597, 1406 
(m), 1314 (s), 1152 (m), 1106, 1093, 1060 (s), 1014, 850, 761 (m), 702 (s), 599 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 358 ([M]+, 100), 313 (12), 97 (10), 83 (11), 71 (13), 69 (26), 57 
(19), 43 (15), 41 (11). HRMS (EI, 70 eV): calcd for C27H18O: 358.13522; found 358.134682. 
 
2,3-Bis((4-tert-butylphenyl)ethynyl)-1H-inden-1-one (39c) Starting with 35 (144 mg, 0.50 
mmol), Pd(PPh3)2Cl2 (52 mg, 15 mol%), dry CuI (19 mg, 20 
mol%),  diisopropylamine (1ml/0.1 mmol of 35), 1-tert-
butyl-4-ethynylbenzene (174 mg, 1.1 mmol) was added  at 
room temperature, 39c was isolated after chromatography 
(silica gel, n-heptane/EtOAc) as a colourless oil (207 mg, 
94%). 1H NMR (300 MHz, CDCl3):  = 1.26 (s, 3H, 3CH3), 
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1.27 (s, 3H, 3CH3), 7.24-7.27 (m, 2H, ArH), 7.31 (d, J = 8.6 Hz, ArH), 7.37 (d, J = 8.6 Hz, 
ArH), 7.37-7.42 (m, 2H, ArH), 7.47 (d, J = 8.6 Hz, 2H, ArH), 7.52 (d, J = 8.6 Hz, 2H, ArH). 
13C NMR (62.8 MHz, CDCl3):  = 31.1, 31.2 (6CH3), 34.9, 35.0, 81.5, 83.0, 103.8, 111.9 (C), 
120.0, 121.7 (CH), 121.9, 122.7 (C), 123.0, 128.3, 128.6, 129.0 (CH), 129.3 (C), 129.9, 130.1, 
132.0, 132.3, 133.2 (CH), 142.9, 143.2, 152.4, 153.8, 193.0 (C). IR (KBr): v = 3082, 2931 
(w), 1720 (s), 1590, 1405 (m), 1312 (s), 1156 (m), 1109, 1096, 1063 (s), 1010, 850, 761 (m), 
703 (s), 621 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 442 ([M]+, 32), 428 (10), 427 (28), 426 
(13), 355 (10), 281 (10), 253 (10), 207 (13), 178 (12), 165 (13), 163 (20), 161 (23), 149 (15), 
135 (10), 111 (12), 97 (20), 91 (17), 85 (18), 83 (24), 81 (12), 78 (65), 73 (23), 71 (32), 60 
(16), 57 (74), 44 (90), 43 (49), 41 (21). HRMS (EI, 70 eV): calcd for C33H30O: 442.22912; 
found 442.227998. 
 
2,3-Di(dec-1-ynyl)-1H-inden-1-one (39d) Starting with 35 (142 mg, 0.50 mmol), 
Pd(PPh3)2Cl2 (52 mg, 15 mol%), dry CuI (19 mg, 20 
mol%), diisopropylamine (1ml/0.1 mmol of 35), dec-1-
yne (152 mg, 1.1 mmol) was added  at room temperature, 
39d was isolated after chromatography (silica gel, n-
heptane/EtOAc) as a colourless oil (185 mg, 92%). 1H 
NMR (300 MHz, CDCl3):  = 0.79-0.83 (m, 6H, 2CH3), 
1.19-1.27(m, 20H, 10CH2), 1.36-1.46 (m, 4H, 2CH2), 
1.53-1.64(m, 4H, 2CH2), 7.11-7.16 (m, 1H, ArH), 7.18-
7.21 (m, 1H, ArH), 7.30-7.35 (m, 2H, ArH). 13C NMR 
(62.8 MHz, CDCl3):  = 14.0 (2CH3), 20.3, 20.6, 22.6, 28.4, 28.5, 28.8, 29.0, 29.1, 29.2, 31.8, 
31.9, 72.6, 74.7, 104.7, 113.4 (C), 120.7, 122.5 (CH), 124.1, 129.1 (C), 129.4, 134.0 (CH), 
143.4, 143.6, 192.8 (C). IR (KBr): v = 2961, 2932, 2872 (w), 1708 (s), 1600, 1462, 1359, 
1219, 1089, 763, 528 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 358 ([M]+, 100), 313 (12), 97 
(10), 83 (11), 71 (13), 69 (26), 57 (19), 43 (15), 41 (11). HRMS (EI, 70 eV): calcd for 
C27H18O: 372.20838; found 372.208533. 
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11.8 Synthesis of Arylated Pyrazoles by Site-Selective Suzuki-Miyaura Reactions of 
Tribromopyrazoles. 
 
11.8.1 Synthesis of Arylated Pyrazoles 
 
To a 1,4-dioxane solution (4 mL) of 41a-b ( 0.5 mmol) was added Pd(PPh3)4 (3-5 mol %) or 
Pd(OAc)2 (5 mol-%), SPhos (10 mol-%), at 20 C under argon atmosphere. After stirring for 
30 min, the arylboronic acid 19 (1.0) equiv. per bromine atom of the substrate), K3PO4 (1.5 
equiv. per bromine atom of the substrate) and water (1.0 mL) were added. The mixture was 
heated for 12 h at 100 	C. After cooling to 20 C, the mixture was diluted with H2O, extracted 
with CH2Cl2 (3 x 25 mL), dried (Na2SO4), and filtered. The solvent of the filtrate was 
concentrated in vacuo and the residue was purified by column chromatography 
(heptanes/EtOAc). 
 
11.8.2 Synthesis of mono-arylated Pyrazoles (42a-e) 
 
3,4-Dibromo-1-methyl-5-p-tolyl-1H-pyrazole (42a) Starting with 41a (200 mg, 0.62 mmol), 
Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 1 mL) and p-
tolylboronic acid (84 mg, 0.62 mmol), 42a was isolated as a  white 
solid (155 mg, 76%). Reaction temperature: 60 °C for 4h. 1H NMR 
(300 MHz, CDCl3):  = 2.35 (s, 3 H, CH3), 3.70 (s, 3H, NCH3), 7.19 (d, 2H, J = 8.5 Hz, ArH), 
7.24 (d, 2H, J = 8.5 Hz, ArH). 13C NMR (75.4 MHz, CDCl3):  = 21.4 (CH3), 38.5 (NCH3), 
96.2, 125.0, 127.1 (C), 129.5, 129.6 (CH), 139.9, 143.3 (C). IR (KBr): v = 2948, 2918, 2852 
(w), 1484, 1361, 1273, 995 (m), 823 (s), 720 (w), 575 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) 
= 330 ([M, 81Br2]+, 100), 329 ([M, 79Br81Br]+, 100), 328 ([M, 79Br2]+, 51), 170 (10), 169 (10). 
HRMS (EI, 70 eV): calcd for C12H10N2Br2 (M+, [79Br, 81Br]): 329.91848; found 329.919092. 
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3,4-Dibromo-5-(4-ethylphenyl)-1-methyl-1H-pyrazole (42b) Starting with 41a (200 mg, 
0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 1 
mL) and 4-ethylphenylboronic acid (93 mg, 0.62 mmol), 42b was 
isolated as a  white solid (168 mg, 79%). Reaction temperature: 60 
°C for 4h. 1H NMR (300 MHz, CDCl3):  = 1.20 (t, J = 7.4 Hz, CH2CH3), 2.63 (q, J = 7.6 Hz, 
CH2), 3.69 (s, 3H, NCH3), 7.20 (d, J = 8.4 Hz, 2H, ArH), 7.25 (d, J = 8.4 Hz, 2H, ArH). 13C 
NMR (75.5 MHz, CDCl3):  = 15.2 (CH3), 28.7 (CH2), 38.5 (NCH3), 96.2, 125.1, 127.1 (C), 
128.3, 129.5 (CH), 143.3, 146.0 (C). IR (KBr): v = 2963, (m), 2929, 2848 (w), 1613 (m), 
1485 (m), 1363 (s), 1274, 1117, 1004 (m) 994, 837 (s), 791, 613 (w), 577 (m) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 344 ([M, 81Br2]+, 100), 343 ([M, 79Br81Br]+, 100), 342 ([M, 79Br2]+, 51), 
331 (37), 329 (75), 327 (38). HRMS (ESI+): calcd for C12H13Br2N2 ([M+1]+, 79Br2): 342.944; 
found 342.9442, calcd for ([M+1]+, 79Br81Br): 344.942; found 344.9424, calcd for ([M+1]+, 
81Br2): 346.9401; found 346.9402. 
 
3,4-Dibromo-5-(4-tert-butylphenyl)-1-methyl-1H-pyrazole (42c) Starting with 41a (200 
mg, 0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 
M, 1 mL) and 4-tert-butylphenylboronic acid (110 mg, 0.62 mmol), 
42c was isolated as a  white solid (186 mg, 81%). Reaction 
temperature: 60 °C for 4h. 1H NMR (300 MHz, CDCl3):  = 1.29 (s, 9H, 3CH3), 3.72 (s, 3H, 
NCH3), 7.25 (d, J = 7.1 Hz, 2H, ArH), 7.44 (d, J = 6.9 Hz, 2H, ArH). 13C NMR (62.8 MHz, 
CDCl3):  = 31.2 (CH3), 34.8 (C), 38.6 (NCH3), 96.2, 124.9 (C), 125.7 (CH), 127.2 (C), 129.2 
(CH), 143.3, 152.8 (C). IR (KBr): v = 3031, 2954, 2865 (w), 1680 (m), 1363 (m), 1266 (s), 
1109 (m), 994, 839 (s), 694 (m), 587 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 374 ([M, 
81Br2]+, 23), 373 ([M, 79Br281Br2]+, 7), 372 ([M, 79Br2]+, 48), 370 (27), 359 (45), 358 (11), 357 
(100), 356 (13), 355 (54), 329 (18), 164 (17). HRMS (ESI+): calcd for C14H17Br2N2 ([M+1]+, 
79Br2): 370.9753; found 370.9751, calcd for ([M+1]+, 79Br81Br): 372.9733; found 372.973, 
calcd for ([M+1]+, 81Br2): 374.9714; found 374.9709. 
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3,4-Dibromo-5-(3-chlorophenyl)-1-methyl-1H-pyrazole (42d). Starting with 41a (200 mg, 
0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 1 mL) 
and 3-chlorophenylboronic acid (97 mg, 0.62 mmol), 42d was isolated 
as a  white solid (158 mg, 73%). Reaction temperature: 60 °C for 4h. 1H 
NMR (300 MHz, CDCl3):  = 3.73 (s, 3H, NCH3), 7.20-7.23 (m, 1H, ArH), 7.31-7.33 (m, 1H, 
ArH), 7.38 (s, 1 H, ArH), 7.39-7.40 (m, 1 H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 38.7 
(NCH3), 96.8, 125.7, 127.4 (C), 127.8, 129.6, 129.9, 130.2 (CH), 134.8, 141.8 (C). IR (KBr): 
v = 3059, 2945, 2926, 2850 (w), 1600, 1565, 1461, 1366, 1272, 1080, 996, 897 (m), 784 (s), 
686 (s), 593 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 354 ([M, 81Br237Cl2]+, 14), 353 ([M, 
81Br237Cl35Cl]+, 8), 352 ([M, 81Br235Cl]+, 70), 351 ([M, 81Br37Cl]+, 100), 350 ([M, 81Br2]+, 100), 
349 ([M, 79Br81Br]+, 9), 348 ([M, 79Br2]+, 45), 147 (10). HRMS (ESI+): calcd for 
C10H8Br2Cl2N2 ([M+1]+, 79Br2): 348.8737; found 348.874, calcd for ([M+1]+, 81Br2): 
350.8716; found 350.8726, calcd for ([M+1]+, 81Br235Cl2): 352.8693; found 352.8700. 
.  
3,4-Dibromo-5-(4-chlorophenyl)-1-methyl-1H-pyrazole (42e). Starting with 41a (200 mg, 
0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 1 
mL) and 4-chlorophenylboronic acid (97 mg, 0.62 mmol), 42e was 
isolated as a  white solid (156 mg, 71%). Reaction temperature: 60 
°C for 4h. 1H NMR (300 MHz, CDCl3):  = 3.69 (s, 3H, NCH3), 7.26 (d, J = 8.5 Hz, 2H, 
ArH), 7.42 (d, J = 8.5 Hz, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 38.6 (NCH3), 96.6, 
126.3, 127.3 (C), 129.2, 130.9 (CH), 136.0, 142.1 (C). IR (KBr): v = 3028, 2952, 2851 (w), 
1473, 1359, 1264, 1089 (m), 996, 836 (s), 775, 715, 644, 574 (m) cm-1. GC-MS (EI, 70 eV): 
m/z (%) = 354 ([M, 81Br237Cl2]+, 13), 353 ([M, 81Br237Cl35Cl]+, 8), 352 ([M, 81Br235Cl]+, 70), 
351 ([M, 81Br37Cl]+, 12), 350 ([M, 81Br2]+, 100), 349 ([M, 79Br81Br]+, 8), 348 ([M, 79Br2]+, 45), 
147 (11). HRMS (ESI+): calcd for C10H8Br2Cl2N2 ([M+1]+, 79Br2): 348.8736; found 348.873, 
calcd for ([M+1]+, 81Br2): 350.8715; found 350.8725, calcd for ([M+1]+, 81Br235Cl2): 
352.8692; found 352.8709. 
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3,4-Dibromo-5-(4-fluorophenyl)-1-methyl-1H-pyrazole (42f). Starting with 41a (200 mg, 
0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 1 
mL) and 4-fluorophenylboronic acid (87 mg, 0.62 mmol), 42f was 
isolated as a  white solid (155 mg, 75%). Reaction temperature: 60 °C 
for 4h. 1H NMR (300 MHz, CDCl3):  = 3.71 (s, 3H, NCH3), 7.13-7.19 (m, 2H, 2H, ArH), 
7.28-7.34 (m, 2H, 2H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -110.1. 13C NMR (62.8 
MHz, CDCl3):  = 38.5 (NCH3), 96.6 (C), 116.1 (d, J = 21.8 Hz, CH), 123.9 (d, J = 3.2 Hz, 
C), 127.2 (C), 131.6 (d, J = 10.8 Hz, CH), 142.3 (C), 163.4 (d, J = 244.7 Hz, C). IR (KBr): 
v = 3038, 2951, 2855 (w), 1730 (w), 1606, 1541 (m), 1484, 1361, 1219 (s), 1159, 997 (m), 
839 (s), 816, 721, 611, 575 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 334 ([M, 81Br2]+, 100), 
334 ([M, 79Br81Br]+, 8), 332 ([M, 79Br2]+, 79), 174, 136 (11), 131 (12). HRMS (ESI+): calcd 
for C10H8Br2N2 ([M+1]+, 79Br81Br): 334.9013; found 334.9016. 
 
3,4-Dibromo-5-(4-methoxyphenyl)-1-methyl-1H-pyrazole (42g). Starting with 41a (200 
mg, 0.62 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 
1 mL) and 4-methoxyphenylboronic acid (94 mg, 0.62 mmol), 42g 
was isolated as a  white solid (167 mg, 78%). Reaction temperature: 
60 °C for 4h. 1H NMR (300 MHz, CDCl3):  = 3.67 (s, 3H, CH3), 3.78 (s, 3H, CH3), 6.93 (d, J 
= 8.8 Hz, 2H, ArH), 7.23 (d, J = 8.8 Hz, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 37.5 
(NCH3), 54.3 (OCH3), 95.2 (C), 113.2 (CH), 118.9, 126.0 (C), 129.9 (CH), 142.1, 159.5 (C). 
IR (KBr): v = 3012, 2922, 2839 (w), 1607, 1539, 1481, 1366, 1257, 1176, 1025, 991 (m), 831 
(s), 803 (m), 765, 687, 613, 573 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 346 ([M, 81Br2]+, 
100), 345 ([M, 79Br 81Br]+, 8), 344 ([M, 79Br]+, 51), 333 (11), 331 (23), 329 (11). HRMS 
(ESI+): calcd for C11H11Br2 N2 ([M+1]+, 79Br2): 344.9233; found 344.9234, calcd for ([M+1]+, 
79Br81Br): 346.9213; found 346.9214, calcd for ([M+1]+, 81Br2): 348.9193; found 348.9194. 
 
1-Benzyl-3,4-dibromo-5-(4-methoxyphenyl)-1H-pyrazole (42h). Starting with 41b (200 
mg, 0.50 mmol), Pd(PPh3)2Cl2 (13 mg, 3 mol%), K2CO3 (H2O, 2 M, 
1 mL) and 4-methoxyphenylboronic acid (79 mg, 0.50 mmol), 42h 
was isolated as a  white solid (165 mg, 78%). Reaction temperature: 
60 °C for 4h. 1H NMR (300 MHz, CDCl3):  = 3.75 (s, 3H, OCH3), 
5.12 (s, 2H, CH2), 6.86 (d, J = 7.1 Hz, 2H, ArH), 6.94 (d, J = 7.0 Hz, 
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ArH), 7.09-7.20 (m, 5 H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 54.5 (CH2), 55.3 (OCH3), 
97.0 (C), 114.3 (CH), 120.0 (C), 127.1 (CH), 127.8 (C), 127.9, 128.7, 131.1 (CH), 136.3, 
143.5, 160.6 (C). IR (KBr): v = 3031, 3002, 2957, 2917, 2833 (w), 1608, 1540, 1482, 1447, 
1367, 1357 (m), 1248, 1174 (s), 1029, 998 (s), 833 (m), 726 (s), 562 (m). GC-MS (EI, 70 eV): 
m/z (%) = 424 ([M, 81Br2]+, 41), 322 ([M, 79Br 81Br]+, 85), 420 ([M, 79Br2]+, 45), 234 (10), 143 
(11), 91 (100), 65 (11). HRMS (ESI+): calcd for C17H15Br2N2O ([M+1]+, 79Br2): 420.9546; 
found 420.9543, calcd for ([M+1]+, 79Br81Br): 422.9526; found 422.9526, calcd for ([M+1]+, 
81Br2): 424.9508; found 424.9506. 
 
11.8.3 Synthesis of symmetrical triarylPyrazoles (43a-e) 
 
1-Methyl-3,4,5-tri-(p-tolyl)-1H-pyrazole (43a). Starting with 41a (200 mg, 0.62 mmol), 
Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-%),  K2CO3 
(H2O, 2 M, 1 mL) and p-tolylboronic acid (272 mg, 2.0 mmol), 
46a was isolated as a  white solid (198 mg, 91%). Reaction 
temperature: 90 °C for 6h. 1H NMR (300 MHz, CDCl3):  = 2.20 
(s, 3H, CH3), 2.24 (s, 3H, CH3), 2.28 (s, 3H, CH3), 3.76 (s, 3H, 
NCH3), 6.84 (d, J = 8.3 Hz, 2H, ArH), 6.89 (d, J = 8.3 Hz, 2H, ArH), 6.99 (d, J = 8.3 Hz, 2H, 
ArH), 7.03 (d, J = 8.3 Hz, 2H, ArH), 7.09 (d, J = 7.8 Hz, 2H, ArH), 7.27 (d, J = 8.1 Hz, 2H, 
ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.1, 21.2, 21.3 (CH3), 37.2 (NCH3), 118.7, 127.3 
(C), 127.9, 128.7, 128.9, 129.1 (CH), 129.3 (C), 130.0, 130.2 (CH), 130.7, 135.6, 136.8, 
138.2, 142.1, 148.4 (C). IR (KBr): v = 3018, 2919, 2872 (w), 1579, 1523, 1440, 1315, 1277, 
1182, 1112, 1005, 975 (m), 818 (s), 750, 723, 657, 613 (m) cm-1. GC-MS (EI, 70 eV): m/z 
(%) = 352 ([M]+, 100), 351 (36). HRMS (ESI+): calcd for C25H25N2 [M+1]+: 353.2012; found 
353.2012. 
 
3,4,5-Tris(4-ethylphenyl)-1-methyl-1H-pyrazole (43b). Starting with 41 (200 mg, 0.62 
mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-
%),  K2CO3 (H2O, 2 M, 1 mL) and 4-ethylphenylboronic 
acid (300 mg, 2.0 mmol), 46b was isolated as a white solid 
(217 mg, 89%). Reaction temperature: 90 °C for 6h. 1H 
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NMR (300 MHz, CDCl3):  = 1.09-1.20 (m, 9H, 3CH3), 2,46-2.63 (m, 6H, 3CH2), 3.76 (s, 
3H, NCH3), 6.89 (d, J = 8.2 Hz, 2H, ArH), 6.92 (d, J = 8.4 Hz, 2H, ArH), 7.02 (d, J = 8.0 Hz, 
2H, ArH), 7.06 (d, J = 8.3 Hz, 2H, ArH), 7.10 (d, J = 8.7 Hz, 2H, ArH), 7.30 (d, J = 8.2 Hz, 
2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 14.1, 14.2, 14.3 (CH3), 27.3, 27.5, 27.6 (CH2), 
36.2 (NCH3), 117.6 (C), 126.4, 126.5 (CH), 126.6 (C), 126.8, 126.9, 129.0, 129.2 (CH), 
129.7, 130.0, 140.8 141.1, 142.0, 143.3, 147.4 (C). IR (KBr): v = 3019, 2961, 2871 (w), 1573, 
1521, 1440, 1358, 1260, 1114, 1047, 1006, 976 (m), 833 (s), 753, 657, 615 (m) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 394([M]+, 100), 379 (29). HRMS (ESI+): calcd for C28H31N2 (M+ 1): 
395.2482; found 395.24.86. 
 
3,4,5-Tris(4-tert-butylphenyl)-1-methyl-1H-pyrazole (43c). Starting with 41 (200 mg, 0.62 
mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 
mol-%),  K2CO3 (H2O, 2 M, 1 mL) and 4-tert-
butylphenylboronic acid (356 mg, 2.0 mmol), 46c was 
isolated as a  white solid (254 mg, 86%). Reaction 
temperature: 90 °C for 6h. 1H NMR (250 MHz, CDCl3): 
 = 1.20 (s, 9H, 3CH3), 1.22 (s, 9H, 3CH3), 1.25 (s, 9H, 
3CH3), 3.75 (s, 3H, NCH3), 6.93 (d, J = 8.4 Hz, 2H, ArH), 7.08 (d, J = 8.5 Hz, 2H, ArH), 7.10 
(d, J = 7.3 Hz, 2H, ArH), 7.18 (d, J = 8.2 Hz, 2H, ArH), 7.28 (d, J = 8.2 Hz, 2H, ArH), 7.33 
(d, J = 8.5 Hz, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 31.2, 31.3, 31.4 (CH3), 37.3 
(NCH3), 118.6 (C), 124.8, 125.0, 125.2, (CH), 126.2 (C), 127.5, 129.8, 130.0 (CH), 130.4, 
130.8, 142.1, 148.3, 148.8, 149.9, 151.2 (C). IR (KBr): v = 3029, 2959, 2867 (w), 1525, 1436, 
1362, 1264, 1201, 1128, 1016, 975 (m), 838 (s), 799, 727, 656, 550 (m) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 478 ([M]+, 96), 464 (37), 463 (100), 224 (14). HRMS (ESI, 70 eV): calcd for 
C34H42N2 (M+ 1): 478.33425; found 478.334253. 
 
3,4,5-Tris(3,5-dimethylphenyl)-1-methyl-1H-pyrazole (43d). Starting with 41 (200 mg, 
0.62 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-%),  
K2CO3 (H2O, 2 M, 1 mL) and 3,5-dimethylphenylboronic acid (300 
mg, 2.0 mmol), 46d was isolated as a  white solid (204 mg, 84%). 
Reaction temperature: 90 °C for 6h.  1H NMR (250 MHz, CDCl3): 
 = 2.06 (s, 6H, 2CH3), 2.14 (s, 6H, 2CH3), 2.20 (s, 6H, 2CH3), 
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3.74 (s, 3H, NCH3), 6.61 (s, 2H, ArH), 6.69 (s, 1H, ArH), 6.74 (s, 1H, ArH), 6.79 (s, 2H, 
ArH), 6.89 (s, 1H, ArH), 7.04 (s, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.1, 21.2, 
21.3 (6CH3), 37.3 (NCH3), 123.3 (C), 125.8, 127.8, 127.9, 128.2, 128.8, 130.0 (CH), 130.2, 
133.2, 133.4, 136.9, 137.3, 138.0, 142.3, 148.3 (C). IR (KBr): v = 3003, 2915, 2857, 1738 
(w), 1600 (s), 1444, 1358, 1261, 1152, 1036, 912 (m), 848 (s), 789, 733, 694, 651 (m) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 394([M]+, 100), 393 (26). HRMS (ESI+): calcd for C28H31N2 
(M+1): 395.2482; found 395.2483. 
 
3,4,5-Tris(4-methoxyphenyl)-1-methyl-1H-pyrazole (43e). Starting with 41 (200 mg, 0.62 
mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-
%),  K2CO3 (H2O, 2 M, 1 mL) and 4-methoxyphenylboronic 
acid (304 mg, 2.0 mmol), 46e was isolated as a  white solid 
(200 mg, 81%). Reaction temperature: 90 °C for 6h.  1H 
NMR (250 MHz, CDCl3):  = 3.66 (s, 3H, CH3), 3.69 (s, 3H, 
CH3), 3.71 (s, 3H, CH3), 3.74 (s, 3H, CH3), 6.63 (d, J = 8.8 
Hz, 2H, ArH), 6.72 (d, J = 8.8 Hz, 2H, ArH), 6.79 (d, J = 8.8 Hz, 2H, ArH), 6.88 (d, J = 8.8 
Hz, 2H, ArH), 7.06 (d, J = 8.5 Hz, 2H, ArH), 7.31 (d, J = 8.5 Hz, 2H, ArH). 13C NMR (75.4 
MHz, CDCl3):  = 37.2 (NCH3), 55.0 (OCH3), 55.1 (OCH3), 55.2 (OCH3), 113.6, 113.7, 
113.9 (CH), 118.1, 122.5, 126.0, 126.3, 126.7 (C), 129.2, 131.4, 131.5 (CH), 141.8, 148.1, 
158.0, 158.8, 159.9 (C). IR (KBr): v = 3019, 2961, 2871 (w), 1573, 1521, 1440, 1358, 1260, 
1114, 1047, 1006, 976 (m), 833 (s), 753, 657, 615 cm-1. GC-MS (EI, 70 eV): m/z (%) = 400 
([M]+, 100), 399 (13), 385 (20). HRMS (ESI, 70 eV): calcd for C25H25N2O3 (M+ H): 401.186; 
found 401.1868. 
 
11.8.4 Synthesis of unsymmetrical triarylated Pyrazoles (44a-g) 
 
1-Methyl-3,4-diphenyl-5-p-tolyl-1H-pyrazole (44a). Starting with 42a (200 mg, 0.60 
mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-%),  
K2CO3 (H2O, 2 M, 1 mL) and p-tolylboronic acid (158 mg, 1.3 
mmol), 47a was isolated as a  white solid (188 mg, 97%). Reaction 
temperature: 90 °C for 6h. 1H NMR (300 MHz, CDCl3):  = 2.28 (s, 
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3 H, CH3), 3.78 (s, 3 H, NCH3), 6.95-6.98 (m, 2H, ArH), 7.03-7.05 (m, 1H, ArH), 7.07-7.10 
(m, 4H, ArH), 7.06-7.09 (m, 2H, ArH), 7.15-7.22 (m, 4H, ArH), 7.37-7.40 (m, 1H, ArH). 13C 
NMR (62.8 MHz, CDCl3):  = 21.3, 37.3 (NCH3), 118.9 (C), 126.2, 128.0, 129.2, 130.0, 
130.4 (CH), 122.5 (C), 127.9, 128.8, 128.9, 130.2 (CH), 130.4, 133.4, 138.3, 142.3, 148.4 (C). 
IR (KBr): v = 3051, 2921, 2850 (w), 1600, 1519 (w), 1483, 1356, 1232, 1006, 831 (m), 760, 
694 (s), 626, 566 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 324 ([M]+, 100), 323 (53). HRMS 
(ESI+): calcd for C23H21N2 ([M+1]+): 325.1699; found 325.1703. 
 
3,4-Bis(4-methoxyphenyl)-1-methyl-5-p-tolyl-1H-pyrazole (44b). Starting with 42a (200 
mg, 0.60 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 
mol-%),  K2CO3 (H2O, 2 M, 1 mL) and 4-
methoxyphenylboronic acid (197 mg, 1.3 mmol), 47b was 
isolated as a white solid (193 mg, 84%). Reaction temperature: 
90 °C for 6h.  1H NMR (300 MHz, CDCl3):  = 2.28 (s, 3 H, 
CH3), 3.68 (s, 3 H, CH3), 3.71 (s, 3 H, CH3), 3.76 (s, 3H, CH3), 
6.63-6.66 (m, 3H, ArH), 6.72-6.75 (m, 3H, ArH), 6.87-6.90 (m, 3H, ArH), 7.02-7.10 (m, 5H, 
ArH), 7.30-7.33 (m, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 21.3 (CH3), 37.2 (NCH3), 
37.2 (NCH3), 55.0, 55.1 (OCH3), 113.5, 113.6 (CH), 118.1, 125.9, 126.2, 127.3 (C), 129.1, 
129.2, 130.0, 131.4 (CH), 138.1, 142.0, 148.1, 157.9, 158.8 (C). IR (KBr): v = 3011, 2923, 
2832, 1611 (w), 1520, 1432, 1283 (m), 1241 (s), 1172 (s), 1033, 837, 807 (m), 755, 612, 530 
(m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 384 ([M]+, 100), 341 (13), 327 (22), 277 (39), 246 
(22), 198 (23). HRMS (ESI+): calcd for C25H25N2O2 [M+1]: 385.1911; found 385.1914. 
 
5-(4-Ethylphenyl)-1-methyl-3,4-diphenyl-1H-pyrazole (44c). Starting with 42b (200 mg, 
0.58 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-
%),  K2CO3 (H2O, 2 M, 1 mL) and phenylboronic acid (155 mg, 
1.27 mmol), 47c was isolated as a  white solid (174 mg, 89%). 
Reaction temperature: 90 °C for 6h. 1H NMR (300 MHz, CDCl3): 
 = 1.18 (t, J = 7.5 Hz, 3H, CH3), 2.59 (q, J = 7.6 Hz, 2H, CH2), 3.79 (s, 3H, NCH3), 6.96-
6.99 (m, 2H, ArH), 7.05-7.10 (m, 5H, ArH), 7.17-7.21 (m, 5H, ArH), 7.37-7.40 (m, 2H, ArH). 
13C NMR (62.8 MHz, CDCl3):  = 15.1 (CH3), 28.5 (CH2), 37.3 (NCH3), 125.5 (C), 126.2, 
127.2, 127.9, 128.0, 128.1 (CH), 128.5, 128.7 (C), 130.0, 130.4 (CH), 133.5, 142.3, 144.5, 
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148.4 (C). IR (KBr): v = 3051, 2959, 2924, 2848, 1603, 1519, 1454, 1361, 1277, 1117, 1058, 
1007, 973, 916 (w), 841 (m), 761, 696 (s), 627, 536 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 
338 ([M]+,  100), 337 (45). HRMS (EI, 70 eV): calcd for C24H23N2 [M+H]: 339.1856; found 
339.1861. 
 
5-(4-Ethylphenyl)-3,4-bis(4-methoxyphenyl)-1-methyl-1H-pyrazole (44d). Starting with 
42b (200 mg, 0.58 mmol), Pd(OAc)2 (7 mg, 5 mol-%), 
SPhos (25 mg, 10 mol-%),  K2CO3 (H2O, 2 M, 1 mL) and 4-
methoxyphenylboronic acid (193 mg, 1.27 mmol), 47d was 
isolated as a  white solid (189 mg, 82%). Reaction 
temperature: 90 °C for 6h. 1H NMR (300 MHz, CDCl3):  = 
1.17 (t, J = 7.5 Hz, 3H, CH3), 2.58 (q, J = 7.6 Hz, 2H, CH2), 
3.68 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 3.76 (s, 3H, NCH3), 6.64 (d, J = 8.8 Hz, 2H, ArH), 
6.73 (d, J = 9.0 Hz, 2H, ArH), 6.89 (d, J = 8.8 Hz, 2H, ArH), 7.07 (d, J = 8.2 Hz, 2H, ArH), 
7.11 (d, J = 8.2 Hz, 2H, ArH), 7.32 (d, J = 9.1 Hz, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  
= 15.1 (CH3), 28.5 (CH2), 37.2 (NCH3), 55.0, 55.1 (OCH3), 113.5, 113.6 (CH), 118.1, 125.9, 
126.2, 127.4 (C), 127.9, 129.2, 130.0, 131.4 (CH), 142.1, 144.3, 148.1, 157.9, 158.8 (C). IR 
(KBr): v = 3010, 2961, 2925, 2832 (w), 1612, 1578, 1547, 1520, 1463, 1433, 1354, 1283 (m), 
1242, 1171 (s), 1110, 1034, 973 (m), 833 (s), 809, 756, 608, 544 (m) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 398 ([M]+, 100), 397 (12), 383 (18). HRMS (ESI+): calcd for C26H27N2O2 
[M+1]: 399.2067; found 399.2071. 
 
5-(4-Chlorophenyl)-1-methyl-3,4-diphenyl-1H-pyrazole (44e). Starting with 42e (200 mg, 
0.57 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 mol-
%), K2CO3 (H2O, 2 M, 1mL) and phenylboronic acid (152 mg, 
1.25 mmol), 47e was isolated as a  white solid (169 mg, 86%). 
Reaction temperature: 90 °C for 6h.  1H NMR (300 MHz, 
CDCl3):  = 3.85 (s, 3H, NCH3), 6.99-7.02 (m, 2H, ArH), 7.09-7.12 (m, 2H, ArH), 7.22-7.25 
(m, 3H, ArH), 7.28-7.34 (m, 2H, ArH), 7.38-7.42 (m, 3H, ArH), 7.50-7.54 (m, 2H, ArH). 13C 
NMR (75.4 MHz, CDCl3):  = 37.5 (NCH3), 119.2 (C), 127.0 (CH), 127.1 (C), 127.2, 128.1, 
128.2, 128.3, 128.8, 130.4, 130.5 (CH), 133.4, 133.5, 140.2, 141.1, 141.9, 148.5 (C). IR 
(KBr): v = 3011, 2923, 2832, 1611 (w), 1520, 1432, 1283 (m), 1241 (s), 1172 (s), 1033, 837, 
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807 (m), 755, 612, 530 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 346 ([M, 37Cl2]+, 100), 345 
([M, 35Cl 37Cl]+, 34), 344 ([M, 35Cl2]+, 99). HRMS (EI, 70 eV): calcd for C22H17N2ClO (M+, 
[37Cl]): 346.91433; found 346.914332, calcd for (M+, [35Cl]): 344.91324; found 344.9133. 
. 
5-(4-Methoxyphenyl)-1-methyl-3,4-dip-tolyl-1H-pyrazole (44f). Starting with 42g (200 
mg, 0.58 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos (25 mg, 10 
mol-%),  K2CO3 (H2O, 2 M, 1 mL) and p-tolylboronic acid 
(172 mg, 1.27 mmol), 47g was isolated as a  white solid (177 
mg, 83%). Reaction temperature: 90 °C for 6h. 1H NMR (300 
MHz, CDCl3):  = 2.20 (s, 3 H, CH3), 2.24 (s, 3 H, CH3), 3.73 
(s, 3 H, CH3), 3.75 (s, 3H, CH3), 6.80 (d, J = 7.1 Hz, 2H, ArH),), 6.84 (d, J = 8.3 Hz, 2H, 
ArH), 6.90 (d, J = 8.0 Hz, 2H, ArH), 7.00 (d, J = 7.9 Hz, 2H, ArH), 7.08 (d, J = 7.0 Hz, 2H, 
ArH), 7.28 (d, J = 8.0 Hz, 2H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 21.1, 21.2 (CH3), 
37.2 (NCH3), 55.2 (OCH3), 113.9 (CH), 118.6, 122.5 (C), 127.9, 128.8, 128.9, 130.2 (CH), 
130.6, 130.8 (C), 131.4 (CH), 135.6, 136.8, 141.9, 148.4, 159.5 (C). IR (KBr): v = 2951, 
2920, 2851 (w), 1612, 1529, 1492, 1353, 1286 (m), 1243, 1178 (s), 1107 (m), 1034 (s), 1020, 
845 (m), 824 (s), 800, 755, 721, 614, 530 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 368 ([M]+, 
100), 367 (31). HRMS (ESI+): calcd for C25H25N2O [M+1]+: 369.1961; found 369.1962. 
 
3,4-Bis(3-chlorophenyl)-5-(4-methoxyphenyl)-1-methyl-1H-pyrazole (44g). Starting with 
42g (200 mg, 0.58 mmol), Pd(OAc)2 (7 mg, 5 mol-%), SPhos 
(25 mg, 10 mol-%),  K2CO3 (H2O, 2 M, 1 mL) and 3-
chlorophenylboronic acid (198 mg, 1.27 mmol), 47h was 
isolated as a  white solid (175 mg, 74%). Reaction 
temperature: 90 °C for 6h. 1H NMR (300 MHz, CDCl3):  = 3.75 (s, 3 H, CH3), 3.76 (s, 3H, 
CH3), 6.81-6.82 (m, 4H, ArH), 6.85 (s, 1H, ArH), 6.94 (s, 1H, ArH), 7.03-7.08 (m, 4H, ArH), 
711-7.15 (m, 2H, ArH). 13C NMR (62.8 MHz, CDCl3):  = 37.3 (NCH3), 55.2 (OCH3), 114.1 
(CH), 117.7, 121.4, (C), 126.2, 126.7, 127.5, 127.9, 128.5, 129.4, 130.0, 130.1, 131.3 (CH), 
133.9, 134.2, 135.0, 135.1, 142.4, 146.9, 159.8 (C). IR (KBr): v = 3057, 2926, 2835 (w), 
1611, 1597, 1469, 1358, 1290 (m), 1247 (s), 1174, 1077, 1032, 998, 846 (m), 784, 730, 698 
(s), 604 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 410 ([M, 37Cl2]+, 100), 409 ([M, 35Cl37Cl]+, 
40), 408 ([M, 35Cl2]+, 100), 407 ([M+, 25). HRMS (ESI+): calcd for C23H19Cl2N2O [M+1]+: 
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(M+, 35Cl37Cl]): 409.0869; found 409.0867, calcd for [M+1]+: (M+, [37Cl2]): 411.0844; found 
411.0855. 
 
                  11.9 Synthesis of Unsymmetrical Arylated Furans by Suzuki-Miyaura Cross-Coupling 
and Metal-Halide exchange Reactions of 2,3,4,5-Tetrabromofuran 
 
11.9.1 Synthesis of arylfurans 
 To a dioxane or toluene/dioxane (4:1) suspension (2.5 mL) of the tetrabromo furan, Pd(PPh3)4 
(2-3 mol%) and of the arylboronic acid (1.0 to 1.1 equiv.) was added an aqueous solution of 
K2CO3 (2 M, 0.5 mL). The mixture was heated at the indicated temperature (80 °C) under 
Argon atmosphere for the indicated period of time (3-5 h). The reaction mixture was diluted 
with water and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
flash chromatography (silica gel, EtOAc / heptanes). 
 11.9.2 Synthesis of symmetrical tetraarylfurans (46a-c) 
 
2,3,4,5-Tetra-p-tolylfuran (46a). Following the General procedure compound 46a was 
prepared from 45 (96 mg, 1.0 mmol), Pd(PPh3)4 (06 mg, 2 
mol%), toluene/dioxane (4:1, 2.5 mL), 2M K2CO3 (0.5 mL) and 
p-tolylboronic acid 19b (136 mg, 1.0 mmol) as a white solid  
(108 mg, 90%). 1H NMR (300 MHz, CDCl3):   = 2.23 (s, 12H, 
4CH3), 6.94-6.99 (m, 10H, ArH), 7.30-7.33 (m, 4H, ArH). 13C 
NMR (62.9 MHz, CDCl3):  = 21.2, 21.3 (CH3), 124.3 (C), 125.7 (CH), 128.4 (C), 128.9, 
129.0, 130.2 (CH), 130.3, 136.4, 136.8, 147.5 (C). IR (KBr): v = 2958, 2931, 2835 (w), 1782, 
1604 (m), 1520, 1493, 1234 (m), 1161 (s), 1073, 944 (m), 820 (s), 640, 567 (m). cm-1. GC-
MS (EI, 70 eV): m/z (%) = 484 (M+, 100), 351 (13). HRMS (EI, 70 eV): calcd. for C36H36O 
(M+): 484.27607; found: 484.27607. 
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2,3,4,5-Tetrakis(4-chlorophenyl)furan (46b). Following the General procedure compound 
46b was prepared from 45 (96 mg, 0.25 mmol), Pd(PPh3)4 
(06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 2M K2CO3 
(0.5 mL) and 4-chlorophenylboronic acid (156 mg, 1.0 
mmol) as a highly viscous colourless oil (104 mg, 82%). 1H 
NMR (250 MHz, CDCl3):   = 6.94-6.98 (m, 4H, ArH), 
7.16-7.19 (m, 8H, ArH), 7.30-7.33 (m, 4H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 123.9 
(C), 127.1, 128.6, 128.7, 129.0 (CH), 130.8, 131.4, 133.6, 133.7, 147.3 (C). IR (KBr): v = 
2948, 2923, 2805 (w), 1784, 1602 (m), 1510, 1483, 1224 (m), 1151 (s), 1063, 934 (m), 810 
(s), 645, 566 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 515 (M+, [37Cl4], 3), 513 (M+, 
[35Cl37Cl3], 18), 511 (M+, [35Cl237Cl2], 28), 509 (M+, [35Cl337Cl1], 74), 507 (M+, [35Cl4], 100), 
371 (22), 369 (26), 299 (10), 184 (12), 183 (23), 170 (51), 168 (15), 155 (13), 139 (16), 131 
(15). HRMS (EI, 70 eV): m/z = calcd. for C28H16OCl4 (M+, [35Cl4]): 507.99498, found: 
507.99498; calcd. for (M+, [35Cl337Cl]): 509.99203, found 509.99605; calcd. for (M+, 
[35Cl237Cl2]): 511.98908, found 511.989530; calcd. for (M+, [35Cl37Cl3]): 513.98613, found 
513.987468. 
 
2,3,4,5-Tetrakis(4-(trifluoromethyl)phenyl)furan (46c). Following the General procedure 
compound 46c was prepared from 45 (96 mg, 0.25 
mmol), Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 
2.5 mL), 2M K2CO3 (0.5 mL) and 4-(trifluoromethyl) 
phenylboronic acid (190 mg, 0.25 mmol) as a white solid 
(143 mg, 89%). 1H NMR (300 MHz, CDCl3):   = 7.19 
(d, 4H, J = 7.9 Hz, ArH), 7.48-7.51 (m, 12H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -62.6, 
-62.8.  13C NMR (62.9 MHz, CDCl3):  = 123.8 (q, JF,C = 272.2 Hz, CF3), 125.1 (C), 125.7 (q, 
JF,C = 3.9 Hz, CH), 125.9 (q, JF,C = 3.4 Hz, CH), 126.2 (CH), 129.6 (q, JF,C = 32.8 Hz, C-
CF3), 129.7 (q, JF,C = 32.0 Hz, C-CF3),  130.5 (CH), 132.9, 135.6, 148.0. IR (KBr): v = 3052, 
2923(w), 1695, 1612, 1446 (m), 1333 (s), 1168 (m), 1132 (m), 1080, 810, 740 (m), 682 (s), 
642, 589 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 644 (M+, 100), 625 (11), 471 (31), 173 
(27), 145 (22). HRMS (EI, 70 eV): m/z = calcd. for C32H16OF12 [M+]: 644.10041, found: 
644.100370.  
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11.9.3 Synthesis of 2-aryl-3,4,5-tribromofurans (47a-d) 
 
2,3,4-Tribromo-5-(3-chlorophenyl)furan (47a). Following the General procedure A 
compound 47a was prepared from 45 (96 mg, 0.25 mmol), Pd(PPh3)4 (06 
mg, 2 mol%), toluene/dioxane (4:1, 5 mL), 2M K2CO3 (0.5 mL) and 3-
chlorophenylboronic acid 19c (39 mg, 0.25 mmol) as a highly viscous 
colourless oil (90 mg, 87%). 1H NMR (300 MHz, CDCl3):   = 7.25-7.33 
(m, 2H, ArH), 7.73-7.76 (m, 2H, ArH), 7.82 (brs, 1H, ArH).  13C NMR (75.5 MHz, CDCl3):   
= 100.9, 107.3, 122.1, 122.2 (C), 122.4, 124.3, 127.9, 128.9 (CH), 133.8, 149.2 (C).  IR 
(KBr): v = 3093, 3066, 2961, 2921 (w), 1789, 1769, 1596 (s), 1514, 1471 (m), 1418, 1401, 
1315, 1260, 1204 (w), 1164, 1111, 1089, 1065, 1003, 958, 884 (m), 681 (s) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 416 (M+, [81Br279Br], 100), 379 (9), 351 (16), 307 (94), 256 (19), 228 (17). 
HRMS (EI, 70 eV): calcd. for C10H4OClBr3 (M+, [79Br3]): 411.74953, found: 411.749450; 
calcd. For (M+, [81Br79Br2]): 413.74749, found 413.747368; calcd. for (M+, [81Br279Br]): 
415.74544, found 415.745451; (M+, [81Br3]): 417.74339, found 417.743243. 
 
2,3,4-Tribromo-5-(4-(trifluoromethyl)phenyl)furan (47b). Following the General 
procedure A compound 47b was prepared from 45 (96 mg, 0.25 
mmol), Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 
2M K2CO3 (0.5 mL) and 3-(trifluoromethyl)phenylboronic acid (51 
mg, 0.27 mmol) as a highly viscous colourless oil (95 mg, 85%). 1H 
NMR (300 MHz, CDCl3):  = 7.46-7.57 (m, 2H, ArH), 8.03-8.10 (m, 
2H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -62.9. 13C NMR (62.9 MHz, CDCl3):  = 
102.2, 108.4 (C), 122.1 (q, JF,C = 3.9 Hz, CH), 123.4 (C), 123.8 (q, JF,C = 272.3 Hz, CF3), 
125.4 (q, JF,C = 3.6 Hz, CH), 128.3 (CH), 129.1 (C), 129.2 (CH), 132.8 (q, JF,C = 32.9 Hz, C-
CF3), 150.1 (C).  IR (KBr): v = 3083, 3060, 2951, 2931 (w), 1776, 1757, 1583 (s), 1504, 1461 
(m), 1418, 1403, 1317, 1261, 1203 (w), 1167, 1088, 1064, 998, 884 (m), 676 (s) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 451 ([M+, 81Br3], 12), 449 ([M+, 79Br81Br2]+, 12), 447 ([M+, 81Br79Br2]+, 
100), 445 ([M+, 79Br3]+, 33), 343 (49), 342 (11), 341 (97), 339 (49), 290 (11), 288 (12), 262 
(22), 260 (22), 181 (31), 161 (11). HRMS (EI, 70 eV): m/z = calcd. for C11H4OBr3F3 (M+, 
[79Br,79Br,79Br]): 445.77589, found: 445.775839; calcd. for (M+, [81Br,79Br,79Br]): 447.77384, 
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found 447.773857; calcd. for (M+, [81Br,81Br,79Br]): 449.77180, found 449.771888; calcd. for 
(M+, [81Br,81Br,81Br]): 451.76975, found 451.76975. 
 
2,3,4-Tribromo-5-(4-fluorophenyl)furan (47c). Following the General procedure A 
compound 47c was prepared from 45 (96 mg, 0.25 mmol), Pd(PPh3)4 
(06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 2M K2CO3 (0.5 mL) 
and 4-fluorophenylboronic acid (38 mg, 0.27 mmol) as a highly 
viscous colourless oil (87 mg, 88%). 1H NMR (300 MHz, CDCl3):   = 7.01-7.09 (m, 2H, 
ArH), 7.77-7.85 (m, 2H, ArH). 19F NMR (282.4 MHz, CDCl3):   = -110.9.  13C NMR (62.9 
MHz, CDCl3):  = 100.5, 108.0 (C), 115.8 (d, JF,C = 22.3 Hz, CH), 122.3 (C), 124.8 (d, JF,C = 
1.0 Hz, C), 127.5 (d, JF,C = 8.1 Hz, CH), 150.9 (C), 162.6 (d, JF,C = 249.2 Hz, CF). IR (KBr): 
v = 3072, 1887 (w), 1782, 1604 (m), 1523, 1491, 1233, 1159 (s), 1071, 943 (m), 828 (s), 641, 
597 (m). cm-1. GC-MS (EI, 70 eV): m/z (%) = 402 (M+, [81Br3], 5), 400 (M+, [81Br279Br], 10), 
398 (M+, [81Br279Br2], 34), 396 (M+, [79Br3], 100), 376 (10). HRMS (EI, 70 eV): m/z = calcd. 
for C10H4Br3FO (M+, [81Br3]): 402.79186, found: 402.791732; calcd. for (M+, [79Br81Br2]): 
400.87112, found 400.871257; calcd. for (M+, [79Br281Br]): 398.77613, found 398. 776221; 
calcd. for (M+, [81Br3]): 396.67324, found 396.6731562. 
 
2,3,4-Tribromo-5-(4-methoxyphenyl)furan (47d). Following the General procedure A 
compound 47d was prepared from 45 (96 mg, 0.25 mmol), 
Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 mL), 2M 
K2CO3 (0.5 mL) and 4-methoxyphenylboronic acid (41 mg, 0.27 
mmol) as a highly viscous colourless oil (90 mg, 91%). 1H NMR (250 MHz, CDCl3):   = 
3.77 (s, 3H, OCH3), 6.87 (d, J = 8.7 Hz, 2H, ArH), 7.75 (d, J = 8.9 Hz, 2H, ArH). 13C NMR 
(62.9 MHz, CDCl3):   = 55.3 (OCH3), 99.1, 107.7 (C), 114.0 (CH), 121.2, 121.3 (C), 127.1 
(CH), 151.8, 160.0 (C). IR (KBr): v = 3070, 1886 (w), 1781, 1601 (m), 1520, 1481, 1222, 
1145 (s), 1064, 932 (m), 815 (s), 634, 577 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 414 (M+, 
[81Br3], 4), 412 (M+, [81Br279Br], 12) 410 (M+, [81Br279Br2], 43), 408 (M+, [79Br3], 100), 376 
(10), 300 (13). HRMS (EI, 70 eV): calcd. for C11H7Br3O2 (M+, [81Br3]): 414.89397, found: 
414.893850; calcd. for (M+, [79Br81Br2]): 412.99102, found 412.991369; calcd. for (M+, 
[79Br281Br]): 410.88710, found 410.887321; calcd. for (M+, [81Br3]): 408.76424, found 
408.764562. 
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11.9.4 Synthesis of unsymmetrical tetraarylfurans (48a-d) 
 
3,4-Bis(4-tert-butylphenyl)-2,5-bis(3-(trifluoromethyl)phenyl)furan (48a). Following the 
General procedure A compound 48a was prepared from 45 (102 
mg, 0.20 mmol), Pd(PPh3)4 (05 mg, 2 mol%), toluene/dioxane 
(4:1, 2.5 mL), 2M K2CO3 (0.5 mL) and 4-tert-
butylphenylboronic acid (78 mg, 0.44 mmol) as a highly viscous 
colourless oil (115 mg, 93%). 1H NMR (300 MHz, CDCl3):  = 
1.23 (s, 18H, 6CH3), 8.03 (d, 4H, J = 8.4 Hz, ArH), 7.23 (d, 4H, 
J = 8.4 Hz, ArH), 7.32-7.39 (m, 4H, ArH), 7.54 (brs, 2H, ArH), 
7.62-7.66 (m, 2H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -63.1. 13C NMR (62.8 MHz, 
CDCl3):  = 31.2 (6CH3), 34.6 (C), 122.5 (q, JF,C = 3.9 Hz, CH), 123.7 (q, JF,C = 3.9 Hz, CH), 
124.2 (q, JF,C = 278 Hz, CF3), 125.5 (CH), 126.6 (C), 128.7, 128.8, 129.7 (CH), 129.9 (C), 
130.7 (d, JF,C = 32.7 Hz, C-CF3), 131.4, 146.9, 150.7. IR (KBr): v = 3023, 3060, 2953, 2911 
(w), 1782, 1760, 1556 (s), 1510, 1462 (m), 1405, 1314, 1260, 1203 (w), 1162, 1114, 1080, 
1060, 999, 948, 871 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 620 (M+, 71), 605 (26), 565 
(11), 564 (33), 492 (11), 491 (37), 479 (14), 173 (100), 161 (84), 145 (20), 57 (24), 43 (12). 
HRMS (EI, 70 eV): m/z = calcd. for C38H34OF6 [M+]: 620.25084, found: 620.250900. 
 
3,4-Diphenyl-2,5-bis(3-(trifluoromethyl)phenyl)furan (48b). Following the General 
procedure A compound 48b was prepared from 45 (102 mg, 0.20 
mmol), Pd(PPh3)4 (05 mg, 2 mol%), toluene/dioxane (4:1, 2.5 
mL), 2M K2CO3 (0.5 mL) and phenylboronic acid (54 mg, 0.44 
mmol) as a highly viscous colourless oil (87 mg, 86%). 1H NMR 
(300 MHz, CDCl3):  = 7.06-7.09 (m, 4H, ArH), 7.18-7.22 (m, 
6H, ArH), 7.29-7.46 (m, 4H, ArH), 7.57 (d, 2H, J = 7.7 Hz, ArH), 
7.69 (brs, 2H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -63.0.  13C NMR (65.5 MHz, 
CDCl3):   = 122.4 (q, JF,C = 3.9 Hz, CH), 123.9(q, JF,C = 272.7 Hz, CF3),  124.0 (q, JF,C = 3.9 
Hz, CH), 125.2 (C), 126.0, 127.7, 128.7, 128.9, 130.1 (CH), 130.9 (d, JF,C = 32.3 Hz, C-CF3), 
131.3, 132.1, 146.9 (C). IR (KBr): v = 3062, 2926 (w), 1693, 1610, 1448 (m), 1330 (s), 1166 
(m), 1122 (m), 1070, 801, 750 (m), 692 (s), 652, 579 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 
O
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508 (M+8), 368 (10), 367 (39), 257 (13), 236 (12), 173 (87), 165 (10), 145 (27), 137 (14), 135 
(13), 125 (14), 123 (15), 121 (10), 112 (12), 111 (25), 110 (13), 109 (16), 105 (100), 99 (11), 
98 (17), 97 (42), 96 (23), 95 (27), 93 (10), 91 (10), 85 (28), 84 (20), 83 (46), 82 (25), 81 (44), 
78 (13), 77 (30), 73 (13), 71 (44), 70 (24), 69 (96), 68 (17), 67 (22), 63 (11), 57 (71), 56 (21), 
55 (51), 43 (50), 41 (38). HRMS (EI, 70 eV): m/z = calcd. for C30H18OF6 [M+]: 508.12564, 
found: 508.125078. 
 
3,4-Bis(4-tolyl)-2,5-bis(3-(trifluoromethyl)phenyl)furan (48c). Following the General 
procedure A compound 48c was prepared from 45 (102 mg, 0.20 
mmol), Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane (4:1, 2.5 
mL), 2M K2CO3 (0.5 mL) and p-tolylboronic acid (60 mg, 0.44 
mmol) as a highly viscous colourless oil (100 mg, 93%). 1H NMR 
(300 MHz, CDCl3):  = 2.25 (s, 6H, CH3), 6.94-7.02 (m, 8H, 
ArH), 7.25-7.30 (m, 2H, ArH), 7.38 (d, J = 7.95, 2H, ArH), 7.55 
(d, J = 7.95, 2H, ArH),  7.71 (brs, 2H, ArH). 19F NMR (300 MHz, CDCl3):   = -63.01. 13C 
NMR (62.9 MHz, CDCl3):  = 21.3 (CH3), 122.4 (q, JF,C = 4.1 Hz, CH), 123.8 (q, JF,C = 3.8 
Hz, CH),  123.9 (q, JF,C = 272.6 Hz, CF3), 126.6 (C), 128.8 (CH), 129.1 (C), 129.4, 129.9 
(CH), 130.9 (q, JF,C = 32.4 Hz, C-CF3), 131.4, 137.4, 146.8 (C).  IR (KBr): v = 3028, 2922, 
2867 (w), 1746, 1691, 1609, 1511, 1327, 1222, 1164 (w), 1123 (s), 1071, 961, 801 (m), 693 
(s), 655, 572 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 536 [M+], 100), 363 (18). HRMS (EI, 
70 eV): m/z = calcd. for C32H22OF6 [M+]: 536.15694, found: 536.157343. 
 
3,4-Bis(3,5-dimethylphenyl)-2,5-bis(3-(trifluoromethyl)phenyl)furan (48d). Following the 
General procedure A compound 48d was prepared from 45 (102 
mg, 0.20 mmol), Pd(PPh3)4 (06 mg, 2 mol%), toluene/dioxane 
(4:1, 2.5 mL), 2M K2CO3 (0.5 mL) and 3,5-dimethylphenylboronic 
acid (66 mg, 0.44 mmol) as a highly viscous colourless oil (99 mg, 
88%). 1H NMR (300 MHz, CDCl3):   = 2.13 (s, 12H, 4CH3), 6.71 
(s, 4H, ArH), 6.82 (s, 2H, ArH), 7.27-7.39 (m, 4H, A rH), 7.56-
7.61 (m, 2H, ArH),  7.72 (brs, 2H, ArH). 19F NMR (300 MHz, CDCl3):   = -63.05. 13C NMR 
(62.9 MHz, CDCl3):   = 21.3 (CH3), 122.4 (q, JF,C = 4.1 Hz, CH), 123.7 (q, JF,C = 4.1 Hz, 
CH), 124.0 (q, JF,C = 270.3 Hz, CF3),  126.9 (C), 127.8, 128.6, 128.8, 129.3 (CH), 130.7 (q, 
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JF,C = 31.2 Hz, C-CF3),  131.5, 131.9, 137.9, 146.6 (C). IR (KBr): v = 3076, 3066, 2919, 2862 
(w), 1789, 1769, 1596 (s), 1514, 1471 (m), 1418, 1401, 1315, 1260, 1204 (w), 1164, 1111, 
1089, 1065, 1601, 1485, 1446, 1353, 1322, 1164 (m), 1113, 1072 (s), 899, 864, 797 (m), 688 
(s), 694 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 564 (M+, 100), 391 (19). HRMS (EI, 70 
eV): m/z = calcd. for C34H26OF6 [M+]: 564.18824, found: 564.188743. 
 
2,3,4-Tris(3,5-dimethylphenyl)-5-(3-(trifluoromethyl)phenyl)furan (49a). Following the 
General procedure  compound 49a was prepared from 47b (112 
mg, 0.25 mmol), Pd(PPh3)4 (09 mg, 3 mol%), dioxane 5 mL, 2M 
K2CO3 (0.5 mL) and 3,5-dimethylphenylboronic acid (123 mg, 
0.82 mmol) as a highly viscous colourless oil (113 mg, 87%). 1H 
NMR (300 MHz, CDCl3):  = 2.12 (s, 6H, 2CH3), 2.13 (s, 6H, 
2CH3), 2.17 (s, 6H, 2CH3), 6.72 (brs, 4H, ArH), 6.72 (s, 1H, 
ArH), 6.72 (brs, 2H, ArH),  7.08 (s, 2H, ArH), 7.24-7.36 (m, 2H, ArH), 7.57 (d, 1H, J = 8.0 
Hz, ArH), 7.72 (brs, 1H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -63.0.  13C NMR (62.9 
MHz, CDCl3):  = 21.1, 21.2, 21.3 (2CH3), 122.2 (q, JF,C = 3.8 Hz, CH), 123.2 (q, JF,C = 4.0 
Hz, CH), 123.7 (CH), 124.3 (q, JF,C = 276 Hz, CF3), 125.3, 126.8 (C), 127.9, 128.1, 128.5, 
128.6, 128.7, 129.0, 129.2 (CH), 130.6 (C), 130.7 (d, JF,C = 32.9 Hz, C-CF3), 131.9, 132.4, 
132.6, 137.4, 137.7, 137.8, 145.7, 148.4 (C). IR (KBr): v = 3055, 2917 (w), 1678, 1600, 1428 
(m), 1320 (s), 1101 (m), 1111 (m), 1060, 794, 740 (m), 682 (s), 651, 576 (m) cm-1. GC-MS 
(EI, 70 eV): m/z (%) = 524 (M+), 10), 423 (18), 383 (15), 173 (13), 133 (100), 105 (20). 
HRMS (EI, 70 eV): m/z = calcd. for C35H31F3 [M+]: 524.23215, found: 524.231988.  
 
2,3,4-Tris(4-tert-butylphenyl)-5-(3-(trifluoromethyl)phenyl)furan (49b). Following the 
General procedure A compound 49b was prepared from 47b 
(112 mg, 0.25 mmol), Pd(PPh3)4 (09 mg, 2 mol%), dioxane .5 
mL), 2M K2CO3 (0.5 mL) and 4-tert-butylphenylboronic acid 
(146 mg, 0.82 mmol) as a highly viscous colourless oil (141 
mg, 93%). 1H NMR (300 MHz, CDCl3):   = 1.23 (s, 9H, 
3CH3), 1.24 (s, 9H, 3CH3), 1.24 (s, 9H, 3CH3),  6.98-7.05 (m, 
4H, ArH), 7.17-7.25 (m, 8H, ArH), 7.39-7.43 (m, 2H, ArH), 7.56-7.61 (m, 2H, ArH). 19F 
NMR (282.4 MHz, CDCl3):  = -63.1.  13C NMR (62.9 MHz, CDCl3):  = 31.2, 31.3, 31.3 
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(CH3), 34.5, 34.6 (C), 122.3 (q, JF,C = 4.2 Hz, CH), 123.2 (q, JF,C = 3.9 Hz, CH), 124.2 (q, JF,C 
= 277.8 Hz, CF3), 124.6 (C), 125.1, 125.3, 125.4, 125.5 (CH), 126.6, 128.0 (C),128.4 (CH), 
128.9, 129.6 (C), 129.8, 129.9 (CH), 130.3 (q, JF,C = 31.3 Hz, C-CF3),  131.8, 145.8, 148.4, 
149.9, 150.4, 150.5 (C). IR (KBr): v = 3064, 2922 (w), 1692, 1603, 1437 (m), 1320 (s), 1155 
(m), 1103 (m), 1055, 740 (m), 682 (s), 642, 569 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 608 
(M+, 50), 593 (14), 251 (18), 173 (11), 163 (16), 162 (15), 161 (100), 57 (14). HRMS (EI, 70 
eV): m/z = calcd. for C41H43OF3 [M+]: 608.32605, found: 608.326028. 
 
11.9.5 Synthesis of 3,4,5-Tribromofurans (50a-b) 
 
To a THF solution of tetrabromofuran (96 mg, 0.25 mmol) was added of n-butyllithium (0.28 
mmol in heptane) at -78°C. After stirring for 10 min at -78 °C, the electrophile (0.28 mmol) 
was added. After warming of the mixture to 20 °C within 6 h, a saturated aqueous solution of 
NH4Cl (30 mL) was added. The organic and the aqueous layer were separated and the latter 
was extracted with ethyl acetate (2x10 mL). The combined organic layers were dried 
(Na2SO4), filtered and the solvent of the filtrate was removed under vacuum. The residue was 
purified by chromatography (fine silica gel, n-heptane). 
 
11.9.6 Metal-halide exchange reactions. Synthesis of (50a-b) 
 
Trimethyl(3,4,5-tribromofuran-2-yl)silane (50a) Following the General procedure A 
compound 50a was prepared from 45 (96 mg, 0.25 mmol), n-BuLi (0.14 
mL, 0.28 mmol), Me3SiCl (0.03 mL, 0.25 mmol), TMEDA (0.04 mL, 0.28 
mmol) in 5 mL THF. as a highly viscous colourless oil (81 mg, 87%). 1H 
NMR (250 MHz, CDCl3):   = 0.00 (s, 9H, CH3). 13C NMR (62.9 MHz, CDCl3):  = 0.00 
(CH3), 107.6, 116.5, 128.5, 162.2 (C). IR (KBr): v = 2813, 2643, 2511 (m), 1694, 1582 (s), 
1414 (m), 1263 (s), 1049, 895, 853, 760, 712, 689, 640 (m) cm-1. GC-MS (EI, 70 eV): m/z 
(%) = 381 (M+, [81Br3], 2), 379 (M+, [81Br279Br], 12), 377 (M+, [81Br279Br2], 100), 375 (M+, 
[79Br3], 99), 300 (15), 73 (13). HRMS (EI, 70 eV): m/z = calcd. for C7H9Br3OSi (M+, [81Br3]): 
381.78286, found: 414.782753; calcd. for (M+, [79Br81Br2]): 379.88210, found 379.882457; 
O SiBr
BrBr
 169  
calcd. for (M+, [79Br281Br]): 377.77609, found 377.776132; calcd. for (M+, [81Br3]): 
375.87519, found 375.875023. 
 
2-Benzyl-3,4,5-tribromofuran (50b) 
 Following the General procedure A compound 50b was prepared from 45 
(96 mg, 0.25 mmol), n-BuLi (0.14 mL, 0.28 mmol), benzylchloride (0.02 
mL, 0.25 mmol), TMEDA (0.04 mL, 0.28 mmol) in 5 mL THF. as a highly 
viscous colourless oil (91 mg, 93%). 1H NMR (250 MHz, CDCl3):   = 
3.91 (s, 2H, CH2), 7.21-7.26 (m, 5H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 33.3 (CH2), 
102.0, 105.6, 121.4 (C), 127.0, 128.4, 128.7 (CH), 136.0, 153.8 (C). IR (KBr): v = 2912, 2815 
(m), 1684, 1572 (s), 1404 (m), 1253 (s), 1040, 890, 849, 751, 689, 643 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 397 (M+, [81Br3], 13), 395 (M+, [81Br279Br], 100), 393 (M+, [81Br79Br2], 99), 
391 (M+, [79Br3], 34), 317 (36), 315 (68), 313 (34), 235 (43), 233 (41), 208 (54), 206 (53), 127 
(51), 126 (42), 103 (10), 91 (24), 77 (14), 51 (10). HRMS (EI, 70 eV): m/z = calcd. for 
C11H7Br3O (M+, [81Br3]): 381.80415, found: 391.803659; calcd. for (M+, [79Br3]): 393.80211, 
found 393.801704; calcd. for (M+, [79Br281Br]): 395.80006, found 395.799563; calcd. for (M+, 
[81Br3]): 397.79801, found 397.797494. 
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Appendix  
12. Crystallographic Data  
 
12.1 Crystal data and structure refinement for Ethyl 3-(bis(4 fluorophenyl)methyl)-6-
hydroxy-2,4,5-trimethylbenzoate  (8d) 
 
Table 29.  Crystal data and structure refinement for (8d) 
Identification code      rk168 
Empirical formula      C25H24F2O3 
Formula weight      410.44 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Triclinic,  
Space group (H.-M.)      P   
Space group (Hall)      -P 1 
Unit cell dimensions     a = 10.605 (6) Å      = 68.615 (14)° 
       b = 10.646 (8) Å       = 62.324 (10)° 
       c = 11.003 (6) Å      
 = 89.512 (16)° 
Volume      1004.7 (10) Å3 
Z       2 
Density (calculated)     1.357Mg m3 
Absorption coefficient    0.10 mm-1 
F(000)       1808 
Crystal size      0.81 × 0.71 × 0.28 mm 
 range for data collection    5.5 to 59.9° 
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Index ranges      -14h14, -14k14, -14l15 
Reflections collected     5264 
Independent reflections    4638 [R(int) = 0.042] 
Absorption correction     multi-scan 
Max. and min. transmission    0.924 and 0.973 
Refinement method     Full-matrix  
restraints / parameters     0 /260 
Goodness-of-fit on F2     1.02 
Final R indices [I>2	(I)]    R1 = 0.0524, wR2 = 0.1241 
R indices (all data)     R1 = 0.1014, wR2 = 0.1376 
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12.2 Crystal data and structure refinement for Benzyl 3-(1-(4-bromophenyl)ethyl)-6-
hydroxy-2,4-dimethylbenzoate (8m) 
Table 30.  Crystal data and structure refinement for  (8m) 
Identification code      rk159 
Empirical formula      C24H23BrO3 
Formula weight      439.33 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)      C2/c 
Space group (Hall)      -C 2yc 
Unit cell dimensions     a = 20.984 (17) Å      
       b = 10.76 (1) Å         = 107.158 (15)°
       c = 18.696 (16) Å       
Volume      4034 (6) Å3 
Z       8 
Density (calculated)     1.447Mg m3 
Absorption coefficient    2.06 mm-1 
F(000)       1808 
Crystal size      0.81 × 0.54 × 0.36 mm 
 range for data collection    6.9 to 67.5° 
Index ranges      -29h29, -15k15, -26l24 
Reflections collected     5860 
Independent reflections    5860 [R(int) = 0.045] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.904 and 0.989 
Refinement method     Full-matrix  
restraints / parameters     0 /260 
Goodness-of-fit on F2     1.03 
Final R indices [I>2	(I)]    R1 = 0.0514, wR2 = 0.1231 
R indices (all data)     R1 = 0.1004, wR2 = 0.1366 
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12.3 Crystal data and structure refinement for 2-(Phenyl)-6-phenyl-2H-pyran-4(3H)-one 
(11i). 
Table 31.  Crystal data and structure refinement for (11i)  
Identification code      rk137 
Empirical formula      C17H14O2 
Formula weight      250.28 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)       P21/c 
Space group (Hall)      -P 2ybc 
Unit cell dimensions     a = 12.1517 (5) Å   
       b = 5.8375 (3) Å       = 107.397 (2)° 
c = 19.2787 (9) Å  
Volume      1304.99 (11) Å3 
Z       4 
Density (calculated)     1.274Mg/m3 
Absorption coefficient    0.08mm-1 
F(000)       528 
Crystal size      0.37 × 0.19 × 0.16mm 
 range for data collection    7.3 to 65.2° 
Index ranges      -16h17,-5k8,-27l25 
Reflections collected     15043 
Independent reflections    3791 [R(int) = 0.041] 
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Absorption correction      multi-scan 
Refinement method      Full-matrix  
Data/restraints / parameters     188 
Goodness-of-fit on F2      1.060 
Final R indices [I>2	(I)]     R1 = 0.0469, wR2 = 0.130 
R indices (all data)      R1  0.047, wR2 = 0.130 
Largest diff. peak and hole     0.169 and -0.205 e.Å-3 
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12.4 Crystal data and structure refinement for 2-(3-bromophenyl)-6-phenyl-2H-
pyran-4(3H)-one  (11m) 
Table 32.  Crystal data and structure refinement for (11m) 
Identification code      rk138 
Empirical formula      C17H13BrO2 
Formula weight      329.18  
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)      P21/n 
Space group (Hall)      -P 2yn 
Unit cell dimensions     a = 8.833 (15) Å  
       b = 9.953 (16) Å  = 105.87 (2)° 
       c = 15.95 (3) Å  
Volume      1349 (4) Å3 
Z       4 
Density (calculated)     1.621 Mg m3 
Absorption coefficient    0.147 mm-1 
F(000)       664 
Crystal size      0.85 × 0.48 × 0.18 mm 
 range for data collection    6.3 to 59.4° 
Index ranges      -12h12, -10k14, -22l20 
Reflections collected     12768 
Independent reflections    3860 [R(int) = 0.041] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.978 and 0.929 
Refinement method     Full-matrix  
restraints / parameters     0 /198 
Goodness-of-fit on F2     1.03 
Final R indices [I>2	(I)]    R1 = 0.0524, wR2 = 0.1241 
R indices (all data)     R1 = 0.1014, wR2 = 0.1376 
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12.5 Crystal data and structure refinement 2-(2-chloro-4-(trifluoromethyl)phenyl)-6-
methyl-2H-pyran-4(3H)-one (16c)  
 
Table 33.  Crystal data and structure refinement for (16c) 
Identification code      rk317 
Empirical formula      C13H10ClF3O2 
Formula weight      290.66 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)      P21/n 
Space group (Hall)       -P 2yn 
Unit cell dimensions  a = 12.5015 (3) Å                                                                
b = 8.5069 (2) Å  = 104.911 (1)° 
                c = 12.5928 (3) Å 
 Volume      1294.14 (5) Å3 
Z       4 
Density (calculated)     1.492 Mg m3 
Absorption coefficient    0.33 mm-1 
F(000)       592 
Crystal size      0.88 × 0.34 × 0.21 mm 
 range for data collection    5.8 to 59.9° 
Index ranges      -17h17, -11k10, -15l17 
Reflections collected     14181 
Independent reflections    3059 [R(int) = 0.019] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.763 and 0.935 
Refinement method     Full-matrix  
restraints / parameters     0 /201 
Goodness-of-fit on F2     1.08 
Final R indices [I>2	(I)]    R1 = 0.0514, wR2 = 0.1211 
R indices (all data)     R1 = 0.1034, wR2 = 0.1346 
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12.6 Crystal data and structure refinement for 2-benzoyl-5-((4-methoxyphenyl) 
ethynyl)phenyl trifluoromethanesulfonate (25c) 
Table 34.  Crystal data and structure refinement for (25c) 
Identification code      rk245 
Empirical formula      C23H15F3O5S 
Formula weight      460.41  
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Triclinic 
Space group (H.-M.)      P  
Space group (Hall)      -P 1 
Unit cell dimensions     a = 10.331 (7) Å       = 87.53 (3)°  
       b = 12.233 (9) Å        = 76.243 (19)° 
       c = 17.833 (13) Å      
 = 73.62 (2)° 
Volume      2100 (3) Å3 
Z       4 
Density (calculated)     1.457Mg m3 
Absorption coefficient    0.21 mm-1 
F(000)       944 
Crystal size      0.48 × 0.23 × 0.05 mm 
 range for data collection    7.7 to 57.8° 
Index ranges      -12h13, -12k15, -23l23 
Reflections collected     35297 
Independent reflections    9431 [R(int) = 0.045] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.904 and 0.989 
Refinement method     Full-matrix  
restraints / parameters     0 /579 
Goodness-of-fit on F2     1.02 
Final R indices [I>2	(I)]    R1 = 0.0523, wR2 = 0.1245 
R indices (all data)     R1 = 0.1024, wR2 = 0.1366 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12.7 Crystal data and structure refinement 2,4'-sulfonylbis((p-tolylethynyl)benzene) 
(31b)  
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Table 35.  Crystal data and structure refinement for (31b) 
Identification code      rk197 
Empirical formula      C30H22O2S 
Formula weight      446.54 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Triclinic 
Space group (H.-M.)      Pi 
Space group (Hall)      -P 1 
Unit cell dimensions     a = 13.60 (2) Å        = 116.478 (19)° 
                                                                                     b = 13.699 (11) Å      = 99.78 (4)° 
       c = 14.695 (12) Å     
 = 98.96 (3)° 
Volume      2331 (4) Å3 
Z       4 
Density (calculated)     1.272Mg m3 
Absorption coefficient    0.16 mm-1 
F(000)       936 
Crystal size      0.99 × 0.23 × 0.15 mm 
 range for data collection    6.8 to 59.9° 
Index ranges      -19h19, -19k19, -20l20 
Reflections collected     46473 
Independent reflections    46473 [R(int) = 0.042] 
Absorption correction     multi-scan 
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Max. and min. transmission    0.855 and 0.976 
Refinement method     Full-matrix  
restraints / parameters     0 /599 
Goodness-of-fit on F2     1.01 
Final R indices [I>2	(I)]    R1 = 0.0514, wR2 = 0.1231 
R indices (all data)     R1 = 0.1004, wR2 = 0.1276 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12.8 Crystal data and structure 2-Phenyl-3-(4-(trifluoromethyl)phenyl)-1H-inden-1-
one (37b) 
Table 37.  Crystal data and structure refinement for (37b) 
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Identification code      rk443 
Empirical formula      C 22H13F3O 
Formula weight      350.32 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)      P21/n 
Space group (Hall)      -P 2ybc 
Unit cell dimensions     a = 11.8365(7) Å  = 90.00 
       b = 9.2961 (5) Å  = 109.29 (3)° 
       c = 16.2375 (9) Å  
 = 90.00 
Volume      1386 (4) Å3 
Z       4 
Density (calculated)     1.380 Mg m3 
Absorption coefficient    0.106 mm-1 
F(000)       720 
Crystal size      0.97 × 0.53 × 0.13 mm 
 range for data collection    5.1 to 62.3° 
Index ranges      -16h12, -12k12, -22l22 
Reflections collected     4467 
Independent reflections    3407 [R(int) = 0.041] 
Absorption correction     multi-scan 
Max. and min. transmission    0.978 and 0.929 
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Refinement method     Full-matrix  
restraints / parameters     0 /263 
Goodness-of-fit on F2     1.058 
Final R indices [I>2	(I)]    R1 = 0.0667, wR2 = 0.1401 
R indices (all data)     R1 = 0.486, wR2 = 0.1301 
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12.9 Crystal data and structure refinement for 1-benzyl-3,4-dibromo-5-(4-
methoxyphenyl)-1H-pyrazole (42h) 
Table 38.  Crystal data and structure refinement for (42h) 
Identification code      rk467b 
Empirical formula      C 17H14Br2N2O 
Formula weight      422.12 
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      orthorhombic 
Space group (H.-M.)      Pbca 
Space group (Hall)      -P 2ac,2ab 
Unit cell dimensions     a = 15.2948(8) Å  = 90.00 
       b = 7.9054 (4) Å  = 101.3 (3)° 
       c = 26.5505 (14) Å  
 = 90.00 
Volume      1455 (4) Å3 
Z       4 
Density (calculated)     1.747 Mg m3 
Absorption coefficient    0.072 mm-1 
F(000)       1664 
Crystal size      0.36 × 0.27 × 0.20 mm 
 range for data collection    5.32 to 59.45° 
Index ranges      -21h21, -11k7, -36l23 
Reflections collected     18172 
Independent reflections    4569 [R(int) = 0.031] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.988 and 0.989 
Refinement method     Full-matrix  
restraints / parameters     0 /200 
Goodness-of-fit on F2     1.054 
Final R indices [I>2	(I)]    R1 = 0.0588, wR2 = 0.664 
R indices (all data)     R1 = 0.300, wR2 = 0.622 
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12.10 Crystal data and structure refinement for 2,3,4,5-tetrakis(4-
(trifluoromethyl)phenyl)furan (49c) 
Table 36.  Crystal data and structure refinement for (49c) 
Identification code      rk321 
Empirical formula      C32H16F12O 
Formula weight      644.45  
Temperature       173(2) K 
Wavelength       0.71073 Å 
Crystal system      Monoclinic 
Space group (H.-M.)      P21/n 
Space group (Hall)      -P 2yn 
Unit cell dimensions     a = 10.4995 (3) Å  
       b = 10.2082 (3) Å  = 99.821 (2)° 
       c = 26.4963 (8) Å  
Volume      2798.28 (14) Å3 
Z       4 
Density (calculated)     1.530 Mg m3 
Absorption coefficient    0.147 mm-1 
F(000)       1296 
Crystal size      0.51 × 0.23 × 0.15 mm 
 range for data collection    5.6 to 46.1° 
Index ranges      -13h13, -13k12, -34l34 
Reflections collected     26676 
Independent reflections    6752 [R(int) = 0.039] 
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Absorption correction     multi-scan 
Max. and min. transmission    0.978 and 0.929 
Refinement method     Full-matrix  
restraints / parameters     0/490 
Goodness-of-fit on F2     1.052 
Final R indices [I>2	(I)]    R1 = 0.0524, wR2 = 0.1241 
R indices (all data)     R1 = 0.1014, wR2 = 0.1376 
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